10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

FORM 10-Q 

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the quarterly period ended April 30, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from                                to                                     .

Commission File No. 001-34807

Verint Systems Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		11-3200514
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)
175 Broadhollow Road
Melville,	New York	11747
(Address of Principal Executive Offices)		(Zip Code)

	(631)	962-9600
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
		The NASDAQ Stock Market, LLC
Common Stock, $.001 par value per share	VRNT	(NASDAQ Global Select Market)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☑

There were 64,286,441 shares of the registrant’s common stock outstanding on May 15, 2023.

Verint Systems Inc. and Subsidiaries
Index to Form 10-Q
As of and For the Period Ended April 30, 2023
		Page
Cautionary Note on Forward-Looking Statements		ii
Part I.	Financial Information	1
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	2
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Income (Loss)	4
	Condensed Consolidated Statements of Stockholders’ Equity	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	32
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	46
Item 4.	Controls and Procedures	48
Part II.	Other Information	49
Item 1.	Legal Proceedings	49
Item 1A.	Risk Factors	49
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	49
Item 3.	Defaults Upon Senior Securities	49
Item 4.	Mine Safety Disclosures	50
Item 5.	Other Information	50
Item 6.	Exhibits	51
Signature		52

i

Cautionary Note on Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include, but are not limited to, financial projections, statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. Forward-looking statements may appear throughout this report, including without limitation, in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, and are often identified by future or conditional words such as “will”, “plans”, “expects”, “intends”, “believes”, “seeks”, “estimates”, or “anticipates”, or by variations of such words or by similar expressions. There can be no assurance that forward-looking statements will be achieved. By their very nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause our actual results or conditions to differ materially from those expressed or implied by such forward-looking statements. Important risks, uncertainties, assumptions, and other factors that could cause our actual results or conditions to differ materially from our forward-looking statements include, among others:

•uncertainties regarding the impact of changes in macroeconomic and/or global conditions, including as a result of slowdowns, recessions, economic instability, rising interest rates, tightening credit markets, inflation, instability in the banking sector, political unrest, armed conflicts (such as the Russian invasion of Ukraine), actual or threatened trade wars, natural disasters, or outbreaks of disease (such as the COVID-19 pandemic), as well as the resulting impact on spending by customers or partners, on our business;

•risks that our customers or partners delay, downsize, cancel, or refrain from placing orders, or renewing subscriptions or contracts, or are unable to honor contractual commitments or payment obligations due to challenges or uncertainties in their budgets, liquidity, or businesses;

•risks associated with our ability to keep pace with technological advances and challenges and evolving industry standards, including achieving and maintaining the competitive differentiation of our solution platform; to adapt to changing market potential from area to area within our markets; and to successfully develop, launch, and drive demand for new, innovative, high-quality products and services that meet or exceed customer challenges and needs, while simultaneously preserving our legacy businesses and migrating away from areas of commoditization;

•risks due to aggressive competition in all of our markets and our ability to keep pace with competitors, some of whom may be able to grow faster than us or have greater resources than us, including in areas such as sales and marketing, branding, technological innovation and development, and recruiting and retention;

•risks associated with our ability to properly execute on our SaaS transition, including successfully transitioning customers to our cloud platform and the increased importance of subscription renewal rates, and risk of increased variability in our period-to-period results based on the mix, terms, and timing of our transactions;

•risks relating to our ability to properly identify and execute on growth or strategic initiatives, manage investments in our business and operations, and enhance our existing operations and infrastructure, including the proper prioritization and allocation of limited financial and other resources;

•risks associated with our ability to or costs to retain, recruit, and train qualified personnel and management in regions in which we operate either physically or remotely, including in new markets and growth areas we may enter, due to competition for talent, increased labor costs, applicable regulatory requirements, or otherwise;

•challenges associated with selling sophisticated solutions and cloud-based solutions, which may incorporate newer technologies whose adoption and use-cases are still emerging, including with respect to longer sales cycles, more complex sales processes and customer approval processes, more complex contractual and information security requirements, and assisting customers in understanding and realizing the benefits of our solutions and technologies, as well as with developing, offering, implementing, and maintaining an enterprise-class, broad solution portfolio;

•risks that we may be unable to maintain, expand, and enable our relationships with partners as part of our growth strategy while avoiding excessive concentration with any one partner;

•risks associated with our reliance on third-party suppliers, partners, or original equipment manufacturers (“OEMs”) for certain services, products, or components, including companies that may compete with us or work with our competitors;

ii

•risks associated with our significant international operations, including exposure to regions subject to political or economic instability, fluctuations in foreign exchange rates, inflation, increased financial accounting and reporting burdens and complexities, and challenges associated with a significant portion of our cash being held overseas;

•risks associated with a significant part of our business coming from government contracts and associated procurement processes and regulatory requirements;

•risks associated with our ability to identify suitable targets for acquisition or investment or successfully compete for, consummate, and implement mergers and acquisitions, including risks associated with valuations, legacy liabilities, reputational considerations, capital constraints, costs and expenses, maintaining profitability levels, expansion into new areas, management distraction, post-acquisition integration activities, and potential asset impairments;

•risks associated with complex and changing domestic and foreign regulatory environments, including, among others, with respect to data privacy, artificial intelligence, information security, government contracts, anti-corruption, trade compliance, climate change or other environmental, social and governance matters, tax, and labor matters, relating to our own operations, the products and services we offer, and/or the use of our solutions by our customers;

•risks associated with the mishandling or perceived mishandling of sensitive or confidential information and data, including personally identifiable information or other information that may belong to our customers or other third parties, including in connection with our software as a service (“SaaS”) or other hosted or managed services offerings or when we are asked to perform service or support;

•risks associated with our reliance on third parties to provide certain cloud hosting or other cloud-based services to us or our customers, including the risk of service disruptions, data breaches, or data loss or corruption;

•risks that our solutions or services, or those of third-party suppliers, partners, or OEMs which we use in or with our offerings or otherwise rely on, including third-party hosting platforms, may contain defects, vulnerabilities, or develop operational problems;

•risk that we or our solutions may be subject to security vulnerabilities or lapses, including cyber-attacks, information technology system breaches, failures, or disruptions;

•risks that our intellectual property rights may not be adequate to protect our business or assets or that others may make claims on our intellectual property, claim infringement on their intellectual property rights, or claim a violation of their license rights, including relative to free or open source components we may use;

•risks associated with significant leverage resulting from our current debt position or our ability to incur additional debt, including with respect to liquidity considerations, covenant limitations and compliance, fluctuations in interest rates, dilution considerations (with respect to our convertible notes), and our ability to maintain our credit ratings;

•risks that we may experience liquidity or working capital issues and related risks that financing sources may be unavailable to us on reasonable terms or at all;

•risks arising as a result of contingent or other obligations or liabilities assumed in our acquisition of our former parent company, Comverse Technology, Inc. (“CTI”), or associated with formerly being consolidated with, and part of a consolidated tax group with, CTI, or as a result of the successor to CTI’s business operations, Mavenir Inc. (“Mavenir”), being unwilling or unable to provide us with certain indemnities to which we are entitled;

•risks associated with changing accounting principles or standards, tax laws and regulations, tax rates, and the continuing availability of expected tax benefits;

•risks relating to the adequacy of our existing infrastructure, systems, processes, policies, procedures, internal controls, and personnel, and our ability to successfully implement and maintain enhancements to the foregoing, for our current and future operations and reporting needs, including related risks of financial statement omissions, misstatements, restatements, or filing delays;

•risks associated with market volatility in the prices of our common stock and convertible notes based on our performance, third-party publications or speculation, or other factors, and risks associated with actions of activist stockholders;

•risks associated with Apax Partners’ significant ownership position and potential that its interests will not be aligned with those of our common stockholders; and

iii

•risks associated with the February 1, 2021 spin-off of our former Cyber Intelligence Solutions business, including the possibility that the spin-off transaction does not achieve the benefits anticipated, does not qualify as a tax-free transaction, or exposes us to unexpected claims or liabilities.

These risks, uncertainties, assumptions, and challenges, as well as other factors, are discussed in greater detail in “Risk Factors” under Item 1A of our Annual Report on Form 10-K for the year ended January 31, 2023. You are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date of this report. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances after the date any such statement is made, except as otherwise required under the federal securities laws. If we were in any particular instance to update or correct a forward-looking statement, investors and others should not conclude that we would make additional updates or corrections thereafter except as otherwise required under the federal securities laws.

iv

Part I

Item 1.   Financial Statements

VERINT SYSTEMS INC. AND SUBSIDIARIES
Index to Condensed Consolidated Financial Statements (Unaudited)
	Page
Condensed Consolidated Balance Sheets as of April 30, 2023 and January 31, 2023	2
Condensed Consolidated Statements of Operations for the Three Months Ended April 30, 2023 and 2022	3
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended April 30, 2023 and 2022	4
Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended April 30, 2023 and 2022	5
Condensed Consolidated Statements of Cash Flows for the Three Months Ended April 30, 2023 and 2022	6
Notes to Condensed Consolidated Financial Statements	7

1

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Unaudited)

	April 30,		January 31,
(in thousands, except share and per share data)	2023		2023
Assets
Current Assets:
Cash and cash equivalents	$	260,719	$	282,099
Short-term investments	3,646		697
Accounts receivable, net of allowance for credit losses of $1.4 million and $1.3 million, respectively	157,786		188,414
Contract assets, net	58,862		60,444
Inventories	13,553		12,628
Prepaid expenses and other current assets	62,079		75,374
Total current assets	556,645		619,656
Property and equipment, net	61,511		64,810
Operating lease right-of-use assets	35,128		37,649
Goodwill	1,354,761		1,347,213
Intangible assets, net	77,457		85,272
Other assets	152,913		159,001
Total assets	$	2,238,415	$	2,313,601
Liabilities, Temporary Equity, and Stockholders' Equity
Current Liabilities:
Accounts payable	$	33,878	$	43,631
Accrued expenses and other current liabilities	152,761		155,944
Contract liabilities	254,418		271,476
Total current liabilities	441,057		471,051
Long-term debt	409,672		408,908
Long-term contract liabilities	15,914		18,047
Operating lease liabilities	39,198		40,744
Other liabilities	72,865		80,381
Total liabilities	978,706		1,019,131
Commitments and Contingencies
Temporary Equity:
Preferred Stock — $0.001 par value; authorized 2,207,000 shares
Series A Preferred Stock; 200,000 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively; aggregate liquidation preference and redemption value of $203,467 and $206,067 at April 30, 2023 and January 31, 2023, respectively.	200,628		200,628
Series B Preferred Stock; 200,000 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively; aggregate liquidation preference and redemption value of $203,467 and $206,067 at April 30, 2023 and January 31, 2023, respectively.	235,693		235,693
Total temporary equity	436,321		436,321
Stockholders' Equity:
Common stock — $0.001 par value; authorized 240,000,000 shares; issued 64,286,000 and 65,404,000 shares; outstanding 64,286,000 and 65,404,000 shares at April 30, 2023 and January 31, 2023, respectively.	64		65
Additional paid-in capital	1,008,498		1,055,157
Accumulated deficit	(42,038)		(45,333)
Accumulated other comprehensive loss	(145,589)		(154,099)
Total Verint Systems Inc. stockholders' equity	820,935		855,790
Noncontrolling interest	2,453		2,359
Total stockholders' equity	823,388		858,149
Total liabilities, temporary equity, and stockholders' equity	$	2,238,415	$	2,313,601

See notes to condensed consolidated financial statements.

2

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended April 30,
(in thousands, except per share data)	2023		2022
Revenue:
Recurring	$	166,439	$	159,367
Nonrecurring	50,127		58,539
Total revenue	216,566		217,906
Cost of revenue:
Recurring	39,643		41,028
Nonrecurring	26,795		32,068
Amortization of acquired technology	1,965		3,639
Total cost of revenue	68,403		76,735
Gross profit	148,163		141,171
Operating expenses:
Research and development, net	31,782		30,947
Selling, general and administrative	101,279		102,882
Amortization of other acquired intangible assets	6,330		6,844
Total operating expenses	139,391		140,673
Operating income	8,772		498
Other income (expense), net:
Interest income	1,982		199
Interest expense	(2,781)		(1,501)
Other income, net	24		1,674
Total other (expense) income, net	(775)		372
Income before provision for income taxes	7,997		870
Provision for income taxes	4,363		296
Net income	3,634		574
Net income attributable to noncontrolling interests	339		288
Net income attributable to Verint Systems Inc.	3,295		286
Dividends on preferred stock	(5,200)		(5,200)
Net loss attributable to Verint Systems Inc. common shares	$	(1,905)	$	(4,914)
Net loss per common share attributable to Verint Systems Inc.:
Basic	$	(0.03)	$	(0.08)
Diluted	$	(0.03)	$	(0.08)
Weighted-average common shares outstanding:
Basic	64,940		64,947
Diluted	64,940		64,947

See notes to condensed consolidated financial statements.

3

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited) 

	Three Months Ended April 30,
(in thousands)	2023		2022
Net income	$	3,634	$	574
Other comprehensive income (loss), net of reclassification adjustments:
Foreign currency translation adjustments	8,612		(29,890)
Net decrease from foreign exchange contracts designated as hedges	(123)		(188)
Benefit from income taxes on net decrease from foreign exchange contracts designated as hedges	21		33
Other comprehensive income (loss)	8,510		(30,045)
Comprehensive income (loss)	12,144		(29,471)
Comprehensive income attributable to noncontrolling interests	339		288
Comprehensive income (loss) attributable to Verint Systems Inc.	$	11,805	$	(29,759)

See notes to condensed consolidated financial statements.

4

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

	Verint Systems Inc. Stockholders’ Equity
	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Loss		Total Verint Systems Inc. Stockholders’ Equity				Total Stockholders’ Equity
(in thousands)	Shares	Par Value				Treasury Stock		Accumulated Deficit						Non-controlling Interests
Balances as of January 31, 2023	65,404	$	65	$	1,055,157	$	—	$	(45,333)	$	(154,099)	$	855,790	$	2,359	$	858,149
Net income	—	—		—		—		3,295		—		3,295		339		3,634
Other comprehensive income	—	—		—		—		—		8,510		8,510		—		8,510
Stock-based compensation — equity-classified awards	—	—		13,436		—		—		—		13,436		—		13,436
Common stock issued for stock awards and stock bonuses	475	—		—		—		—		—		—		—		—
Common stock repurchased and retired	(1,593)	(1)		(60,095)		—		—		—		(60,096)		—		(60,096)
Distribution to noncontrolling interest	—	—		—		—		—		—		—		(245)		(245)
Balances as of April 30, 2023	64,286	$	64	$	1,008,498	$	—	$	(42,038)	$	(145,589)	$	820,935	$	2,453	$	823,388
Balances as of January 31, 2022	66,211	$	66	$	1,125,152	$	—	$	(54,509)	$	(118,515)	$	952,194	$	2,385	$	954,579
Net income	—	—		—		—		286		—		286		288		574
Other comprehensive loss	—	—		—		—		—		(30,045)		(30,045)		—		(30,045)
Stock-based compensation — equity-classified awards	—	—		16,011		—		—		—		16,011		—		16,011
Common stock issued for stock awards and stock bonuses	466	1		(1)		—		—		—		—		—		—
Treasury stock acquired	(2,000)	—		—		(105,666)		—		—		(105,666)		—		(105,666)
Balances as of April 30, 2022	64,677	$	67	$	1,141,162	$	(105,666)	$	(54,223)	$	(148,560)	$	832,780	$	2,673	$	835,453

See notes to condensed consolidated financial statements.

5

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended April 30,
(in thousands)	2023		2022
Cash flows from operating activities:
Net income	$	3,634	$	574
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,503		18,048
Stock-based compensation, excluding cash-settled awards	14,814		18,364
Losses on early retirements of debt	237		—
Other, net	45		2,163
Changes in operating assets and liabilities, net of effects of business combinations and divestitures:
Accounts receivable	31,124		41,766
Contract assets	1,923		4,024
Inventories	(937)		68
Prepaid expenses and other assets	21,278		(8,686)
Accounts payable and accrued expenses	(6,821)		(5,694)
Contract liabilities	(19,245)		(9,645)
Deferred income taxes	90		(1,074)
Other, net	(3,638)		(5,982)
Net cash provided by operating activities	60,007		53,926
Cash flows from investing activities:
Purchases of property and equipment	(4,923)		(5,224)
Maturities and sales of investments	232		250
Purchases of investments	(3,180)		(250)
Cash paid for capitalized software development costs	(1,868)		(2,003)
Change in restricted bank time deposits, and other investing activities, net	(1,019)		20
Net cash used in investing activities	(10,758)		(7,207)
Cash flows from financing activities:
Proceeds from borrowings	100,000		—
Repayments of borrowings and other financing obligations	(100,530)		(775)
Payments of debt-related costs	(9)		(93)
Purchases of treasury stock and common stock for retirement	(60,294)		(105,213)
Preferred stock dividend payments	(10,400)		(10,400)
Distributions paid to noncontrolling interest	(245)		—
Payments of contingent consideration for business combinations (financing portion), and other financing activities	(8)		(1,549)
Net cash used in financing activities	(71,486)		(118,030)
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents	859		(2,431)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	(21,378)		(73,742)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	282,161		358,868
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$	260,783	$	285,126
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period to the condensed consolidated balance sheets:
Cash and cash equivalents	$	260,719	$	285,046
Restricted cash and cash equivalents included in prepaid expenses and other current assets	6		23
Restricted cash and cash equivalents included in other assets	58		57
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	$	260,783	$	285,126

See notes to condensed consolidated financial statements.

6

VERINT SYSTEMS INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

1.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Description of Business

Unless the context otherwise requires, the terms “Verint”, “we”, “us”, and “our” in these notes to condensed consolidated financial statements refer to Verint Systems Inc. and its consolidated subsidiaries.

Verint helps brands provide Boundless Customer Engagement™. For more than two decades, the world’s most iconic brands – including more than 85 of the Fortune 100 companies – have trusted Verint to provide the technology and domain expertise they require to effectively build enduring customer relationships.

Through the Verint Customer Engagement Cloud Platform, we offer our customers and partners solutions that are based on artificial intelligence (“AI”) and are developed specifically for customer engagement. These solutions automate workflows across enterprise silos to optimize the workforce expense and at the same time drive an elevated consumer experience. Our solutions are used by approximately 10,000 organizations in over 175 countries across a diverse set of verticals, including financial services, healthcare, utilities, technology, and government. Our customers include large enterprises with thousands of employees, as well as small to medium sized business organizations.

Verint is headquartered in Melville, New York, and has approximately 30 offices worldwide. We have approximately 4,200 passionate employees plus a few hundred contractors around the globe exclusively focused on helping brands provide Boundless Customer Engagement™.

Spin-Off of Cognyte Software Ltd.

On February 1, 2021, we completed the spin-off (the “Spin-Off”) of Cognyte Software Ltd. (“Cognyte”), a company limited by shares incorporated under the laws of the State of Israel whose business and operations consist of our former Cyber Intelligence Solutions business. The Spin-Off of Cognyte was completed by way of a pro rata distribution in which holders of Verint’s common stock, par value $0.001 per share, received one ordinary share of Cognyte, no par value, for every share of common stock of Verint held of record as of the close of business on January 25, 2021. After the distribution, we do not beneficially own any ordinary shares of Cognyte and no longer consolidate Cognyte into our financial results for periods ending after January 31, 2021. The Spin-Off was intended to be generally tax-free to our stockholders for U.S. federal income tax purposes.

Apax Convertible Preferred Stock Investment

On December 4, 2019, we announced that an affiliate (the “Apax Investor”) of Apax Partners (“Apax”) would make an investment in us in an amount of up to $400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the “Investment Agreement”), on May 7, 2020, the Apax Investor purchased $200.0 million of our Series A convertible preferred stock (“Series A Preferred Stock”). In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock (the “Series B Preferred Stock” and together with the Series A Preferred Stock, the “Preferred Stock”). As of April 30, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 9, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment.

Preparation of Condensed Consolidated Financial Statements

The condensed consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and on the same basis as the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the U.S. Securities and Exchange Commission (“SEC”), except for the recently adopted accounting pronouncements described below. The condensed consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the periods ended April 30, 2023 and 2022, and the condensed consolidated balance sheet as of April 30, 2023, are not audited but reflect all adjustments that, in the opinion of management, are of a normal recurring nature and that are considered necessary for a fair presentation of the results for the periods shown. The condensed consolidated balance sheet as of January 31, 2023 is derived from the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended January 31, 2023. Certain information and disclosures normally included in annual consolidated financial statements have been omitted

7

pursuant to the rules and regulations of the SEC. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the SEC. The results for interim periods are not necessarily indicative of a full year’s results.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our condensed consolidated balance sheet, but separately from our stockholders’ equity.

Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment.

We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Significant Accounting Policies

There have been no material changes in our significant accounting policies during the three months ended April 30, 2023, as compared to the significant accounting policies described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023.

Recently Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which adds contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with revenue recognition guidance. We adopted this standard on a prospective basis for the annual and interim periods beginning February 1, 2023. The adoption of this standard did not have any impact on our condensed consolidated financial statements as the ultimate impact is dependent on the size and frequency of future acquisitions and does not affect contract assets or contract liabilities related to acquisitions completed prior to the adoption date.

In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extends the period of time entities can utilize the reference rate reform relief guidance under ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting from December 31, 2022 to December 31, 2024. We expect to elect various optional expedients for contract modifications related to financial instruments affected by the reference rate reform through the effective date of December 31, 2024, as extended by ASU 2022-06. The application of this guidance did not have any impact on our consolidated financial statements.

In August 2022, the Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new book minimum tax of 15% on consolidated adjusted GAAP pre-tax earnings for corporations with average income in excess of $1 billion and is effective for us in tax years beginning after December 31, 2022. We do not expect to be subject to the corporate minimum tax. In addition, the IRA also introduced a nondeductible 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. During the three months ended April 30, 2023 the calculated excise tax was $0.4 million and was recognized as part of the cost basis of shares acquired in our consolidated statement of stockholders' equity. We do not expect taxes due on future repurchases of our shares to have a material effect on our business.

8

New Accounting Pronouncements Not Yet Effective

There are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on our condensed consolidated financial statements and related disclosures.

2.    REVENUE RECOGNITION

We derive our revenue primarily from providing customers the right to access our cloud-based solutions, the right to use our software for an indefinite or specified period of time, and related services and support based on when access or control of the software passes to our customers or the services are provided, in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. Revenue is reported net of applicable sales and use tax, value-added tax and other transaction taxes imposed on the related transactions, including mandatory government charges that are passed through to our customers.

We determine revenue recognition through the following five steps:

•Identification of the contract, or contracts, with a customer

•Identification of the performance obligations in the contract

•Determination of the transaction price

•Allocation of the transaction price to the performance obligations in the contract

•Recognition of revenue when, or as, performance obligations are satisfied.

We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.

Disaggregation of Revenue

The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions.

•Recurring revenue primarily consists of:

◦Cloud revenue, which consists primarily of software as a service (“SaaS”) revenue and optional managed services revenue.

▪SaaS revenue consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period).

▪Bundled SaaS revenue is recognized over time.

▪Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one- and three-year time frame. Unbundled SaaS can be deployed in the cloud, either by us or a cloud partner.

◦Support revenue, which consists of initial and renewal support.

•Nonrecurring revenue primarily consists of our perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties.

9

	Three Months Ended April 30,
(in thousands)	2023		2022
Recurring revenue:
Bundled SaaS revenue	$	59,453	$	49,285
Unbundled SaaS revenue	57,695		45,445
Optional managed services revenue	12,865		15,913
Total cloud revenue	130,013		110,643
Support revenue	36,426		48,724
Total recurring revenue	166,439		159,367
Nonrecurring revenue:
Perpetual revenue	24,334		33,258
Professional services revenue	25,793		25,281
Total nonrecurring revenue	50,127		58,539
Total revenue	$	216,566	$	217,906

Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:

(in thousands)	April 30, 2023		January 31, 2023
Accounts receivable, net	$	157,786	$	188,414
Contract assets, net	$	58,862	$	60,444
Long-term contract assets, net (included in other assets)	$	35,845	$	37,950
Contract liabilities	$	254,418	$	271,476
Long-term contract liabilities	$	15,914	$	18,047

We receive payments from customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to multi-year unbundled SaaS contracts and arrangements where our right to consideration is subject to the contractually agreed upon billing schedule. We expect billing and collection of a majority of our contract assets to occur within the next twelve months and asset impairment charges related to contract assets were immaterial in the three months ended April 30, 2023 and 2022. As of April 30, 2023, two partners, both authorized global resellers of our solutions, accounted for more than 10% of our aggregated accounts receivable and contract assets; Partner A was approximately 22% and Partner B was approximately 15%. As of January 31, 2023, Partner A and Partner B each accounted for approximately 15% of our aggregated accounts receivable and contract assets. Credit losses relating to these customers have historically been immaterial.

Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract. Revenue recognized during the three months ended April 30, 2023 and 2022 from amounts included in contract liabilities at the beginning of each period was $101.5 million and $96.9 million, respectively.

Remaining Performance Obligations

Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The majority of our arrangements are for periods of up to three years, with a significant portion being one year or less.

We elected to exclude amounts of variable consideration attributable to sales- or usage-based royalties in exchange for a license of our IP from the remaining performance obligations. The timing and amount of revenue recognition for our remaining performance obligations is influenced by several factors, including seasonality, the timing of renewals, the timing of delivery of software licenses, the average length of the contract terms, and foreign currency exchange rates.

10

The following table provides information about when we expect to recognize our remaining performance obligations:

(in thousands)	April 30, 2023		January 31, 2023
RPO:
Expected to be recognized within 1 year	$	435,708	$	464,346
Expected to be recognized in more than 1 year	256,195		262,695
Total RPO	$	691,903	$	727,041

3.    NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.

The following table summarizes the calculation of basic and diluted net loss per common share attributable to Verint Systems Inc. for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands, except per share amounts)	2023		2022
Net income	$	3,634	$	574
Net income attributable to noncontrolling interests	339		288
Net income attributable to Verint Systems Inc.	3,295		286
Dividends on preferred stock	(5,200)		(5,200)
Net loss attributable to Verint Systems Inc. for basic net loss per common share	(1,905)		(4,914)
Dilutive effect of dividends on preferred stock	—		—
Net loss attributable to Verint Systems Inc. for diluted net loss per common share	$	(1,905)	$	(4,914)
Weighted-average shares outstanding:
Basic	64,940		64,947
Dilutive effect of employee equity award plans	—		—
Dilutive effect of 2021 Notes	—		—
Dilutive effect of assumed conversion of preferred stock	—		—
Diluted	64,940		64,947
Net loss per common share attributable to Verint Systems Inc.:
Basic	$	(0.03)	$	(0.08)
Diluted	$	(0.03)	$	(0.08)

We excluded the following weighted-average potential common shares from the calculations of diluted net loss per common share during the applicable periods because their inclusion would have been anti-dilutive:

	Three Months Ended April 30,
(in thousands)	2023	2022
Common shares excluded from calculation:
Stock options and restricted stock-based awards	2,080	1,571
Series A Preferred Stock	5,498	5,498
Series B Preferred Stock	3,980	3,980

In periods for which we report a net loss attributable to Verint Systems Inc. common shares, basic net loss per common share and diluted net loss per common share are identical since the effect of all potential common shares is anti-dilutive and therefore excluded.

For the three months ended April 30, 2023, the average price of our common stock did not exceed the $62.08 per share conversion price of our 2021 Notes (as defined in Note 7, “Long-Term Debt”), and other requirements for the 2021 Notes to be

11

convertible were not met. The 2021 Notes will have a dilutive impact on net income per common share at any time when the average market price of our common stock for a quarterly reporting period exceeds the conversion price.

The Capped Calls (as defined in Note 7, “Long-Term Debt”) do not impact our diluted earnings per common share calculations as their effect would be anti-dilutive. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the $62.08 conversion price, with such reduction and/or offset subject to a cap of $100.00.

Further details regarding the 2021 Notes and Capped Calls appear in Note 7, “Long-Term Debt”.

The weighted-average common shares underlying the assumed conversion of the Preferred Stock, on an as-converted basis, were excluded from the calculations of diluted net loss per common share for the three months ended April 30, 2023 and 2022, as their effect would have been anti-dilutive. Further details regarding the Preferred Stock investment appear in Note 9, “Convertible Preferred Stock”.

4.    CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

The following tables summarize our cash, cash equivalents, and short-term investments as of April 30, 2023 and January 31, 2023:

	April 30, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	148,871	$	—	$	—	$	148,871
Money market funds	80,624		—		—		80,624
Commercial paper	30,975		—		—		30,975
U.S. Treasury bills	249		—		—		249
Total cash and cash equivalents	$	260,719	$	—	$	—	$	260,719
Short-term investments:
Bank time deposits	$	3,646	$	—	$	—	$	3,646
Total short-term investments	$	3,646	$	—	$	—	$	3,646

	January 31, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	134,289	$	—	$	—	$	134,289
Money market funds	96,941		—		—		96,941
Commercial paper	50,869		—		—		50,869
Total cash and cash equivalents	$	282,099	$	—	$	—	$	282,099
Short-term investments:
Bank time deposits	$	697	$	—	$	—	$	697
Total short-term investments	$	697	$	—	$	—	$	697

Bank time deposits which are reported within short-term investments consist of deposits held outside of the United States with maturities of greater than 90 days, or without specified maturity dates which we intend to hold for periods in excess of 90 days. All other bank deposits are included within cash and cash equivalents.

During the three months ended April 30, 2023 and 2022, proceeds from maturities and sales of short-term investments were $0.2 million and $0.3 million, respectively.

12

5.    BUSINESS COMBINATIONS AND DIVESTITURES

Three Months Ended April 30, 2023

We did not complete any business combinations during the three months ended April 30, 2023.

Year Ended January 31, 2023

During the year ended January 31, 2023, we completed two business combinations:

•In August 2022, we completed the acquisition of a company with conversational AI technology including six employees.

•In January 2023, we completed the acquisition of a provider of appointment scheduling solutions including approximately 20 employees.

These business combinations were not material to our consolidated financial statements.

The combined consideration for these business combinations was approximately $38.4 million, including $26.1 million of combined cash paid at the closings, contingent consideration with an estimated fair value of $12.2 million, and purchase price adjustments of $0.1 million. The combined consideration was partially offset by $4.2 million of combined cash received in the acquisitions. The contingent consideration had a maximum payout amount of approximately $21.4 million as of the respective acquisition dates, and is contingent upon the achievement of certain performance targets over periods extending through January 2026. Cash paid for these business combinations was funded by cash on hand.

The combined purchase prices were allocated to intangible assets, including the recognition of $6.0 million of developed technology, $4.2 million of customer relationships, and $0.1 million of trade names. The acquisitions resulted in the recognition of $25.6 million of goodwill, of which $5.1 million is deductible for income tax purposes and $20.5 million is not deductible. Included among the factors contributing to the recognition of goodwill in these transactions were synergies in products and technologies, and the addition of skilled, assembled workforces. We incurred approximately $0.2 million of acquisition related costs, which were recorded as selling, general, and administrative expenses for the three months ended April 30, 2023.

Revenue and net income (loss) attributable to these acquisitions for the three months ended April 30, 2023 were not material.

Other Business Combination Information

For the three months ended April 30, 2023 and 2022, we recorded a charge of $0.2 million and benefit of $0.2 million, respectively, within selling, general and administrative expenses for changes in the fair values of contingent consideration obligations associated with business combinations, which was based on our historical business combinations achieving certain objectives and milestones. The aggregate fair values of the remaining contingent consideration obligations associated with business combinations was $12.9 million at April 30, 2023, of which $7.1 million was recorded within accrued expenses and other current liabilities, and $5.8 million was recorded within other liabilities.

Payments of contingent consideration earned under these agreements were $0.3 million and $2.7 million for the three months ended April 30, 2023 and 2022, respectively.

Divestiture

In March 2023, we completed the sale of an insignificant product line that we inherited as part of a legacy acquisition and did not fit with our current business priorities or strategic direction. The total consideration for the sale was $0.7 million, which is payable to us in three equal installments beginning July 2023, and through March 2025. The transaction reduced goodwill by $0.3 million and intangible assets by $0.2 million and resulted in a gain of approximately $0.2 million, which was recorded within other income, net in our condensed consolidated statement of operations.

6.    INTANGIBLE ASSETS AND GOODWILL

13

Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and removed from our condensed consolidated balance sheets, consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,478	$	(396,652)	$	61,826
Acquired technology	227,375		(211,851)		15,524
Trade names	4,487		(4,380)		107
Distribution network	2,440		(2,440)		—
Total intangible assets	$	692,780	$	(615,323)	$	77,457

 

	January 31, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,013	$	(390,113)	$	67,900
Acquired technology	229,317		(212,065)		17,252
Trade names	4,479		(4,359)		120
Distribution network	2,440		(2,440)		—
Total intangible assets	$	694,249	$	(608,977)	$	85,272

Total amortization expense recorded for acquisition-related intangible assets was $8.3 million and $10.5 million for the three months ended April 30, 2023 and 2022, respectively. The reported amount of net acquisition-related intangible assets can fluctuate from the impact of changes in foreign currency exchange rates on intangible assets not denominated in U.S. dollars.

Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows:

(in thousands)
Years Ending January 31,	Amount
2024 (remainder of year)	$	24,068
2025	16,730
2026	15,346
2027	11,572
2028	6,905
2029 and thereafter	2,836
Total	$	77,457

There were no impairments of acquired intangible assets during the three months ended April 30, 2023 and 2022.

Goodwill activity for the three months ended April 30, 2023 was as follows: 

14

(in thousands)	Amount
Three Months Ended April 30, 2023
Goodwill, gross, at January 31, 2023	$	1,403,256
Accumulated impairment losses through January 31, 2023	(56,043)
Goodwill, net, at January 31, 2023	1,347,213
Foreign currency translation and other	7,408
Business combinations, including adjustments to prior period acquisitions	140
Goodwill, net, at April 30, 2023	$	1,354,761
Balance at April 30, 2023
Goodwill, gross, at April 30, 2023	$	1,410,804
Accumulated impairment losses through April 30, 2023	(56,043)
Goodwill, net, at April 30, 2023	$	1,354,761

No events or circumstances indicating the potential for goodwill impairment were identified during the three months ended April 30, 2023.

7.    LONG-TERM DEBT

The following table summarizes our long-term debt at April 30, 2023 and January 31, 2023:

	April 30,		January 31,
(in thousands)	2023		2023
2021 Notes	$	315,000	$	315,000
Term Loan	—		100,000
Revolving Credit Facility	100,000		—
Less: unamortized debt discounts and issuance costs	(5,328)		(6,092)
Total debt	409,672		408,908
Less: current maturities	—		—
Long-term debt	$	409,672	$	408,908

2021 Notes

On April 9, 2021, we issued $315.0 million in aggregate principal amount of 0.25% convertible senior notes due April 15, 2026 (the “2021 Notes”), unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum.

We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the Capped Calls described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate an interest rate swap, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of April 30, 2023, the 2021 Notes were not convertible.

We incurred approximately $8.9 million of issuance costs in connection with the 2021 Notes, which were deferred and are presented as a reduction of long-term debt, and which are being amortized as interest expense over the term of the 2021 Notes.

15

Including the impact of the deferred debt issuance costs, the effective interest rate on the 2021 Notes was approximately 0.83% at April 30, 2023.

Based on the closing market price of our common stock on April 30, 2023, the if-converted value of the 2021 Notes was less than their aggregate principal amount.

Capped Calls

In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the “Capped Calls”) with certain counterparties. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap.

The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. Our exercise rights under the Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of April 30, 2023, no Capped Calls have been exercised.

Pursuant to their terms, the Capped Calls qualify for classification within stockholders’ equity, and their fair value is not remeasured and adjusted as long as they continue to qualify for stockholders’ equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital.

Credit Agreement

On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, 2021, and 2023, as further described below (as amended, the “Credit Agreement”).

The Credit Agreement provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan originally set to mature on June 29, 2024 (the “Term Loan”), and a $300.0 million revolving credit facility maturing on April 9, 2026 (the “Revolving Credit Facility”). The Revolving Credit Facility replaced our prior $300.0 million revolving credit facility (the “Prior Revolving Credit Facility”) and is subject to increase and reduction from time to time according to the terms of the Credit Agreement. The majority of the proceeds from the Term Loan were used to repay all outstanding term loans under our prior credit agreement.

Optional prepayments of loans under the Credit Agreement are generally permitted without premium or penalty. During the three months ended April 30, 2021, in addition to our regular quarterly $1.1 million principal payment, we repaid $309.0 million of our Term Loan, reducing the outstanding principal balance to $100.0 million. On April 27, 2023, we repaid the remaining $100.0 million outstanding principal balance on our Term Loan utilizing proceeds from borrowings under our Revolving Credit Facility, along with $0.5 million of accrued interest thereon. As a result, $0.2 million of combined deferred debt issuance costs and unamortized discount associated with the Term Loan were written off and are included within interest expense on our condensed consolidated statement of operations for the three months ended April 30, 2023.

Interest rates on loans under the Credit Agreement are periodically reset, at our option, originally at either a Eurodollar Rate (which was derived from LIBOR) or an ABR Rate (each as defined in the Credit Agreement), plus in each case a margin.

On May 10, 2023, we entered into an amendment to the Credit Agreement (the “Fourth Amendment”) related to the planned phase-out of LIBOR by the UK Financial Conduct Authority. Effective July 1, 2023, borrowings under the Credit Agreement will bear interest, at our option, at either: (i) the alternate base rate (as defined in the Credit Agreement), plus the applicable margin therefor (as defined in the Credit Agreement) or (ii) the adjusted Term Secured Overnight Financing Rate published by the CME Term SOFR Administrator (as more fully defined and set forth in the Credit Agreement, “Adjusted Term SOFR”), plus the applicable margin therefor. The applicable margin in each case is determined based on our Leverage Ratio (as defined below) and ranges from 0.25% to 1.25% for borrowings bearing interest at the alternate base rate and from 1.25% to 2.25% for borrowings bearing interest based on Adjusted Term SOFR.

Borrowings outstanding under the Revolving Credit Facility were $100.0 million at April 30, 2023, which is included in long-term debt on our condensed consolidated balance sheet. For borrowings under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement)

16

leverage ratio (the "Leverage Ratio"). As of April 30, 2023, the interest rate on our revolving credit facility borrowings was 6.52%. In addition, we are required to pay a commitment fee with respect to unused availability under the Revolving Credit Facility at rates per annum determined by reference to our Leverage Ratio. The proceeds of borrowings under the Revolving Credit Facility may be used for our working capital and general corporate purposes, including for permitted acquisitions and permitted stock repurchases, and the repayment of term loans, if any.

Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries, and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement.

The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders’ commitments to make loans under the Credit Agreement may be terminated.

Deferred debt issuance costs associated with the Term Loan were amortized using the effective interest rate method, and deferred debt issuance costs associated with the Revolving Credit Facility are being amortized on a straight-line basis.

Interest Expense

The following table presents the components of interest expense incurred on the 2021 Notes and on borrowings under our Credit Agreement, for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
2021 Notes:
Interest expense at 0.25% coupon rate	$	197	$	195
Amortization of deferred debt issuance costs	443		439
Total Interest Expense — 2021 Notes	$	640	$	634
Borrowings under Credit Agreement:
Interest expense at contractual rates	$	1,650	$	560
Amortization of debt discounts	5		5
Amortization of deferred debt issuance costs	204		211
Losses on early retirements of debt	237		—
Total Interest Expense — Borrowings under Credit Agreement	$	2,096	$	776

8.    SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION

Condensed Consolidated Balance Sheets

Inventories consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30,		January 31,
(in thousands)	2023		2023
Raw materials	$	3,505	$	3,325
Work-in-process	40		40
Finished goods	10,008		9,263
Total inventories	$	13,553	$	12,628

Condensed Consolidated Statements of Operations

17

Other income, net consisted of the following for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Foreign currency gains, net	$	237	$	1,713
Other, net	(213)		(39)
Total other income, net	$	24	$	1,674

Condensed Consolidated Statements of Cash Flows

The following table provides supplemental information regarding our condensed consolidated cash flows for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Cash paid for interest	$	2,513	$	930
Cash payments of income taxes, net	$	3,758	$	2,238
Cash payments for operating leases	$	1,640	$	12,195
Non-cash investing and financing transactions:
Finance leases of property and equipment	$	212	$	12
Accrued but unpaid purchases of property and equipment	$	360	$	988
Accrued but unpaid purchases of treasury stock	$	—	$	453
Excise tax on share repurchases	$	417	$	—

9.    CONVERTIBLE PREFERRED STOCK

On December 4, 2019, we entered into the Investment Agreement with the Apax Investor whereby, subject to certain closing conditions, the Apax Investor agreed to make an investment in us in an amount up to $400.0 million as follows:

•On May 7, 2020, we issued a total of 200,000 shares of our Series A Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $2.7 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series A Preferred Stock.

•In connection with the completion of the Spin-Off, on April 6, 2021, we issued a total of 200,000 shares of our Series B Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $1.3 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series B Preferred Stock.

Each of the rights, preferences, and privileges of the Series A Preferred Stock and Series B Preferred Stock are set forth in separate certificates of designation filed with the Secretary of State of the State of Delaware on the applicable issuance date.

Voting Rights

Holders of the Preferred Stock have the right to vote on matters submitted to a vote of the holders of our common stock, on an as-converted basis; however, in no event will the holders of Preferred Stock have the right to vote shares of the Preferred Stock on an as-converted basis in excess of 19.9% of the voting power of the common stock outstanding immediately prior to December 4, 2019.

Dividends and Liquidation Rights

The Preferred Stock ranks senior to the shares of our common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of our affairs. Shares of Preferred

18

Stock have a liquidation preference of the greater of $1,000 per share or the amount that would be received if the shares are converted at the then applicable conversion price at the time of such liquidation.

Each series of Preferred Stock pays dividends at an annual rate of 5.2% until May 7, 2024, and thereafter at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends on the Preferred Stock are cumulative and payable semi-annually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. The dividend rate is subject to increase (i) to 6.0% per annum in the event the number of shares of common stock into which the Preferred Stock could be converted exceeds 19.9% of the voting power of outstanding common stock on December 4, 2019 (unless we obtain shareholder approval of the issuance of common stock upon conversion of the Preferred Stock) and (ii) by 1.0% each year, up to a maximum dividend rate of 10.0% per annum, in the event we fail to satisfy our obligations to redeem the Preferred Stock in specified circumstances.

For the three months ended April 30, 2023, we paid $10.4 million of preferred stock dividends, all of which was accrued as of January 31, 2023, and there were $6.9 million of cumulative undeclared and unpaid preferred stock dividends at April 30, 2023. There were no accrued dividends as of April 30, 2023. We reflected $5.2 million of preferred stock dividends in our condensed consolidated results of operations, for purposes of computing net loss attributable to Verint Systems Inc. common shares, for each of the three months ended April 30, 2023 and 2022.

Conversion

The Series A Preferred Stock was initially convertible into common stock at the election of the holder, subject to certain conditions, at an initial conversion price of $53.50 per share. The initial conversion price represented a conversion premium of 17.1% over the volume-weighted average price per share of our common stock over the 45 consecutive trading days immediately prior to December 4, 2019. In accordance with the Investment Agreement, the Series A Preferred Stock did not participate in the Spin-Off distribution of the Cognyte shares, which occurred on February 1, 2021, and the Series A Preferred Stock conversion price was instead adjusted to $36.38 per share based on the ratio of the relative trading prices of Verint and Cognyte following the Spin-Off. The Series B Preferred Stock is convertible at a conversion price of $50.25, based in part on our trading price over the 20 day trading period following the Spin-Off. As of April 30, 2023, the maximum number of shares of common stock that could be required to be issued upon conversion of the outstanding shares of Preferred Stock was approximately 9.6 million shares and Apax’s ownership in us on an as-converted basis was approximately 13.0%.

At any time after May 7, 2023, in the case of the Series A Preferred Stock, and April 6, 2024, in the case of the Series B Preferred Stock, we will have the option to require that all (but not less than all) of the then-outstanding shares of Preferred Stock of the series convert into common stock if the volume-weighted average price per share of the common stock for at least 30 trading days in any 45 consecutive trading day period exceeds 175% of the then-applicable conversion price of such series (a “Mandatory Conversion”).

We may redeem any or all of the Preferred Stock of a series for cash at any time after May 7, 2026, in the case of the Series A Preferred Stock, and April 6, 2027, in the case of the Series B Preferred Stock, at a redemption price equal to 100% of the liquidation preference of the shares of the Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date, plus a make-whole amount designed to allow the Apax Investor to earn a total 8.0% internal rate of return on such shares.

The Preferred Stock may not be sold or transferred without our prior written consent. The common stock issuable upon conversion of the Preferred Stock is not subject to this restriction. The restriction on the sale or transfer of the Preferred Stock does not apply to certain transfers to one or more permitted co-investors or transfers or pledges of the Preferred Stock pursuant to the terms of specified margin loans entered into by the Apax Investor as well as transfers effected pursuant to a merger, consolidation, or similar transaction consummated by us and transfers that are approved by our board of directors.

At any time after November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, or upon the occurrence of a change of control triggering event (as defined in the certificates of designation), the holders of the applicable series of Preferred Stock will have the right to cause us to redeem all of the outstanding shares of Preferred Stock for cash at a redemption price equal to 100% of the liquidation preference of the shares of such series, plus any accrued and unpaid dividends to, but excluding, the redemption date. Therefore, the Preferred Stock has been classified as temporary equity on our condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023, separate from permanent equity, as the potential required repurchase of the Preferred Stock, however remote in likelihood, is not solely under our control.

19

As of April 30, 2023, the Preferred Stock was not redeemable, and we have concluded that it is currently not probable of becoming redeemable, including from the occurrence of a change in control triggering event. The holders’ redemption rights which occur at November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, are not considered probable because there is a more than remote likelihood that the Mandatory Conversion may occur prior to such redemption rights. We therefore did not adjust the carrying amount of the Preferred Stock to its current redemption amount, which was its liquidation preference at April 30, 2023 plus accrued and unpaid dividends. As of April 30, 2023, the stated value of the liquidation preference for each series of Preferred Stock was $200.0 million and cumulative, unpaid dividends on each series of Preferred Stock was $3.5 million.

Future Tranche Right

We determined that our obligation to issue and the Apax Investor’s obligation to purchase 200,000 shares of the Series B Preferred Stock in connection with the completion of the Spin-Off and the satisfaction of other customary closing conditions (the “Future Tranche Right”) met the definition of a freestanding financial instrument as the Future Tranche Right is legally detachable and separately exercisable from the Series A Preferred Stock. At issuance, we allocated a portion of the proceeds from the issuance of the Series A Preferred Stock to the Future Tranche Right based upon its fair value at such time, with the remaining proceeds being allocated to the Series A Preferred Stock. The Future Tranche Right was remeasured at fair value each reporting period until the settlement of the right (at the time of the issuance of the Series B Preferred Stock), and changes in its fair value were recognized as a non-cash charge or benefit within other income (expense), net on the condensed consolidated statement of operations.

Upon issuance of the Series A Preferred Stock on May 7, 2020, the Future Tranche Right was recorded as an asset of $3.4 million, as the purchase price of the Series B Preferred Stock was greater than its estimated fair value at the expected settlement date. This resulted in a $203.4 million carrying value, before direct and incremental issuance costs, for the Series A Preferred Stock.

Immediately prior to the issuance of the Series B Preferred Stock, the Future Tranche Right was remeasured and upon the issuance of the Series B Preferred Stock in April 2021, the Future Tranche Right was settled, resulting in a reclassification of the $37.0 million fair value of the Future Tranche Right liability at that time to the carrying value of the Series B Preferred Stock. This resulted in a $237.0 million carrying value, before direct and incremental issuance costs, for the Series B Preferred Stock. As a result of the issuance of the Series B Preferred Stock, we no longer recognize changes in the fair value of the Future Tranche Right in our condensed consolidated statements of operations.

10.    STOCKHOLDERS’ EQUITY

Common Stock Dividends

We did not declare or pay any cash dividends on our common stock during the three months ended April 30, 2023 and 2022. Under the terms of our Credit Agreement, we are subject to certain restrictions on declaring and paying cash dividends on our common stock.

In connection with the Spin-Off, each holder of Verint’s common stock received one ordinary share of Cognyte for every share of common stock of Verint held of record as of the close of business on January 25, 2021.

Treasury Stock

From time to time, our board of directors has approved limited programs to repurchase shares of our common stock from our directors or officers in connection with the vesting of restricted stock or restricted stock units to facilitate required income tax withholding by us or the payment of required income taxes by such holders. In addition, the terms of some of our equity award agreements with all grantees provide for automatic repurchases by us for the same purpose if a vesting-related or delivery-related tax event occurs at a time when the holder is not permitted to sell shares in the market. Our stock bonus program contains similar terms. Any such repurchases of common stock occur at prevailing market prices and are recorded as treasury stock.

We periodically purchase common stock from our directors, officers, and other employees to facilitate income tax withholding by us or the payment of required income taxes by such holders in connection with the vesting of equity awards occurring during a Company-imposed trading blackout or lockup period. When treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired.

20

No treasury stock remained outstanding at April 30, 2023 and January 31, 2023, respectively.

Stock Repurchase Programs

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million during the repurchase period.

During the year ended January 31, 2023, we repurchased approximately 649,000 shares of our common stock for a cost of $23.5 million under the current stock repurchase program. During the three months ended April 30, 2023, we repurchased approximately 1,593,000 shares of our common stock for a cost of $60.1 million, including excise tax of $0.4 million, under the current stock repurchase program. During the three months ended April 30, 2023, we retired all 1,593,000 shares, which was recorded as a reduction of common stock and additional paid-in capital. These shares were returned to the status of authorized and unissued shares. Our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the IRA. The excise tax of $0.4 million was recognized as part of the cost basis of shares acquired in the condensed consolidated statements of stockholders’ equity during the three months ended April 30, 2023. Subsequent to April 30, 2023 through June 1, 2023, we repurchased approximately 159,000 shares of our common stock for $5.5 million under this program.

During the three months ended April 30, 2022, we repurchased 2,000,000 shares of our common stock for a cost of $105.7 million under a prior stock repurchase program.

Issuance of Convertible Preferred Stock

On December 4, 2019, in conjunction with the planned Spin-Off, we announced that an affiliate of Apax Partners would invest up to $400.0 million in us, in the form of convertible preferred stock. Under the terms of the Investment Agreement, the Apax Investor purchased $200.0 million of our Series A Preferred Stock, which closed on May 7, 2020. In connection with the completion of the Spin-Off, the Apax Investor purchased $200.0 million of our Series B Preferred Stock, which closed on April 6, 2021. As of April 30, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 9, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss includes items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities and derivative financial instruments designated as hedges. Accumulated other comprehensive loss is presented as a separate line item in the stockholders’ equity section of our condensed consolidated balance sheets. Accumulated other comprehensive loss items have no impact on our net income as presented in our condensed consolidated statements of operations.

The following table summarizes changes in the components of our accumulated other comprehensive loss for the three months ended April 30, 2023:

(in thousands)	Unrealized Losses on Foreign Exchange Contracts Designated as Hedges		Foreign Currency Translation Adjustments		Total
Accumulated other comprehensive loss at January 31, 2023	$	(87)	$	(154,012)	$	(154,099)
Other comprehensive (loss) income before reclassifications	(290)		8,612		8,322
Amounts reclassified out of accumulated other comprehensive loss	(188)		—		(188)
Net other comprehensive (loss) income	(102)		8,612		8,510
Accumulated other comprehensive loss at April 30, 2023	$	(189)	$	(145,400)	$	(145,589)

All amounts presented in the table above are net of income taxes, if applicable. The accumulated net losses in foreign currency translation adjustments primarily reflect the strengthening of the U.S. dollar against the British pound sterling, which has resulted in lower U.S. dollar-translated balances of British pound sterling-denominated goodwill and intangible assets.

21

The amounts reclassified out of accumulated other comprehensive loss into the condensed consolidated statements of operations, with presentation location, for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022		Financial Statement Location
Unrealized losses on derivative financial instruments:
Foreign currency forward contracts	$	(2)	$	—	Cost of recurring revenue
	(20)		(9)		Cost of nonrecurring revenue
	(140)		(49)		Research and development, net
	(65)		(24)		Selling, general and administrative
	(227)		(82)		Total, before income taxes
	39		14		Benefit from income taxes
	$	(188)	$	(68)	Total, net of income taxes

11.   INCOME TAXES

Our interim provision for income taxes is measured using an estimated annual effective income tax rate, adjusted for discrete items that occur within the periods presented.

For the three months ended April 30, 2023, we recorded an income tax provision of $4.4 million on pretax income of $8.0 million, which represented an effective income tax rate of 54.6%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions.

For the three months ended April 30, 2022, we recorded an income tax provision of $0.3 million on pretax income of $0.9 million, which represented an effective income tax rate of 34.0%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, partially offset by lower statutory rates in certain foreign jurisdictions.

As required by the authoritative guidance on accounting for income taxes, we evaluate the realizability of deferred income tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes guidance requires that a valuation allowance be established when it is more-likely-than-not that all or a portion of the deferred income tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred income tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We determined that there is sufficient negative evidence to maintain the valuation allowances against certain state and foreign deferred income tax assets as a result of historical losses in the most recent three-year period in certain state and foreign jurisdictions. We intend to maintain valuation allowances until sufficient positive evidence exists to support a reversal.

We had unrecognized income tax benefits of $87.7 million and $87.9 million (excluding interest and penalties) as of April 30, 2023 and January 31, 2023, respectively, that if recognized, would impact our effective income tax rate. The accrued liability for interest and penalties was $5.3 million and $5.2 million at April 30, 2023 and January 31, 2023, respectively. Interest and penalties are recorded as a component of the provision for income taxes in our condensed consolidated statements of operations. We regularly assess the adequacy of our provisions for income tax contingencies in accordance with the applicable authoritative guidance on accounting for income taxes. As a result, we may adjust the reserves for unrecognized income tax benefits for the impact of new facts and developments, such as changes to interpretations of relevant tax law, assessments from taxing authorities, settlements with taxing authorities, and lapses of statutes of limitation. Further, we believe that it is reasonably possible that the total amount of unrecognized income tax benefits at April 30, 2023 could decrease by approximately $7.0 million in the next twelve months as a result of settlement of certain tax audits or lapses of statutes of limitation. Such decreases may involve the payment of additional income taxes, the adjustment of deferred income taxes including the need for additional valuation allowances, and the recognition of income tax benefits. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. We also believe that it is reasonably possible that new issues may be raised by tax authorities or developments in tax audits may occur, which would require increases or decreases to the balance of reserves for unrecognized income tax benefits; however, an estimate of such changes cannot reasonably be made.

22

12.   FAIR VALUE MEASUREMENTS

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of April 30, 2023 and January 31, 2023:

	April 30, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	80,624	$	—	$	—
U.S. Treasury bills, classified as cash and cash equivalents	249		—		—
Commercial paper, classified as cash and cash equivalents	—		30,975		—
Foreign currency forward contracts	—		5		—
Total assets	$	80,873	$	30,980	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	235	$	—
Contingent consideration — business combinations	—		—		12,884
Total liabilities	$	—	$	235	$	12,884

 

	January 31, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	96,941	$	—	$	—
Commercial paper, classified as cash and cash equivalents	—		50,869		—
Foreign currency forward contracts	—		19		—
Contingent consideration receivable	—		8		—
Total assets	$	96,941	$	50,896	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	124	$	—
Contingent consideration — business combinations	—		—		12,717
Total liabilities	$	—	$	124	$	12,717

The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2023:

	Three Months Ended April 30,
(in thousands)	2023
Fair value measurement at beginning of period	$	12,717
Contingent consideration liabilities recorded for business combinations	—
Changes in fair values, recorded in operating expenses	220
Payments of contingent consideration	(250)
Foreign currency translation and other	197
Fair value measurement at end of period	$	12,884

Our estimated liability for contingent consideration represents potential payments of additional consideration for business combinations, payable if certain defined performance goals are achieved. Changes in fair value of contingent consideration are recorded in the condensed consolidated statements of operations within selling, general and administrative expenses. There

23

were no liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2022.

There were no transfers between levels of the fair value measurement hierarchy during the three months ended April 30, 2023 and 2022.

Fair Value Measurements

Money Market Funds and U.S. Treasury Bills - We value our money market funds and U.S. treasury bills using quoted active market prices for such instruments.

Short-term Investments, Corporate Debt Securities, and Commercial Paper - The fair values of short-term investments, as well as corporate debt securities and commercial paper classified as cash equivalents, are estimated using observable market prices for identical securities that are traded in less-active markets, if available. When observable market prices for identical securities are not available, we value these short-term investments using non-binding market price quotes from brokers which we review for reasonableness using observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model.

Foreign Currency Forward Contracts - The estimated fair value of foreign currency forward contracts is based on quotes received from the counterparties thereto. These quotes are reviewed for reasonableness by discounting the future estimated cash flows under the contracts, considering the terms and maturities of the contracts and market foreign currency exchange rates using readily observable market prices for similar contracts.

Contingent Consideration Assets and Liabilities - Business Combinations and Divestitures - The fair value of the contingent consideration related to business combinations and divestitures is estimated using a probability-adjusted discounted cash flow model. These fair value measurements are based on significant inputs not observable in the market. The key internally developed assumptions used in these models are discount rates and the probabilities assigned to the milestones to be achieved. We remeasure the fair value of the contingent consideration at each reporting period, and any changes in fair value resulting from either the passage of time or events occurring after the acquisition date, such as changes in discount rates, or in the expectations of achieving the performance targets, are recorded within selling, general, and administrative expenses. Increases or decreases in discount rates would have inverse impacts on the related fair value measurements, while favorable or unfavorable changes in expectations of achieving performance targets would result in corresponding increases or decreases in the related fair value measurements. We utilized discount rates ranging from 6.6% to 7.7%, with a weighted average discount rate of 7.2% in our calculation of the estimated fair values of our contingent consideration liabilities as of April 30, 2023. We utilized discount rates ranging from 6.6% to 7.6%, with a weighted average discount rate of 6.9% in our calculations of the estimated fair values of our contingent consideration liabilities as of January 31, 2023. The contingent consideration receivable was fully paid as of April 30, 2023.

Other Financial Instruments

The carrying amounts of accounts receivable, contract assets, accounts payable, and accrued liabilities and other current liabilities approximate fair value due to their short maturities.

The estimated fair value of our Revolving Credit Facility borrowing was approximately $99.0 million at April 30, 2023. The estimated fair value of our Term Loan borrowing was approximately $100 million at January 31, 2023. On April 27, 2023, we repaid in full the remaining $100 million outstanding balance on our Term Loan utilizing proceeds from borrowings under our Revolving Credit Facility. We had no borrowings under our Revolving Credit Facility at January 31, 2023. The estimated fair values of the Term Loan borrowings were based upon indicative bid and ask prices as determined by the agent responsible for the syndication of our term loans. We considered these inputs to be within Level 3 of the fair value hierarchy because we cannot reasonably observe activity in the limited market in which participation in our Term Loan traded. The estimated fair value of borrowings under our Revolving Credit Facility is based upon indicative market values provided by one of our lenders. The indicative prices provided to us as at each of April 30, 2023 and January 31, 2023 did not significantly differ from par value.

The estimated fair values of our 2021 Notes were approximately $279.0 million and $282.0 million at April 30, 2023 and January 31, 2023, respectively. The estimated fair values of the 2021 Notes were determined based on quoted bid and ask prices in the over-the-counter market in which the 2021 Notes traded. We consider these inputs to be within Level 2 of the fair value hierarchy.

Assets and Liabilities Not Measured at Fair Value on a Recurring Basis

24

In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets, operating lease right-of-use assets, and property, plant and equipment, are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.

Investments

During the three months ended April 30, 2023, we invested approximately $1.1 million in a privately-held company via a simple agreement for future equity (“SAFE”). The SAFE provides that, upon the completion by such company of a qualified equity financing, we will automatically receive the number of shares of capital stock of such company equal to the SAFE purchase amount divided by the Discount Price (as such term is defined in the SAFE). If there is a liquidity event affecting such company, such as a change in control or initial public offering, we will receive a cash payment equal to the greater of (a) the SAFE purchase amount or (b) the amount payable on the number of shares of common stock of such company equal to the SAFE purchase amount divided by the Liquidity Price (as such term is defined in the SAFE). Our investment is carried at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer and is included within other assets on the condensed consolidated balance sheets as of April 30, 2023.

The carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was $5.1 million as of April 30, 2023 and January 31, 2023. These investments were included within other assets on the condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023. There were no observable price changes in our investments in privately-held companies during the three months ended April 30, 2023 and 2022. We did not recognize any impairments during the three months ended April 30, 2023 and 2022.

13.   DERIVATIVE FINANCIAL INSTRUMENTS

Our primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk and interest rate risk, when deemed appropriate. We enter into these contracts in the normal course of business to mitigate risks and not for speculative purposes.

Foreign Currency Forward Contracts

Under our risk management strategy, we periodically use foreign currency forward contracts to manage our short-term exposures to fluctuations in operational cash flows resulting from changes in foreign currency exchange rates. These cash flow exposures result from portions of our forecasted operating expenses, primarily compensation and related expenses, which are transacted in currencies other than the U.S. dollar, most notably the Israeli shekel. We also periodically utilize foreign currency forward contracts to manage exposures resulting from forecasted customer collections to be remitted in currencies other than the applicable functional currency, and exposures from cash, cash equivalents and short-term investments denominated in currencies other than the applicable functional currency. These foreign currency forward contracts generally have maturities of no longer than twelve months, although occasionally we will execute a contract that extends beyond twelve months, depending upon the nature of the underlying risk.

We held outstanding foreign currency forward contracts with notional amounts of $6.6 million and $6.8 million as of April 30, 2023 and January 31, 2023, respectively.

Fair Values of Derivative Financial Instruments

The fair values of our derivative financial instruments and their classifications in our condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023 were as follows:

25

		Fair Value at
		April 30,		January 31,
(in thousands)	Balance Sheet Classification	2023		2023
Derivative assets:
Foreign currency forward contracts:
Designated as cash flow hedges	Prepaid expenses and other current assets	$	5	$	19
Total derivative assets		$	5	$	19
Derivative liabilities:
Foreign currency forward contracts:
Designated as cash flow hedges	Accrued expenses and other current liabilities	$	235	$	124
Total derivative liabilities		$	235	$	124

Derivative Financial Instruments in Cash Flow Hedging Relationships

The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the condensed consolidated statement of operations for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022
Net losses recognized in AOCL:
Foreign currency forward contracts	$	(350)	$	(270)
Net losses reclassified from AOCL to the condensed consolidated statements of operations:
Foreign currency forward contracts	$	(227)	$	(82)

For information regarding the line item locations of the net losses on derivative financial instruments reclassified out of AOCL into the condensed consolidated statements of operations, see Note 10, “Stockholders’ Equity”.

All of the foreign currency forward contracts underlying the net unrealized losses recorded in our accumulated other comprehensive loss at April 30, 2023 mature within twelve months, and therefore we expect all such losses to be reclassified into earnings within the next twelve months.

14.    STOCK-BASED COMPENSATION

Stock-Based Compensation Plan

On June 20, 2019, our stockholders approved the Verint Systems Inc. 2019 Long-Term Stock Incentive Plan (the “2019 Plan”). Upon approval of the 2019 Plan, new awards were no longer permitted under our prior stock-based compensation plan (the “2017 Amended Plan”). Awards outstanding at June 20, 2019 under the 2017 Amended Plan or other previous stock-based compensation plans were not impacted by the approval of the 2019 Plan. Collectively, our stock-based compensation plans are referred to herein as the “Plans”.

The 2019 Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance awards, other stock-based awards, and performance compensation awards. Subject to adjustment as provided in the 2019 Plan, up to an aggregate of (i) 9,475,000 shares of our common stock plus (ii) the number of shares of our common stock available for issuance under the 2017 Amended Plan as of June 20, 2019, plus (iii) the number of shares of our common stock that become available for issuance as a result of awards made under the 2017 Amended Plan or the 2019 Plan that are forfeited, cancelled, exchanged, or that terminate or expire, may be issued or transferred in connection with awards under the 2019 Plan. Each stock option or stock-settled stock appreciation right granted under the 2019 Plan will reduce the available plan capacity by one share and each other award denominated in shares that is granted under the 2019 Plan will reduce the available plan capacity by 2.38 shares.

26

In March 2021, our board of directors approved an adjustment of the available plan capacity to the 2019 Plan to 14,239,656 shares based on an adjustment ratio of approximately 1.45 as a result of the Spin-Off.

At our annual meeting of stockholders on June 22, 2023, our stockholders will be asked to consider a proposal to approve the Verint Systems Inc. 2023 Long-Term Stock Incentive Plan (the “2023 Plan”). If the 2023 Plan is approved, no further awards will be made under the 2019 Plan following the date of such approval.

Stock-Based Compensation Expense

We recognized stock-based compensation expense in the following line items on the condensed consolidated statements of operations for the three months ended April 30, 2023 and 2022: 

	Three Months Ended April 30,
(in thousands)	2023		2022
Cost of revenue — recurring	$	296	$	525
Cost of revenue — nonrecurring	140		640
Research and development, net	2,327		2,419
Selling, general and administrative	12,216		14,785
Total stock-based compensation expense	$	14,979	$	18,369

The following table summarizes stock-based compensation expense by type of award for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Restricted stock units and restricted stock awards	$	13,436	$	16,011
Stock bonus program and bonus share program	1,378		2,353
Total equity-settled awards	14,814		18,364
Phantom stock units (cash-settled awards)	165		5
Total stock-based compensation expense	$	14,979	$	18,369

Awards are generally subject to multi-year vesting periods. We recognize compensation expense for awards on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods, reduced by estimated forfeitures.

Awards under our stock bonus and bonus share programs are accounted for as liability-classified awards, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of our common stock, which for awards under our stock bonus program is determined using a discounted average price of our common stock.

Restricted Stock Units and Performance Stock Units

We periodically award RSUs to our directors, officers, and other employees. These awards contain various vesting conditions and are subject to certain restrictions and forfeiture provisions prior to vesting. Some of these awards to executive officers and certain employees vest upon the achievement of specified performance goals or market conditions (performance stock units or “PSUs”).

The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the three months ended April 30, 2023 and 2022:

27

	Three Months Ended April 30,
	2023			2022
(in thousands, except per share data)	Shares or Units	Weighted-Average Grant Date Fair Value		Shares or Units	Weighted-Average Grant Date Fair Value
Beginning balance	2,230	$	52.42	2,454	$	42.99
Granted	1,665	$	37.36	1,557	$	56.42
Released	(475)	$	50.22	(465)	$	42.20
Forfeited	(32)	$	50.63	(47)	$	43.13
Ending balance	3,388	$	45.34	3,499	$	49.07

With respect to our stock bonus program, the activity presented in the table above only includes shares earned and released in consideration of the discount provided under that program. Consistent with the provisions of the Plans under which such shares are issued, other shares issued under the stock bonus program are not included in the table above because they do not reduce available plan capacity (since such shares are deemed to be purchased by the grantee at fair value in lieu of receiving an earned cash bonus). Activity presented in the table above includes all shares awarded and released under the bonus share program. Further details appear below under “Stock Bonus Program” and “Bonus Share Program”.

Our RSU and PSU awards may include a provision which allows the awards to be settled with cash payments upon vesting, rather than with delivery of common stock, at the discretion of our board of directors. As of April 30, 2023, for such awards that are outstanding, settlement with cash payments was not considered probable, and therefore these awards have been accounted for as equity-classified awards and are included in the table above.

In order to achieve an equitable modification of the existing awards following the Spin-Off, we converted unvested awards as of February 1, 2021 by a factor of approximately 1.45, resulting in additional awards being granted to remaining employees denominated solely in Verint common stock. As noted above, a corresponding adjustment was also made to the available capacity under the 2019 Plan.

The following table summarizes PSU activity in isolation under the Plans for the three months ended April 30, 2023 and 2022 (these amounts are also included in the Award Activity Table above for 2023 and 2022):

	Three Months Ended April 30,
(in thousands)	2023	2022
Beginning balance	532	547
Granted	277	278
Released	(230)	(89)
Forfeited	(10)	—
Ending balance	569	736

Excluding PSUs, we granted 1,388,000 RSUs during the three months ended April 30, 2023.

As of April 30, 2023, there was approximately $119.7 million of total unrecognized compensation expense, net of estimated forfeitures, related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 2.2 years.

Stock Bonus Program and Bonus Share Program

Our stock bonus program permits eligible employees to receive a portion of their earned bonuses, otherwise payable in cash, in the form of discounted shares of our common stock. Executive officers are eligible to participate in this program to the extent that capacity remains available under the program following the enrollment of all other participants. Shares awarded to executive officers with respect to the discount feature of the program are subject to a one-year vesting period. This program is subject to annual funding approval by our board of directors and an annual cap on the number of shares that can be issued. Subject to these limitations, the number of shares to be issued under the program for a given year is determined using a five-day trailing average price of our common stock when the awards are calculated, reduced by a discount determined by the board of directors each year (the “discount”). To the extent that this program is not funded in a given year or the number of

28

shares of common stock needed to fully satisfy employee enrollment exceeds the annual cap, the applicable portion of the employee bonuses will generally revert to being paid in cash.

Under our bonus share program, we may provide discretionary bonuses to employees or pay earned bonuses that are outside the stock bonus program in the form of shares of common stock. Unlike the stock bonus program, there is no enrollment for this program and no discount feature.

For bonuses in respect of the year ended January 31, 2023, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate for awards under these two programs, with up to 200,000 shares of common stock, and a discount of 15% approved for awards under our stock bonus program. We currently expect to issue approximately 27,000 shares under the stock bonus program and 178,000 shares under the bonus share program, in respect of the year ended January 31, 2023, which are expected to be issued during the first half of the year ending January 31, 2024.

In March 2023, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate under these two programs, with up to 200,000 shares of common stock, and a discount of 15%, for awards under our stock bonus program for the performance period ending January 31, 2024. Any shares earned under these programs will be issued during the year ended January 31, 2025.

The combined accrued liabilities for these two programs were $9.2 million and $7.9 million at April 30, 2023 and January 31, 2023, respectively.

15.   COMMITMENTS AND CONTINGENCIES

Legal Proceedings

CTI Litigation

In March 2009, one of our former employees, Ms. Orit Deutsch, commenced legal actions in Israel against our former primary Israeli subsidiary, Cognyte Technologies Ltd. (formerly known as Verint Systems Limited or “VSL”) (Case Number 4186/09) and against our former affiliate CTI (Case Number 1335/09). Also, in March 2009, a former employee of Comverse Limited (CTI’s primary Israeli subsidiary at the time), Ms. Roni Katriel, commenced similar legal actions in Israel against Comverse Limited (Case Number 3444/09). In these actions, the plaintiffs generally sought to certify class action suits against the defendants on behalf of current and former employees of VSL and Comverse Limited who had been granted stock options in Verint and/or CTI and who were allegedly damaged as a result of a suspension on option exercises during an extended filing delay period that is discussed in our and CTI’s historical public filings. On June 7, 2012, the Tel Aviv District Court, where the cases had been filed or transferred, allowed the plaintiffs to consolidate and amend their complaints against the three defendants: VSL, CTI, and Comverse Limited.

On October 31, 2012, CTI distributed all of the outstanding shares of common stock of Comverse, Inc., its principal operating subsidiary and parent company of Comverse Limited, to CTI’s shareholders (the “Comverse Share Distribution”). In the period leading up to the Comverse Share Distribution, CTI either sold or transferred substantially all of its business operations and assets (other than its equity ownership interests in Verint and in its then-subsidiary, Comverse, Inc.) to Comverse, Inc. or to unaffiliated third parties. As the result of these transactions, Comverse, Inc. became an independent company and ceased to be affiliated with CTI, and CTI ceased to have any material assets other than its equity interests in Verint. Prior to the completion of the Comverse Share Distribution, the plaintiffs sought to compel CTI to set aside up to $150.0 million in assets to secure any future judgment, but the District Court did not rule on this motion. In February 2017, Mavenir Inc. became successor-in-interest to Comverse, Inc.

On February 4, 2013, Verint acquired the remaining CTI shell company in a merger transaction (the “CTI Merger”). As a result of the CTI Merger, Verint assumed certain rights and liabilities of CTI, including any liability of CTI arising out of the foregoing legal actions. However, under the terms of a Distribution Agreement entered into in connection with the Comverse Share Distribution, we, as successor to CTI, are entitled to indemnification from Comverse, Inc. (now Mavenir) for any losses we may suffer in our capacity as successor to CTI related to the foregoing legal actions.

Following an unsuccessful mediation process, on August 28, 2016, the District Court (i) denied the plaintiffs’ motion to certify the suit as a class action with respect to all claims relating to Verint stock options, (ii) dismissed the motion to certify the suit against VSL and Comverse Limited, and (iii) approved the plaintiffs’ motion to certify the suit as a class action against CTI

29

with respect to claims of current or former employees of Comverse Limited (now part of Mavenir) or of VSL who held unexercised CTI stock options at the time CTI suspended option exercises. The court also ruled that the merits of the case would be evaluated under New York law.

As a result of this ruling (which excluded claims related to Verint stock options from the case), one of the original plaintiffs in the case, Ms. Deutsch, was replaced by a new representative plaintiff, Mr. David Vaaknin. CTI appealed portions of the District Court’s ruling to the Israeli Supreme Court. On August 8, 2017, the Israeli Supreme Court partially allowed CTI’s appeal and ordered the case to be returned to the District Court to determine whether a cause of action exists under New York law based on the parties’ expert opinions.

Following two unsuccessful rounds of mediation in mid to late 2018 and in mid-2019, the proceedings resumed. On April 16, 2020, the District Court accepted the plaintiffs’ application to amend the motion to certify a class action and set deadlines for filing amended pleadings by the parties. CTI submitted a motion to appeal the District Court’s decision to the Israeli Supreme Court, as well as a motion to stay the proceedings in the District Court pending the resolution of the appeal. On July 6, 2020, the Israeli Supreme Court granted the motion for a stay. On July 27, 2020, the plaintiffs filed their response on the merits of the motion for leave to appeal. On December 15, 2021, the Israeli Supreme Court rejected CTI’s motion to appeal and the proceedings in the District Court resumed.

At the recommendation of the District Court, in June 2022, the parties conducted another round of mediation in New York. On July 10, 2022, the parties reached an agreement to settle the matter on terms set forth in a settlement agreement that was executed by all parties and submitted a motion for approval of the settlement agreement to the District Court. Under the terms of the settlement agreement, subject to full and final waiver, Mavenir Inc. and/or Comverse, Inc. and/or Mavenir Ltd. agreed to pay a total of $16.0 million (such amount to be paid in three phases as set forth in the settlement agreement) as compensation to the plaintiffs and members of the class. The compensation amount is comprehensive, final and absolute and includes within it all the amounts and expenses to be paid in connection with the settlement agreement. Under the terms of an associated guaranty agreement, Verint has guaranteed the payment of the compensation amount in the event it is not paid by the primary obligors. On February 7, 2023, the District Court approved the settlement without material changes. As of April 30, 2023, the first installment of the compensation amount had been paid by Mavenir, leaving two installments of approximately $4.7 million each to be paid between September 2023 and April 2024.

Under the terms of the Separation and Distribution Agreement entered into between Verint and Cognyte, Cognyte has agreed to indemnify Verint for Cognyte’s share of any losses that Verint may suffer related to the foregoing legal actions either in its capacity as successor to CTI, to the extent not indemnified by Mavenir, or due to its former ownership of Cognyte and VSL.

As of April 30, 2023, we had a remaining liability of $9.5 million, which is included within accrued expenses and other current liabilities, and an offsetting indemnification receivable of $9.5 million, which is included in prepaid expenses and other current assets. There was no impact to our condensed consolidated statement of operations.

Unfair Competition Litigation and Related Investigation

As previously disclosed, Verint Americas Inc., as successor to ForeSee Results, Inc. (“ForeSee”), was the defendant in two Eastern District of Michigan cases captioned ACSI LLC v. ForeSee Results, Inc., and CFI Group USA LLC v. Verint Americas Inc. The former case was filed on October 24, 2018 against ForeSee Results, Inc. by American Customer Satisfaction Index, LLC (“ACSI LLC”) (Case No. 2:18-cv-13319) and alleged infringement of two federally registered trademarks and common law unfair competition under federal and state law. The latter case was filed on September 5, 2019 against Verint Americas Inc. (as successor in interest to ForeSee) by CFI Group USA LLC (“CFI”) (Case No. 2:19-cv-12602) and alleged unfair competition and false advertising under federal and state law, as well as tortious interference with contract. We believe that the claims asserted by the plaintiffs in these matters were without merit. Following the filing of the Eastern District of Michigan litigation, ForeSee filed affirmative litigation in the U.S. District Court for the District of Delaware (Case No. 1:21-cv-00674, Complaint filed on May 7, 2021) against ACSI LLC, CFI, Claes Fornell, and CFI Software LLC (the “Fornell Group”) asserting fraud and other claims against ACSI LLC, CFI, Fornell, and CFI Software for, among other things, their breach of a “Joinder and Waiver Agreement” entered into in connection with the December 2013 sale of ForeSee to its previous owner and misrepresentations in the associated deal documents. Verint acquired ForeSee in December 2018.

In April 2023, the parties reached an agreement in principle to settle these actions, and on June 1, 2023, the parties signed a definitive settlement agreement. Under the terms of the settlement agreement, Verint will pay $9.0 million to the Fornell Group and the parties have agreed to certain restrictive covenants with respect to the future business activities of both ForeSee and the Fornell Group. The agreement provides that the settlement does not constitute a ruling on the merits, an admission as to any issue of fact or principle of law, or an admission of liability or wrongdoing by either ForeSee or Verint. Following the

30

execution of the settlement agreement, the two cases in Michigan against us, and the case in Delaware filed by us, have been [or are in the process of being] dismissed.

Verint was also informed that the U.S. Attorney’s Office for the Eastern District of Michigan’s Civil Division (“USAO”) is conducting a False Claims Act investigation concerning allegations ForeSee and/or Verint failed to provide the federal government the services described in certain government contracts related to ForeSee’s products inherited by Verint in the acquisition. Verint received a Civil Investigation Demand (“CID”) in connection with this investigation and provided responses. The False Claims Act contains provisions that allow for private persons (“relators”) to initiate actions by filing claims under seal. We believe that this investigation was initiated in coordination with the Eastern District of Michigan litigation discussed above. Verint continues to work cooperatively with the USAO in its review of this matter.

In March 2023, Verint and the Assistant U.S. Attorney overseeing the USAO investigation reached an agreement in principle to resolve the USAO matter. The proposed settlement, which would result in the payment by Verint of $7.0 million and would contain a statement of no admission to liability, is subject to definitive documentation as well as review and approval by the USAO, potential objection by any relators, and approval by a court if the investigation is in connection with a lawsuit initiated by a relator.

As of January 31, 2023, we recognized a $7.0 million legal settlement liability in respect of the USAO matter and a $3.5 million legal settlement liability in respect of the ACSI and CFI matters within accrued expenses and other current liabilities, and a corresponding insurance recovery receivable in prepaid expenses and other current assets on our consolidated balance sheets. These loss accruals and insurance recoveries were offset within selling, general and administrative expenses in our consolidated statements of operations for the year ended January 31, 2023, resulting in no impact on our consolidated statements of operations.

As of April 30, 2023, we have accrued a $7.0 million legal settlement liability in respect of the USAO matter and a $9.0 million legal settlement liability in respect of the ACSI and CFI matters within accrued expenses and other current liabilities. The incremental settlement costs of $5.5 million related to the ACSI and CFI matters as a result of the settlement described above, is included within selling, general and administrative expenses in our condensed consolidated statement of operations for the three months ended April 30, 2023. We reached a final settlement with one of our insurance carriers for a total cumulative insurance recovery of $14.5 million for the losses we incurred related to these actions, which offset settlement and legal expenses during the year ended January 31, 2023. We collected $2.0 million during the year ended January 31, 2023 and $12.5 million was collected in April 2023.

We are a party to various other litigation matters and claims that arise from time to time in the ordinary course of our business. While we believe that the ultimate outcome of any such current matters will not have a material adverse effect on us, their outcomes are not determinable and negative outcomes may adversely affect our financial position, liquidity, or results of operations.

16.   SUBSEQUENT EVENTS

Credit Agreement Amendment

On May 10, 2023, we entered into the Fourth Amendment (“Fourth Amendment”) to the Credit Agreement, with JPMorgan Chase Bank, N.A., as administrative agent, which amended the Credit Agreement to provide for the Eurodollar Rate thereunder, which was derived from LIBOR, together with all related LIBOR-based mechanics and provisions, to be replaced with Term SOFR (as defined in the Credit Agreement) and the administrative agent’s customary Term SOFR interest rate-based mechanics and related provisions. Please refer to Note 7, “Long-Term Debt” for a more detailed discussion of the Fourth Amendment and Credit Agreement.

Settlement of Litigation

On June 1, 2023, Verint and the Fornell Group signed a definitive settlement agreement to settle several litigation matters. Please refer to Note 15, “Commitments and Contingencies” for additional disclosure regarding the settlement.

31

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following management’s discussion and analysis is provided to assist readers in understanding our financial condition, results of operations, and cash flows. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended January 31, 2023 and our unaudited condensed consolidated financial statements and notes thereto contained in this report. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and all of which could be affected by uncertainties and risks. Our actual results may differ materially from the results contemplated in these forward-looking statements as a result of many factors including, but not limited to, those described under “Cautionary Note on Forward-Looking Statements”.

Overview

Macroeconomic Conditions

During the three months ended April 30, 2023, global macroeconomic conditions were, and continue to be, influenced by a number of factors, including, but not limited to, the remaining impacts of the COVID-19 pandemic, the Russia-Ukraine war, labor shortages, supply chain disruptions, inflation, instability in the global banking industry, changes to monetary and fiscal policies by central banks and governments around the world, and the erosion of foreign currencies relative to the U.S. dollar. These items are described further below.

We believe that these conditions are impacting customer and partner spending decisions and have resulted in an increased foreign currency impact on our revenues due to the strengthening of the U.S. dollar as well as decreased demand, increased costs, and reduced margins. See the “Foreign Currency Exchange Rates’ Impact on Results of Operations” section below for a further discussion of the impact that foreign currency exchange rates have had on our results of operations.

COVID-19 Pandemic and Workplace Modifications

As a result of the impact of the COVID-19 pandemic, we have adopted a hybrid work model under which the majority of our employees now work from home on a full or part-time basis. As part of our hybrid model, we have also re-opened some of our offices and have contracted for co-working space in certain locations for employees to use as needed, subject to applicable government regulations. Beginning in the year ended January 31, 2022 and continuing into the three months ended April 30, 2023, we decided to exit or reduce our space under certain office leases. We recognized $0.4 million and $7.6 million of accelerated lease expense and other asset impairments, which were reflected within selling, general, and administrative expenses in our condensed consolidated statement of operations for the three months ended April 30, 2023 and 2022, respectively.

We are in the process of migrating to a new cloud-based IT infrastructure to support the shift to a hybrid work environment and enable us to operate more efficiently. IT charges associated with modifying the workplace, including consolidating and/or migrating data centers and labs to the cloud, simplifying the corporate network, and one-time costs for implementing collaboration tools to enable our hybrid work environment, as well as asset impairment charges and IT facility exit costs were $2.8 million and $1.5 million during the three months ended April 30, 2023 and 2022, respectively, which were reflected within selling, general, and administrative expenses in our condensed consolidated statement of operations.

Russia-Ukraine War

We continue to monitor events associated with the Russian invasion of Ukraine and its global impacts, including applicable trade compliance or other legal requirements regarding permissible activities in the region. Based on the current situation, we do not believe the Russia-Ukraine conflict has had or will have a material impact on our business and results of operations. However, if the Russia-Ukraine conflict worsens or expands, leading to greater global economic disruptions and uncertainty, our business and results of operations could be materially impacted. Our operations and customers in Russia, Belarus, and Ukraine represented immaterial portions of our net assets as of April 30, 2023 and January 31, 2023, and total revenue for the three months ended April 30, 2023 and 2022.

Our Business

32

Verint helps brands provide Boundless Customer Engagement™. For more than two decades, the world’s most iconic brands – including more than 85 of the Fortune 100 companies – have trusted Verint to provide the technology and domain expertise they require to effectively build enduring customer relationships.

Verint is uniquely positioned to help organizations close the Engagement Capacity Gap™ with our differentiated Verint Customer Engagement Cloud Platform. Brands today are challenged by new workforce dynamics, ever-expanding customer engagement channels and exponentially more consumer interactions – often while facing limited budgets and resources. As a result, brands are finding it more challenging to deliver the desired customer experience. This creates a capacity gap, which is widening as the digital transformation continues. Organizations are increasingly seeking technology to close this gap with solutions that are based on artificial intelligence (“AI”) and are developed specifically for customer engagement. These solutions automate workflows across enterprise silos to optimize the workforce expense and at the same time drive an elevated consumer experience.

Verint is headquartered in Melville, New York, and has approximately 30 offices worldwide. We have approximately 4,200 passionate employees plus a few hundred contractors around the globe exclusively focused on helping brands provide Boundless Customer Engagement™.

Key Trends

We believe there are three key market trends that are benefiting Verint today: the acceleration of digital transformation, a changing workforce, and elevated customer expectations.

•Acceleration of Digital Transformation: Digital transformation is accelerating, and it is driving significant change in customer engagement for contact centers and across the enterprise. Long gone are the days when customer journeys were limited to phone calls into a contact center. Today, customer journeys take place across many touchpoints in the enterprise and across many communication and collaboration platforms, with digital leading the way. Many brands understand that as digital rises in importance and telephony becomes more commoditized, organizations need to change business processes and put their primary focus on application capabilities when making customer engagement technology decisions. Customer touchpoints take place in contact centers, in back-office and branch operations, in ecommerce, in digital marketing, in self-service, and in customer experience departments. We believe that the breadth of customer touchpoints across the enterprise and the rapid growth in digital interactions benefit Verint as these trends create demand for new solutions that can increase automation and connect organizational silos to increase efficiency and elevate the customer experience.

•A Changing Workforce: Brands are facing unprecedented challenges when it comes to how they manage their changing workforce. Increasingly, brands are managing employees that may work from anywhere. Providing flexibility for where employees work creates greater challenges in managing and coaching employee teams. And because of the limited resources that are available, brands must drive greater workforce efficiency. They need to find ways to use technology, like AI-powered bots, to augment their workforce. Brands recognize the need to leverage data and automation to achieve greater efficiency. In addition, the importance of employee experience continues to grow, and brands must quickly evolve how they recruit, onboard, and retain employees. We believe that these trends benefit Verint as they create demand for new solutions that can shape the future of work, with a workforce of people and bots working together, increased automation, greater employee flexibility, and a greater focus on the voice of the employees.

•Elevated Customer Expectations: Customer expectations for faster, more consistent, and contextual responses continue to rise and meeting those expectations is becoming increasingly difficult with legacy technology. The proliferation in customer channels and the desire of customers to seamlessly shift between channels creates a more complex customer journey for brands to manage and support. Customers also expect brands to have a deep understanding of the customer’s relationship with that brand — an understanding that is unified across the enterprise, regardless of whether the customer touchpoint is in the contact center, on a website, through a mobile app, in the back office, or in a branch. To develop that deep understanding, brands recognize the need to fuse the data that has traditionally existed in silos across the enterprise and use it to inform and automate the customer experience. We believe that this trend benefits Verint as it creates demand for new solutions that help brands support complex customer journeys and increase automation to meet elevated customer expectations.

While we continue to see significant demand for our solutions, including due to the foregoing key trends, we believe that current macroeconomic conditions, as described above, are impacting customer and partner spending decisions. Future impacts on our business and financial results as a result of these conditions are not estimable at this time and depend, in part, on the

33

extent to which these conditions improve or worsen. See the “Risk Factors” under Item 1A of our Annual Report on Form 10-K for the year ended January 31, 2023 for further discussion of the possible impact of macroeconomic conditions and other global events on our business.

Critical Accounting Policies and Estimates

Note 1, “Summary of Significant Accounting Policies” to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended January 31, 2023 describes the significant accounting policies and methods used in the preparation of the condensed consolidated financial statements appearing in this report. The accounting policies that reflect our more significant estimates, judgments and assumptions in the preparation of our condensed consolidated financial statements are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of our Annual Report on Form 10-K for the year ended January 31, 2023, and include the following:

•Revenue recognition;

•Accounting for business combinations;

•Goodwill and other acquired intangible assets;

•Income taxes; and

•Accounting for stock-based compensation.

There were no significant changes to our critical accounting policies and estimates during the three months ended April 30, 2023.

Results of Operations

Seasonality and Cyclicality

As is typical for many software and technology companies, our business is subject to seasonal and cyclical factors. In most years, our revenue and operating income are typically highest in the fourth quarter and lowest in the first quarter (prior to the impact of unusual or nonrecurring items). Moreover, revenue and operating income in the first quarter of a new year may be lower than in the fourth quarter of the preceding year, in some years, by a significant margin. In addition, we generally receive a higher volume of orders in the last month of a quarter, with orders concentrated in the latter part of that month. We believe that these seasonal and cyclical factors primarily reflect customer spending patterns and budget cycles, as well as the impact of incentive compensation plans for our sales personnel. While seasonal and cyclical factors such as these are common in the software and technology industry, this pattern should not be considered a reliable indicator of our future revenue or financial performance. Many other factors, including general economic conditions, may also have an impact on our business and financial results.

Overview of Operating Results

The following table sets forth a summary of certain key financial information for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands, except per share data)	2023		2022
Revenue	$	216,566	$	217,906
Operating income	$	8,772	$	498
Net loss attributable to Verint Systems Inc. common shares	$	(1,905)	$	(4,914)
Net loss per common share attributable to Verint Systems Inc.:
Basic	$	(0.03)	$	(0.08)
Diluted	$	(0.03)	$	(0.08)

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Our revenue decreased approximately $1.3 million, from $217.9 million in the three months ended April 30, 2022 to $216.6 million in the three months ended April 30, 2023. The decrease consisted of an $8.4 million decrease in nonrecurring revenue, partially offset by a $7.1 million increase in recurring revenue. For additional details on our revenue by category, see “—Revenue”. Revenue in the Americas, in Europe, the Middle East and Africa (“EMEA”), and in the Asia-Pacific (“APAC”) regions represented approximately 70%, 20%, and

34

10% of our total revenue, respectively, in the three months ended April 30, 2023, compared to approximately 67%, 22%, and 11%, respectively, in the three months ended April 30, 2022. Further details of changes in revenue are provided below.

We reported operating income of $8.8 million in the three months ended April 30, 2023 compared to operating income of $0.5 million in the three months ended April 30, 2022. The increase in operating income was primarily due to a $7.0 million increase in gross profit, from $141.2 million to $148.2 million, and a $1.3 million decrease in operating expenses, from $140.7 million to $139.4 million. The decrease in operating expenses consisted of a $1.6 million decrease in selling, general and administrative expenses and a $0.5 million decrease in amortization of other acquired intangible assets, partially offset by a $0.8 million increase in net research and development expenses. Further details of changes in operating income are provided below.

Net loss attributable to Verint Systems Inc. common shares was $1.9 million and diluted net loss per common share was $0.03 in the three months ended April 30, 2023 compared to a net loss attributable to Verint Systems Inc. common shares of $4.9 million and diluted net loss per common share of $0.08 in the three months ended April 30, 2022. The decrease in net loss attributable to Verint Systems Inc. common shares in the three months ended April 30, 2023 was primarily due to a $8.3 million increase in operating income as described above, partially offset by a $4.1 million increase in our provision for income taxes and a $1.2 million increase in total other expense, net. Further details of these changes are provided below.

As of April 30, 2023 and 2022, we employed approximately 4,200 employees plus a few hundred contractors.

Foreign Currency Exchange Rates’ Impact on Results of Operations

A portion of our business is conducted in currencies other than the U.S. dollar, and therefore our revenue, cost of revenue, and operating expenses are affected by fluctuations in applicable foreign currency exchange rates. The income statements of our non-U.S. operations are translated into U.S. dollars at the average exchange rates for each applicable month in a period. Revenue denominated in non-U.S. dollar currency was 20% and 22% of our total revenue for the three months ended April 30, 2023 and 2022, respectively. Our combined cost of revenue and operating expenses denominated in non-U.S. dollar currency were 31% and 30% of our total combined cost of revenue and operating expenses for the three months ended April 30, 2023 and 2022, respectively.

When comparing average exchange rates for the three months ended April 30, 2023 to average exchange rates for the three months ended April 30, 2022, the U.S. dollar strengthened relative to the British pound sterling, the Australian dollar, and the euro, resulting in an overall decrease in our revenue and expenses on a U.S. dollar-denominated basis. For the three months ended April 30, 2023, had foreign currency exchange rates remained unchanged from rates in effect for the three months ended April 30, 2022, our revenue would have been approximately $2.9 million higher and our cost of revenue and operating expenses on a combined basis would have been approximately $4.4 million higher, which would have resulted in a $1.5 million decrease in our operating income.

Revenue

We derive and report our revenue in two categories: (a) recurring revenue, which includes bundled SaaS, unbundled SaaS, hosting services, optional managed services, initial and renewal support revenue, and product warranties, and (b) nonrecurring revenue, which primarily consists of perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties.

The following table sets forth revenue by category for the three months ended April 30, 2023 and 2022:

35

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Recurring revenue
Bundled SaaS revenue	$	59,453	$	49,285	21%
Unbundled SaaS revenue	57,695		45,445		27%
Optional managed services revenue	12,865		15,913		(19)%
Total cloud revenue	130,013		110,643		18%
Support revenue	36,426		48,724		(25)%
Total recurring revenue	166,439		159,367		4%
Nonrecurring revenue
Perpetual revenue	24,334		33,258		(27)%
Professional services revenue	25,793		25,281		2%
Total nonrecurring revenue	50,127		58,539		(14)%
Total revenue	$	216,566	$	217,906	(1)%

Recurring Revenue

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Recurring revenue increased approximately $7.0 million, or 4%, from $159.4 million in the three months ended April 30, 2022 to $166.4 million in the three months ended April 30, 2023. The increase consisted of a $19.3 million increase in cloud revenue, partially offset by a $12.3 million decrease in support revenue. The increase in cloud revenue was primarily due to an increase in unbundled SaaS revenue resulting from support conversion transactions and new cloud deployments and an increase in bundled SaaS revenue due to new customer contracts and existing customers expanding their use of our cloud platform, partially offset by a decrease in optional managed services revenue. The decrease in support revenue was primarily due to customers migrating to our cloud-based solutions.

We expect our revenue mix to continue to shift to our cloud offerings, which is consistent with our cloud-first strategy and a general market shift from on-premises to cloud-based solutions. While we continue to see significant demand for our solutions as our customers accelerate the digitization of their customer interactions and internal operations, we believe that current macroeconomic factors, as described above, are impacting customer and partner spending decisions.

Nonrecurring Revenue

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Nonrecurring revenue decreased approximately $8.4 million, or 14%, from $58.5 million in the three months ended April 30, 2022 to $50.1 million in the three months ended April 30, 2023. The decrease consisted of an $8.9 million decrease in perpetual revenue, partially offset by a $0.5 million increase in professional services revenue. The decrease in perpetual revenue was primarily due to a decrease in on-premises license revenue driven by the continued shift in spending by our customers toward our cloud-based solutions and a decrease in demand for our offerings that include third-party hardware with embedded software. The increase in professional services revenue was primarily driven by an increase in business advisory consulting services.

Cost of Revenue

The following table sets forth the cost of revenue by recurring and nonrecurring, as well as amortization of acquired technology for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Cost of recurring revenue	$	39,643	$	41,028	(3)%
Cost of nonrecurring revenue	26,795		32,068		(16)%
Amortization of acquired technology	1,965		3,639		(46)%
Total cost of revenue	$	68,403	$	76,735	(11)%

Cost of Recurring Revenue

36

Cost of recurring revenue primarily consists of employee compensation and related expenses for our cloud operations and support teams, contractor costs, cloud infrastructure and data center costs, travel expenses relating to optional managed services and support, and royalties due to third parties for software components that are embedded in our cloud-based solutions. Cost of recurring revenue also includes amortization of capitalized software development costs, stock-based compensation expenses, facility costs, and other allocated overhead expenses.

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Cost of recurring revenue decreased approximately $1.4 million, or 3%, from $41.0 million in the three months ended April 30, 2022 to $39.6 million in the three months ended April 30, 2023. The decrease was primarily due to a reduction in service and support costs due to lower personnel costs as a result of a decrease in headcount as well as offshoring certain support activities, and a decrease in general overhead expenses due to a reduced number of offices. Our recurring revenue gross margins increased from 74% in the three months ended April 30, 2022 to 76% in the three months ended April 30, 2023, primarily due to a favorable change in offering mix and a decrease in recurring costs as noted above.

We expect our cost of recurring revenue to increase on an absolute basis in future periods as we continue to invest in our cloud operations to support our growing cloud customer base and enhance the security of our solutions.

Cost of Nonrecurring Revenue

Cost of nonrecurring revenue primarily consists of employee compensation and related expenses, contractor costs, travel expenses relating to installation, training and consulting services, hardware material costs, and royalties due to third parties for software components that are embedded in our on-premises software solutions. Cost of nonrecurring revenue also includes amortization of capitalized software development costs, employee compensation and related expenses associated with our global operations, facility costs, and other allocated overhead expenses.

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Cost of nonrecurring revenue decreased approximately $5.3 million, or 16%, from $32.1 million in the three months ended April 30, 2022 to $26.8 million in the three months ended April 30, 2023. The decrease was primarily driven by a decrease in employee compensation and related expenses due to a decrease in headcount supporting our nonrecurring revenue offerings and a decrease in third-party hardware delivered and related shipping and handling costs. Our nonrecurring gross margins increased from 45% in the three months ended April 30, 2022 to 47% in the three months ended April 30, 2023, primarily due to nonrecurring costs decreasing at a slightly faster rate than nonrecurring revenue.

Amortization of Acquired Technology

Amortization of acquired technology consists of the amortization of technology assets acquired in connection with business combinations.

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Amortization of acquired technology decreased approximately $1.6 million, or 46%, from $3.6 million in the three months ended April 30, 2022 to $2.0 million in the three months ended April 30, 2023. The decrease was attributable to acquired technology intangible assets from historical business combinations becoming fully amortized, partially offset by amortization expense of acquired technology intangible assets associated with recent business combinations.

Further discussion regarding our business combinations appears in Note 5, “Business Combinations and Divestitures” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

Research and Development, Net

Research and development expenses, net (“R&D”) consist primarily of personnel and subcontracting expenses, facility costs, and other allocated overhead, net of certain software development costs that are capitalized. Software development costs are capitalized upon the establishment of technological feasibility and continue to be capitalized through the general release of the related software product.

The following table sets forth research and development, net for the three months ended April 30, 2023 and 2022:

37

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Research and development, net	$	31,782	$	30,947	3%

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. R&D increased approximately $0.9 million, or 3%, from $30.9 million in the three months ended April 30, 2022 to $31.8 million in the three months ended April 30, 2023. This increase was primarily attributable to a $1.4 million increase in employee compensation and related expenses primarily due to increased investment in R&D headcount and an increase of $0.3 million in third-party software components in support of our cloud business, partially offset by a $0.5 million increase in benefits from participation in certain government-sponsored programs for the support of R&D activities and a $0.3 million decrease in general overhead costs.

Selling, General and Administrative Expenses

Selling, general and administrative expenses (“SG&A”) consist primarily of personnel costs and related expenses, professional fees, changes in the fair values of our obligations under contingent consideration arrangements, sales and marketing expenses, including travel costs, sales commissions and sales referral fees, facility costs, communication expenses, and other administrative expenses.

The following table sets forth selling, general and administrative expenses for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Selling, general and administrative	$	101,279	$	102,882	(2)%

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. SG&A decreased approximately $1.6 million, or 2%, from $102.9 million in the three months ended April 30, 2022 to $101.3 million in the three months ended April 30, 2023. This decrease was primarily due to a $7.2 million decrease in accelerated facility costs and asset impairment charges due to the early termination or abandonment of certain office leases in the prior year, a $2.6 million decrease in stock-based compensation expense primarily due to a decrease in the grant date fair value of equity awards and a shorter vesting schedule for prior period grants which became fully vested in the prior year, $1.4 million decrease in facilities expenses and depreciation charges as a result of a reduced number of offices, and a $0.8 million decrease in marketing-related expenses. These decreases in SG&A were partially offset by a $6.1 million increase in professional services expense primarily due to reaching settlement regarding certain legal matters discussed in Note 15, “Commitments and Contingencies” to our condensed consolidated financial statements included under Part I, Item 1 of this report, an increase of $1.5 million in employee compensation and related expenses due to an increase in headcount and general wage inflation, a $1.3 million increase in IT costs and asset impairment charges related to a cloud-based IT infrastructure realignment project, and a $0.9 million increase in third-party software components in order to support our hybrid work environment. SG&A was also impacted by a $0.4 million increase due to a change in the fair value of our obligations under contingent consideration arrangements, from a net benefit of $0.2 million during the three months ended April 30, 2022 to a net charge of $0.2 million during the three months ended April 30, 2023, as a result of revised outlooks for achieving the performance targets under several unrelated contingent consideration arrangements.

Amortization of Other Acquired Intangible Assets

Amortization of other acquired intangible assets consists of the amortization of certain intangible assets acquired in connection with business combinations, including customer relationships, distribution networks, trade names, and non-compete agreements.

The following table sets forth the amortization of other acquired intangible assets for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Amortization of other acquired intangible assets	$	6,330	$	6,844	(8)%

38

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Amortization of other acquired intangible assets decreased approximately $0.5 million, or 8%, from $6.8 million in the three months ended April 30, 2022 to $6.3 million in the three months ended April 30, 2023. The decrease was attributable to acquired customer-related intangible assets from historical business combinations becoming fully amortized, partially offset by amortization expense associated with acquired intangible assets from recent business combinations.

Further discussion regarding our business combinations appears in Note 5, “Business Combinations and Divestitures” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

Other (Expense) Income, Net

The following table sets forth total other (expense) income, net for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Interest income	$	1,982	$	199	*
Interest expense	(2,781)		(1,501)		85%
Other income (expense):
Foreign currency gains, net	237		1,713		(86)%
Other, net	(213)		(39)		*
Total other income, net	24		1,674		(99)%
Total other (expense) income, net	$	(775)	$	372	*

* Percentage is not meaningful.

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Total other (expense) income, net, increased by $1.2 million from $0.4 million of net income in the three months ended April 30, 2022 to $0.8 million of net expense in the three months ended April 30, 2023.

Interest income increased from $0.2 million in the three months ended April 30, 2022 to $2.0 million in the three months ended April 30, 2023 due to higher interest rates on our investments in commercial paper and money market funds, which are included in cash and cash equivalents, as well as our bank time deposits, which are included in short-term investments.

Interest expense increased from $1.5 million in the three months ended April 30, 2022 to $2.8 million in the three months ended April 30, 2023 primarily due to higher interest rates on our Term Loan borrowings. Additionally, during the three months ended April 30, 2023, we recorded $0.2 million of losses on early retirement of debt as a result of repaying the remaining $100.0 million outstanding balance on our Term Loan utilizing proceeds from borrowings under our Revolving Credit Facility. Further discussion regarding our Term Loan and Revolving Credit Facility appears in Note 7, “Long-term Debt” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

We recorded $0.2 million of net foreign currency gains in the three months ended April 30, 2023 compared to $1.7 million of net foreign currency gains in the three months ended April 30, 2022. Our foreign currency gains in the current period resulted primarily from fluctuations associated with the exchange rate movement of the U.S. dollar against the Israeli shekel and the Brazilian real.

Provision for Income Taxes

The following table sets forth our provision for income taxes for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,				% Change
(in thousands)	2023		2022		2023 - 2022
Provision for income taxes	$	4,363	$	296	*

* Percentage is not meaningful.

39

Three Months Ended April 30, 2023 compared to Three Months Ended April 30, 2022. Our effective income tax rate was 54.6% for the three months ended April 30, 2023, compared to an effective income tax rate of 34.0% for the three months ended April 30, 2022. 

For the three months ended April 30, 2023, the effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions. The result was an income tax provision of $4.4 million on pretax income of $8.0 million, which represented an effective income tax rate of 54.6%.

For the three months ended April 30, 2022, the income tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions. The result was an income tax provision of $0.3 million on pretax income of $0.9 million, which represented an effective income tax rate of 34.0%.

Liquidity and Capital Resources

Overview

Our primary recurring source of cash is the collection of proceeds from the sale of products and services to our customers, including cash periodically collected in advance of delivery or performance.

On December 4, 2019, we announced that an affiliate (the “Apax Investor”) of Apax Partners (“Apax”) would make an investment in us in an amount of up to $400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the “Investment Agreement”), on May 7, 2020, the Apax Investor purchased $200.0 million of our Series A convertible preferred stock (“Series A Preferred Stock”) with an initial conversion price of $53.50 per share. In accordance with the Investment Agreement, the Series A Preferred Stock did not participate in the Spin-Off distribution of the Cognyte shares described above and the Series A Preferred Stock conversion price was instead adjusted to $36.38 per share based on the ratio of the relative trading prices of Verint and Cognyte following the Spin-Off. In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock (“Series B Preferred Stock”). The Series B Preferred Stock is convertible at a conversion price of $50.25, based in part on our trading price over the 20 trading day period following the Spin-Off. As of April 30, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%.

Each series of Preferred Stock pays dividends at an annual rate of 5.2% until May 7, 2024, and thereafter at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends will be cumulative and payable semiannually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. We used the proceeds from the Apax investment to repay outstanding indebtedness, to fund a portion of our stock repurchase programs (as described below under “Liquidity and Capital Resources Requirements”), and/or for general corporate purposes. Please refer to Note 9, “Convertible Preferred Stock”, to our condensed consolidated financial statements included under Part I, Item 1 of this report for more information regarding the Apax convertible preferred stock investment.

Our primary recurring use of cash is payment of our operating costs, which consist primarily of employee-related expenses, such as compensation and benefits, as well as general operating expenses for cloud operations, marketing, facilities and overhead costs, and capital expenditures. We also utilize cash for debt service, stock repurchases, dividends on the Preferred Stock, and business acquisitions. Cash generated from operations, along with our existing cash, cash equivalents, and short-term investments, are our primary sources of operating liquidity.

We have historically expanded our business in part by investing in strategic growth initiatives, including acquisitions of products, technologies, and businesses. We may finance such acquisitions using cash, debt, stock, or a combination of the foregoing, however, we have used cash as consideration for substantially all of our historical business acquisitions, including approximately $21.9 million of net cash expended for business acquisitions during the year ended January 31, 2023. There were no business acquisitions during the three months ended April 30, 2023 or 2022. Please refer to Note 5, “Business Combinations and Divestitures”, to our condensed consolidated financial statements included under Part I, Item 1 of this report for more information regarding our recent business combinations.

We continually examine our options with respect to terms and sources of existing and future short-term and long-term capital resources to enhance our operating results and to ensure that we retain financial flexibility, and may from time to time elect to

40

raise capital through the issuance of additional equity or the incurrence of additional debt. On April 9, 2021, we issued $315.0 million in aggregate principal amount of 0.25% convertible senior notes due April 15, 2026, unless earlier converted by the holders pursuant to their terms (the “2021 Notes”). We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the capped call transactions described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the issuance of the Series B Preferred Stock mentioned above, to repay a portion of the outstanding indebtedness under our Credit Agreement, to terminate an interest rate swap agreement, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

A portion of our operating income is earned outside the United States. Cash, cash equivalents, short-term investments, and restricted cash, restricted cash equivalents, and restricted bank time deposits (excluding any long-term portions) held by our subsidiaries outside of the United States were $146.2 million and $126.0 million as of April 30, 2023 and January 31, 2023, respectively, and are generally used to fund the subsidiaries’ operating requirements and to invest in growth initiatives, including business acquisitions. These subsidiaries also held long-term restricted cash and cash equivalents, and restricted bank time deposits of $0.2 million, at April 30, 2023 and January 31, 2023.

We currently intend to continue to indefinitely reinvest a portion of the earnings of our foreign subsidiaries, which, as a result of the 2017 Tax Cuts and Jobs Act, may now be repatriated without incurring additional U.S. federal income taxes.

Should other circumstances arise whereby we require more capital in the United States than is generated by our domestic operations, or should we otherwise consider it in our best interests, we could repatriate future earnings from foreign jurisdictions, which could result in higher effective tax rates. As noted above, we currently intend to indefinitely reinvest a portion of the earnings of our foreign subsidiaries to finance foreign activities. Except to the extent that earnings of our foreign subsidiaries have been subject to U.S. taxation as of April 30, 2023, we have not provided tax on the outside basis difference of foreign subsidiaries nor have we provided for any additional withholding or other tax that may be applicable should a future distribution be made from any unremitted earnings of foreign subsidiaries. Due to complexities in the laws of the foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income and withholding taxes that would have to be provided on such earnings.

The following table summarizes our total cash, cash equivalents, restricted cash, cash equivalents, and bank time deposits, and short-term investments, as well as our total debt, as of April 30, 2023 and January 31, 2023:

	April 30,		January 31,
(in thousands)	2023		2023
Cash and cash equivalents	$	260,719	$	282,099
Restricted cash and cash equivalents, and restricted bank time deposits (excluding long term portions)	283		300
Short-term investments	3,646		697
Total cash, cash equivalents, restricted cash and cash equivalents, restricted bank time deposits, and short-term investments	$	264,648	$	283,096
Total debt, including current portions	$	409,672	$	408,908

Capital Allocation Framework

As noted above, after cash utilization required for working capital, capital expenditures, required debt service, and dividends on the Preferred Stock, we expect that our primary usage of cash will be for business combinations, repayment of outstanding indebtedness, and/or stock repurchases under repurchase programs that may be in place from time to time (subject to the terms of our Credit Agreement). Please see the “Liquidity and Capital Resources Requirements” section below for further information about our recent stock repurchase programs.

Condensed Consolidated Cash Flow Activity

The following table summarizes selected items from our condensed consolidated statements of cash flows for the three months ended April 30, 2023 and 2022:

41

	Three Months Ended April 30,
(in thousands)	2023		2022
Net cash provided by operating activities	$	60,007	$	53,926
Net cash used in investing activities	(10,758)		(7,207)
Net cash used in financing activities	(71,486)		(118,030)
Effect of foreign currency exchange rate changes on cash and cash equivalents	859		(2,431)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	$	(21,378)	$	(73,742)

Our financing activities used $71.5 million of net cash and our investing activities used $10.8 million of net cash during the three months ended April 30, 2023, which was partially offset by $60.0 million of cash generated from operating activities. Further discussion of these items appears below.

Net Cash Provided by Operating Activities

Net cash provided by operating activities is driven primarily by our net income or loss, as adjusted for non-cash items and working capital changes. Operating activities generated $60.0 million of net cash during the three months ended April 30, 2023, compared to $53.9 million generated during the three months ended April 30, 2022. Our operating cash flow in the current period increased primarily due to a $12.5 million insurance reimbursement related to certain legal matters that we have agreed to settle, with payment from us expected this fiscal year, partially offset by higher combined interest and net income tax payments.

Our cash flow from operating activities can fluctuate from period to period due to several factors, including the timing of our billings and collections, the timing and amounts of interest, income tax and other payments, and our operating results.

Net Cash Used in Investing Activities

During the three months ended April 30, 2023, our investing activities used $10.8 million of net cash, consisting primarily of $6.8 million of payments for property, equipment and capitalized software development, $2.9 million of net purchases of short-term investments, and a $1.1 million investment in a privately-held company.

During the three months ended April 30, 2022, our investing activities used $7.2 million of net cash, consisting primarily of payments for property, equipment and capitalized software development costs.

We had no significant commitments for capital expenditures at April 30, 2023.

Net Cash Used in Financing Activities

For the three months ended April 30, 2023, our financing activities used $71.5 million of net cash, primarily due to $100.0 million of repayments of borrowing under our Term Loan, $60.3 million of payments to repurchase common stock, $10.4 million of payments of Preferred Stock dividends, $0.5 million of finance lease payments, and a $0.2 million distribution to a noncontrolling shareholder of one of our subsidiaries, partially offset by $100.0 million of proceeds from borrowings under our Revolving Credit Facility.

For the three months ended April 30, 2022, our financing activities used $118.0 million of net cash, primarily due to $105.2 million of payments to repurchase common stock, $10.4 million of payments of Preferred Stock dividends, $1.6 million for the financing portion of payments under contingent consideration arrangements related to prior business combinations, $0.7 million of finance lease payments, and $0.1 million paid for debt-related issuance fees.

Liquidity and Capital Resources Requirements

Based on past performance and current expectations, we believe that our cash, cash equivalents, short-term investments and cash generated from operations will be sufficient to meet anticipated operating costs, required payments of principal and interest, dividends on Preferred Stock, working capital needs, ordinary course capital expenditures, research and development spending, and other commitments for at least the next 12 months from the issuance of our consolidated financial statements. Currently, we have no plans to pay any cash dividends on our common stock, which are subject to certain restrictions under our Credit Agreement.

42

Our liquidity could be negatively impacted by a decrease in demand for our products and services, including the impact of changes in customer buying behavior due to circumstances over which we have no control, including, but not limited to, the effects of general economic conditions or geopolitical developments. If we determine to make additional business acquisitions or otherwise require additional funds, we may need to raise additional capital, which could involve the issuance of additional equity or debt securities or an increase in our borrowings under our credit facility.

Repurchases of Common Stock

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million during the repurchase period.

During the year ended January 31, 2023, we repurchased approximately 649,000 shares of our common stock for a cost of $23.5 million under the current stock repurchase program. During the three months ended April 30, 2023, we repurchased approximately 1,593,000 shares of our common stock at a cost of $60.1 million, including excise tax of $0.4 million, under this program. Our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the IRA. The excise tax of $0.4 million was recognized as part of the cost basis of shares acquired in the condensed consolidated statements of stockholders' equity during the three months ended April 30, 2023. Subsequent to April 30, 2023 through June 1, 2023, we repurchased approximately 159,000 shares of our common stock for $5.5 million under this program. Repurchases were funded with available cash in the United States.

Financing Arrangements

2021 Notes

On April 9, 2021, we issued $315.0 million in aggregate principal amount of our 2021 Notes, unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum.

We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the Capped Calls described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate an interest rate swap agreement, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of April 30, 2023, the 2021 Notes were not convertible.

Based on the closing market price of our common stock on April 30, 2023, the if-converted value of the 2021 Notes was less than their aggregate principal amount.

Capped Calls

In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the “Capped Calls”) with certain counterparties. The Capped Calls are intended generally to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap.

The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. The Capped Calls have the economic effect of increasing the conversion price of the 2021 Notes from $62.08 per share to $100.00 per share. Our exercise rights under the

43

Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of April 30, 2023, no Capped Calls have been exercised.

Pursuant to their terms, the Capped Calls qualify for classification within stockholders’ equity, and their fair value is not remeasured and adjusted, as long as they continue to qualify for stockholders’ equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital.

Credit Agreement

On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, 2021, and 2023, as further described below (as amended, the “Credit Agreement”).

The Credit Agreement currently provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan originally set to mature on June 29, 2024 (the “Term Loan”), and a $300.0 million revolving credit facility maturing on April 9, 2026 (the “Revolving Credit Facility”). The Revolving Credit Facility replaced our prior $300.0 million revolving credit facility (the “Prior Revolving Credit Facility”), and is subject to increase and reduction from time to time according to the terms of the Credit Agreement.

On April 27, 2023, we repaid the remaining $100.0 million outstanding principal balance on our Term Loan in full utilizing proceeds from our Revolving Credit Facility, along with $0.5 million of accrued interest thereon. As a result, $0.2 million of deferred debt issuance costs associated with the Term Loan were written off and are included within interest expense on our condensed consolidated statement of operations for the three months ended April 30, 2023.

Interest rates on loans under the Credit Agreement are periodically reset, at our option, originally at either a Eurodollar Rate (which was derived from LIBOR) or an ABR Rate (each as defined in the Credit Agreement), plus in each case a margin.

On May 10, 2023, we entered into an amendment to the Credit Agreement (the “Fourth Amendment”) related to the planned phase-out of LIBOR by the UK Financial Conduct Authority. Effective July 1, 2023, borrowings under the Credit Agreement will bear interest, at our option, at either: (i) the alternate base rate (as defined in the Credit Agreement), plus the applicable margin therefor (as defined in the Credit Agreement) or (ii) the adjusted Term Secured Overnight Financing Rate published by the CME Term SOFR Administrator (as more fully defined and set forth in the Credit Agreement, “Adjusted Term SOFR”), plus the applicable margin therefor. The applicable margin in each case is determined based on our Leverage Ratio (as defined below) and ranges from 0.25% to 1.25% for borrowings bearing interest at the alternate base rate and from 1.25% to 2.25% for borrowings bearing interest based on Adjusted Term SOFR.

Borrowings under the Revolving Credit Facility were $100.0 million at April 30, 2023, which is included in long-term debt on our condensed consolidated balance sheet. For borrowings under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement) leverage ratio (the “Leverage Ratio”). As of April 30, 2023, the interest rate on our revolving credit facility borrowings was 6.52%. In addition, we are required to pay a commitment fee with respect to unused availability at rates per annum determined by reference to our Leverage Ratio. The proceeds of borrowings under the Revolving Credit Facility were used to repay the outstanding balance of the Term Loan.

The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.5 to 1. At April 30, 2023, our Leverage Ratio was approximately 1.1 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement.

Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders’ commitments to make loans under the Credit Agreement may be terminated.

Contractual Obligations

44

Our principal commitments primarily consist of long-term debt, dividends on Preferred Stock, leases for office space and open non-cancellable purchase orders. As of April 30, 2023, we believe there have been no material changes to our contractual obligations from those disclosed in Part II, Item 7. — Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended January 31, 2023. For additional information regarding our leases, long-term debt and our commitments and contingencies, see Note 17, “Leases”, in the Form 10-K and Note 7, “Long-Term Debt”, Note 9, “Convertible Preferred Stock”, and Note 15, “Commitments and Contingencies” in the notes to our condensed consolidated financial statements included in Part I, Item 1 of this report.

As of April 30, 2023, our total operating lease liabilities were $46.8 million, of which $7.6 million is included within accrued expenses and other current liabilities (current portions), and $39.2 million is included as operating lease liabilities (long-term portions), on our condensed consolidated balance sheets.

It is not our business practice to enter into off-balance sheet arrangements. However, in the normal course of business, we enter into contracts in which we make representations and warranties that guarantee the performance of our products and services. Historically, there have been no significant losses related to such guarantees.

Our condensed consolidated balance sheet at April 30, 2023 included $52.8 million of non-current tax reserves (including interest and penalties of $5.3 million), net of related benefits for uncertain tax positions. We do not expect to make any significant payments for these uncertain tax positions within the next 12 months.

Contingent Payments Associated with Business Combinations

In connection with certain of our business combinations, we have agreed to make contingent cash payments to the former owners of the acquired companies based upon the achievement of performance targets following the acquisition dates.

For the three months ended April 30, 2023, we made $0.3 million of payments under contingent consideration arrangements. As of April 30, 2023, potential future cash payments, and earned consideration expected to be paid, subsequent to April 30, 2023 under contingent consideration arrangements totaled $21.5 million, the estimated fair value of which was $12.9 million, of which $7.1 million was recorded within accrued expenses and other current liabilities, and $5.8 million was recorded within other liabilities. The performance periods associated with these potential payments extend through January 2026.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, and the potential impact of these pronouncements on our condensed consolidated financial statements, see Note 1, “Basis of Presentation and Significant Accounting Policies” to the condensed consolidated financial statements in Part I, Item 1 of this report.

45

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial condition due to adverse changes in financial market prices and rates. We are exposed to market risk related to changes in interest rates and foreign currency exchange rate fluctuations. To manage the volatility relating to interest rate and foreign currency risks, we periodically enter into derivative instruments including foreign currency forward exchange contracts and interest rate swap agreements. It is our policy to use derivative instruments only to the extent considered necessary to meet our risk management objectives. We use derivative instruments solely to reduce the financial impact of these risks and do not use derivative instruments for speculative purposes.

Interest Rate Risk on Our Debt

In April 2021, we issued $315.0 million in aggregate principal amount of the 2021 Notes. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. Concurrent with the issuance of the 2021 Notes, we entered into capped call transactions with certain counterparties. These separate transactions were completed to reduce our exposure to potential dilution upon conversion of the 2021 Notes.

The 2021 Notes have a fixed annual interest rate of 0.25% and therefore do not have interest rate risk exposure. However, the fair values of the 2021 Notes are subject to interest rate risk, market risk, and other factors due to the convertible feature. The fair values of the 2021 Notes are also affected by our common stock price. Generally, the fair values of the 2021 Notes will increase as interest rates fall and/or our common stock price increases, and decrease as interest rates rise and/or our common stock price decreases. Changes in the fair values of the 2021 Notes do not impact our financial position, cash flows, or results of operations due to the fixed nature of the debt obligations. We do not carry the 2021 Notes at fair value on our consolidated balance sheet, but we report the fair value of the 2021 Notes for disclosure purposes.

Interest rates on loans under the Credit Agreement are periodically reset, at our option, originally at either a Eurodollar Rate or an ABR Rate (each as defined in the Credit Agreement), plus, in each case, a margin. On May 10, 2023, we entered into an amendment to the Credit Agreement (the “Fourth Amendment”) related to the planned phase-out of LIBOR by the UK Financial Conduct Authority. Effective July 1, 2023, borrowings under the Credit Agreement will bear interest, at our option, at either: (i) the alternate base rate (as defined in the Credit Agreement), plus the applicable rate margin therefor (as defined in the Credit Agreement) or (ii) the adjusted Term Secured Overnight Financing Rate published by the CME Term SOFR Administrator (as more fully defined and set forth in the Credit Agreement, “Adjusted Term SOFR”), plus the applicable margin therefor. The applicable margin in each case is determined based on our leverage ratio (described above) and ranges from 0.25% to 1.25% for borrowings bearing interest at the alternate base rate and from 1.25% to 2.25% for borrowings bearing interest based on Adjusted Term SOFR.

On April 27, 2023, we repaid in full the remaining $100.0 million outstanding principal balance related to our Term Loan with $100.0 million of proceeds from borrowings under our Revolving Credit Facility. For loans under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement) leverage ratio. As of April 30, 2023, the interest rate on our $100.0 million of borrowings under our Revolving Credit Facility was 6.52%. A hypothetical 10% change in interest rates during any of the periods presented would not have had a material impact on our financial statements.

Inflation Risk

While we continue to see significant demand for our solutions as our customers accelerate the digitization of their customer interactions and internal operations, we believe that current macroeconomic factors, including increased inflation rates, are impacting customer and partner spending decisions. Given the current macroeconomic environment, we continue to look for ways to manage costs and mitigate any changes in our customers’ purchasing behavior that may occur due to significant inflationary pressure or other factors. If our costs, in particular labor, sales and marketing, and cloud hosting costs, become subject to sustained or increased inflationary pressure, we may be unable to fully offset such higher costs through price increases, which could harm our business, financial condition, and results of operations.

The section entitled “Quantitative and Qualitative Disclosures About Market Risk” under Part II, Item 7A of our Annual Report on Form 10-K for the year ended January 31, 2023 provides detailed quantitative and qualitative discussions of the market risks affecting our operations. Other than as described above under “Interest Rate Risk on Our Debt” and “Inflation Risk”, and the market risk that is created by the global market disruptions and uncertainties resulting from macroeconomic factors discussed in

46

“Management’s Discussion and Analysis of Financial Condition and Results of Operations” included under Part I, Item 2 of this report, we believe that our market risk profile did not materially change during the three months ended April 30, 2023.

47

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management conducted an evaluation under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of April 30, 2023. Disclosure controls and procedures are those controls and other procedures that are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified by the rules and forms promulgated by the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As a result of this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of April 30, 2023.

Changes in Internal Control Over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended April 30, 2023, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be achieved. Further, the design of a control system must reflect the impact of resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the possibility that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by individual acts, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all possible conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

48

Part II

Item 1. Legal Proceedings

See Note 15, “Commitments and Contingencies” to our condensed consolidated financial statements under Part I, Item 1 of this report for information regarding our legal proceedings.

Item 1A.  Risk Factors

There have been no material changes to the Risk Factors described in Part I “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended January 31, 2023. In addition to the other information set forth in this Quarterly Report, you should carefully consider the risks discussed in our Annual Report on Form 10-K, which could materially affect our business, financial condition, or operating results. The risks described in our Annual Report on Form 10-K are not the only risks facing us, however. Additional risks and uncertainties not currently known to us or that we currently deem to be insignificant also may materially and adversely affect our business, financial condition, or operating results in the future.

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock not to exceed, in the aggregate, $200.0 million during the repurchase period. During the year ended January 31, 2023, we repurchased approximately 649,000 shares under this stock repurchase program for an aggregate purchase price of $23.5 million. During the three months ended April 30, 2023, we repurchased 1,593,000 shares under this stock repurchase program for $60.1 million, including excise tax of $0.4 million. Subsequent to April 30, 2023 through June 1, 2023, we repurchased approximately 159,000 shares of our common stock for $5.5 million under this program. Repurchases were financed with available cash in the United States.

From time to time, we have purchased common stock from our directors, officers, and other employees to facilitate income tax withholding by us or the payment of income taxes by such holders upon vesting of equity awards occurring during a Company-imposed trading blackout or lockup period.

On August 16, 2022, the U.S. government enacted the Inflation Reduction Act (the "IRA") into law. The IRA imposes a 1% excise tax on share repurchases, which is effective for us for repurchases completed after December 31, 2022. We reflect the excise tax within equity as part of the repurchase of the common stock.

Share repurchase activity during the three months ended April 30, 2023 was as follows:

Period	Total Number Shares Purchased	Average Price Paid per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
February 1, 2023 - February 28, 2023	126,193	$	38.08	126,193	$	171,752
March 1, 2023 - March 31, 2023	430,387	36.34		430,387	156,112
April 1, 2023 - April 30, 2023	1,036,269	37.83		1,036,269	116,911
	1,592,849	$	37.45	1,592,849

(1) Represents the approximate weighted-average price paid per share and excludes excise tax.

Item 3. Defaults Upon Senior Securities

49

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

50

Item 6.  Exhibits

The following exhibit list includes agreements that we entered into or that became effective during the three months ended April 30, 2023:

Number	Description	Filed Herewith / Incorporated by Reference from
10.1	Fourth Amendment, dated May 10, 2023, to the Credit Agreement dated June 29, 2017, among Verint Systems Inc., as borrower, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent	Form 8-K filed on May 16, 2023
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
32.1	Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)	Filed herewith
32.2	Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)	Filed herewith
101.INS	XBRL Instance Document	Filed herewith
101.SCH	XBRL Taxonomy Extension Schema Document	Filed herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	Filed herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	Filed herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase Document	Filed herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	Filed herewith

(1)These exhibits are being “furnished” with this periodic report and are not deemed “filed” with the SEC and are not incorporated by reference in any filing of the company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

51

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Verint Systems Inc.
June 7, 2023	/s/ Grant Highlander
	Grant Highlander
	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

52

EX-31.1

Exhibit 31.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Dan Bodner, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Verint Systems Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated:	June 7, 2023	By:	/s/ Dan Bodner
			Dan Bodner
			Chief Executive Officer
			Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Grant Highlander, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Verint Systems Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated:	June 7, 2023	By:	/s/ Grant Highlander
			Grant Highlander
			Chief Financial Officer
			Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Verint Systems Inc. (the “Company”) on Form 10-Q for the period ended April 30, 2023 (the “Report”), I, Dan Bodner, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	June 7, 2023	/s/ Dan Bodner
		Dan Bodner
		Chief Executive Officer
		Principal Executive Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

CERTIFICATION REQUIRED BY 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Verint Systems Inc. (the “Company”) on Form 10-Q for the period ended April 30, 2023 (the “Report”), I, Grant Highlander, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	June 7, 2023	/s/ Grant Highlander
		Grant Highlander
		Chief Financial Officer
		Principal Financial Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Cover Page - shares	3 Months Ended
	Apr. 30, 2023	May 15, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-34807
Entity Registrant Name	Verint Systems Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3200514
Entity Address, Address Line One	175 Broadhollow Road
Entity Address, City or Town	Melville,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11747
City Area Code	(631)
Local Phone Number	962-9600
Title of 12(b) Security	Common Stock, $.001 par value per share
Trading Symbol	VRNT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		64,286,441
Entity Central Index Key	0001166388
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Current Assets:
Cash and cash equivalents	$ 260,719	$ 282,099
Short-term investments	3,646	697
Accounts receivable, net of allowance for credit losses of $1.4 million and $1.3 million, respectively	157,786	188,414
Contract assets, net	58,862	60,444
Inventories	13,553	12,628
Prepaid expenses and other current assets	62,079	75,374
Total current assets	556,645	619,656
Property and equipment, net	61,511	64,810
Operating lease right-of-use assets	35,128	37,649
Goodwill	1,354,761	1,347,213
Intangible assets, net	77,457	85,272
Other assets	152,913	159,001
Total assets	2,238,415	2,313,601
Current Liabilities:
Accounts payable	33,878	43,631
Accrued expenses and other current liabilities	152,761	155,944
Contract liabilities	254,418	271,476
Total current liabilities	441,057	471,051
Long-term debt	409,672	408,908
Long-term contract liabilities	15,914	18,047
Operating lease liabilities	39,198	40,744
Other liabilities	72,865	80,381
Total liabilities	978,706	1,019,131
Commitments and Contingencies
Temporary Equity:
Preferred Stock	436,321	436,321
Stockholders' Equity:
Common stock — $0.001 par value; authorized 240,000,000 shares; issued 64,286,000 and 65,404,000 shares; outstanding 64,286,000 and 65,404,000 shares at April 30, 2023 and January 31, 2023, respectively.	64	65
Additional paid-in capital	1,008,498	1,055,157
Accumulated deficit	(42,038)	(45,333)
Accumulated other comprehensive loss	(145,589)	(154,099)
Total Verint Systems Inc. stockholders' equity	820,935	855,790
Noncontrolling interest	2,453	2,359
Total stockholders' equity	823,388	858,149
Total liabilities, temporary equity, and stockholders' equity	2,238,415	2,313,601
Series A Preferred Stock
Temporary Equity:
Preferred Stock	200,628	200,628
Series B Preferred Stock
Temporary Equity:
Preferred Stock	$ 235,693	$ 235,693

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Allowance for credit losses	$ 1,400	$ 1,300
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	2,207,000	2,207,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	240,000,000	240,000,000
Common stock, issued (in shares)	64,286,000	65,404,000
Common Stock, outstanding (in shares)	64,286,000	65,404,000
Series A Preferred Stock
Preferred stock, issued (in shares)	200,000	200,000
Preferred stock, outstanding (in shares)	200,000	200,000
Preferred stock, liquidation preference value	$ 203,467	$ 206,067
Preferred stock, redemption value	$ 203,467	$ 206,067
Series B Preferred Stock
Preferred stock, issued (in shares)	200,000	200,000
Preferred stock, outstanding (in shares)	200,000	200,000
Preferred stock, liquidation preference value	$ 203,467	$ 206,067
Preferred stock, redemption value	$ 203,467	$ 206,067

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenue:
Revenue	$ 216,566	$ 217,906
Cost of revenue:
Amortization of acquired technology	1,965	3,639
Total cost of revenue	68,403	76,735
Gross profit	148,163	141,171
Operating expenses:
Research and development, net	31,782	30,947
Selling, general and administrative	101,279	102,882
Amortization of other acquired intangible assets	6,330	6,844
Total operating expenses	139,391	140,673
Operating income	8,772	498
Other income (expense), net:
Interest income	1,982	199
Interest expense	(2,781)	(1,501)
Other income, net	24	1,674
Total other (expense) income, net	(775)	372
Income before provision for income taxes	7,997	870
Provision for income taxes	4,363	296
Net income	3,634	574
Net income attributable to noncontrolling interests	339	288
Net income attributable to Verint Systems Inc.	3,295	286
Dividends on preferred stock	(5,200)	(5,200)
Net loss attributable to Verint Systems Inc. common shares	$ (1,905)	$ (4,914)
Net loss per common share attributable to Verint Systems Inc.:
Basic (in dollars per share)	$ (0.03)	$ (0.08)
Diluted (in dollars per share)	$ (0.03)	$ (0.08)
Weighted-average common shares outstanding:
Basic (in shares)	64,940	64,947
Diluted (in shares)	64,940	64,947
Recurring
Revenue:
Revenue	$ 166,439	$ 159,367
Cost of revenue:
Cost of revenue	39,643	41,028
Nonrecurring
Revenue:
Revenue	50,127	58,539
Cost of revenue:
Cost of revenue	$ 26,795	$ 32,068

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 3,634	$ 574
Other comprehensive income (loss), net of reclassification adjustments:
Foreign currency translation adjustments	8,612	(29,890)
Net decrease from foreign exchange contracts designated as hedges	(123)	(188)
Benefit from income taxes on net decrease from foreign exchange contracts designated as hedges	21	33
Other comprehensive income (loss)	8,510	(30,045)
Comprehensive income (loss)	12,144	(29,471)
Comprehensive income attributable to noncontrolling interests	339	288
Comprehensive income (loss) attributable to Verint Systems Inc.	$ 11,805	$ (29,759)

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Total Verint Systems Inc. Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss	Non-controlling Interests
Beginning balances (in shares) at Jan. 31, 2022			66,211
Beginning balances at Jan. 31, 2022	$ 954,579	$ 952,194	$ 66	$ 1,125,152	$ 0	$ (54,509)	$ (118,515)	$ 2,385
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	574	286				286		288
Other comprehensive (loss) income	(30,045)	(30,045)					(30,045)
Stock-based compensation — equity-classified awards	16,011	16,011		16,011
Common stock issued for stock awards and stock bonuses (in shares)			466
Common stock issued for stock awards and stock bonuses	0		$ 1	(1)
Treasury stock acquired (in shares)			(2,000)
Treasury stock acquired	(105,666)	(105,666)			(105,666)
Ending balances (in shares) at Apr. 30, 2022			64,677
Ending balances at Apr. 30, 2022	835,453	832,780	$ 67	1,141,162	(105,666)	(54,223)	(148,560)	2,673
Beginning balances (in shares) at Jan. 31, 2023			65,404
Beginning balances at Jan. 31, 2023	858,149	855,790	$ 65	1,055,157	0	(45,333)	(154,099)	2,359
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,634	3,295				3,295		339
Other comprehensive (loss) income	8,510	8,510					8,510
Stock-based compensation — equity-classified awards	13,436	13,436		13,436
Common stock issued for stock awards and stock bonuses (in shares)			475
Common stock repurchased and retired (in shares)			(1,593)
Common stock repurchased and retired	(60,096)	(60,096)	$ (1)	(60,095)
Distribution to noncontrolling interest	(245)							(245)
Ending balances (in shares) at Apr. 30, 2023			64,286
Ending balances at Apr. 30, 2023	$ 823,388	$ 820,935	$ 64	$ 1,008,498	$ 0	$ (42,038)	$ (145,589)	$ 2,453

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities:
Net income	$ 3,634	$ 574
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,503	18,048
Stock-based compensation, excluding cash-settled awards	14,814	18,364
Losses on early retirements of debt	237	0
Other, net	45	2,163
Changes in operating assets and liabilities, net of effects of business combinations and divestitures:
Accounts receivable	31,124	41,766
Contract assets	1,923	4,024
Inventories	(937)	68
Prepaid expenses and other assets	21,278	(8,686)
Accounts payable and accrued expenses	(6,821)	(5,694)
Contract liabilities	(19,245)	(9,645)
Deferred income taxes	90	(1,074)
Other, net	(3,638)	(5,982)
Net cash provided by operating activities	60,007	53,926
Cash flows from investing activities:
Purchases of property and equipment	(4,923)	(5,224)
Maturities and sales of investments	232	250
Purchases of investments	(3,180)	(250)
Cash paid for capitalized software development costs	(1,868)	(2,003)
Change in restricted bank time deposits, and other investing activities, net	(1,019)	20
Net cash used in investing activities	(10,758)	(7,207)
Cash flows from financing activities:
Proceeds from borrowings	100,000	0
Repayments of borrowings and other financing obligations	(100,530)	(775)
Payments of debt-related costs	(9)	(93)
Purchases of treasury stock and common stock for retirement	(60,294)	(105,213)
Preferred stock dividend payments	(10,400)	(10,400)
Distributions paid to noncontrolling interest	(245)	0
Payments of contingent consideration for business combinations (financing portion), and other financing activities	(8)	(1,549)
Net cash used in financing activities	(71,486)	(118,030)
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents	859	(2,431)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	(21,378)	(73,742)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	282,161	358,868
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$ 260,783	$ 285,126

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2023	Apr. 30, 2022
Cash and cash equivalents	$ 260,719	$ 285,046
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	260,783	285,126
Prepaid expenses and other current assets
Restricted cash and cash equivalents	6	23
Other assets
Restricted cash and cash equivalents	$ 58	$ 57

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Apr. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Description of Business

Unless the context otherwise requires, the terms “Verint”, “we”, “us”, and “our” in these notes to condensed consolidated financial statements refer to Verint Systems Inc. and its consolidated subsidiaries.

Verint helps brands provide Boundless Customer Engagement™. For more than two decades, the world’s most iconic brands – including more than 85 of the Fortune 100 companies – have trusted Verint to provide the technology and domain expertise they require to effectively build enduring customer relationships.

Through the Verint Customer Engagement Cloud Platform, we offer our customers and partners solutions that are based on artificial intelligence (“AI”) and are developed specifically for customer engagement. These solutions automate workflows across enterprise silos to optimize the workforce expense and at the same time drive an elevated consumer experience. Our solutions are used by approximately 10,000 organizations in over 175 countries across a diverse set of verticals, including financial services, healthcare, utilities, technology, and government. Our customers include large enterprises with thousands of employees, as well as small to medium sized business organizations.

Verint is headquartered in Melville, New York, and has approximately 30 offices worldwide. We have approximately 4,200 passionate employees plus a few hundred contractors around the globe exclusively focused on helping brands provide Boundless Customer Engagement™.

Spin-Off of Cognyte Software Ltd.

On February 1, 2021, we completed the spin-off (the “Spin-Off”) of Cognyte Software Ltd. (“Cognyte”), a company limited by shares incorporated under the laws of the State of Israel whose business and operations consist of our former Cyber Intelligence Solutions business. The Spin-Off of Cognyte was completed by way of a pro rata distribution in which holders of Verint’s common stock, par value $0.001 per share, received one ordinary share of Cognyte, no par value, for every share of common stock of Verint held of record as of the close of business on January 25, 2021. After the distribution, we do not beneficially own any ordinary shares of Cognyte and no longer consolidate Cognyte into our financial results for periods ending after January 31, 2021. The Spin-Off was intended to be generally tax-free to our stockholders for U.S. federal income tax purposes.

Apax Convertible Preferred Stock Investment

On December 4, 2019, we announced that an affiliate (the “Apax Investor”) of Apax Partners (“Apax”) would make an investment in us in an amount of up to $400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the “Investment Agreement”), on May 7, 2020, the Apax Investor purchased $200.0 million of our Series A convertible preferred stock (“Series A Preferred Stock”). In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock (the “Series B Preferred Stock” and together with the Series A Preferred Stock, the “Preferred Stock”). As of April 30, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 9, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment.

Preparation of Condensed Consolidated Financial Statements

The condensed consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and on the same basis as the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the U.S. Securities and Exchange Commission (“SEC”), except for the recently adopted accounting pronouncements described below. The condensed consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the periods ended April 30, 2023 and 2022, and the condensed consolidated balance sheet as of April 30, 2023, are not audited but reflect all adjustments that, in the opinion of management, are of a normal recurring nature and that are considered necessary for a fair presentation of the results for the periods shown. The condensed consolidated balance sheet as of January 31, 2023 is derived from the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended January 31, 2023. Certain information and disclosures normally included in annual consolidated financial statements have been omitted

pursuant to the rules and regulations of the SEC. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the SEC. The results for interim periods are not necessarily indicative of a full year’s results.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our condensed consolidated balance sheet, but separately from our stockholders’ equity.

Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment.

We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Significant Accounting Policies

There have been no material changes in our significant accounting policies during the three months ended April 30, 2023, as compared to the significant accounting policies described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023.

Recently Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which adds contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with revenue recognition guidance. We adopted this standard on a prospective basis for the annual and interim periods beginning February 1, 2023. The adoption of this standard did not have any impact on our condensed consolidated financial statements as the ultimate impact is dependent on the size and frequency of future acquisitions and does not affect contract assets or contract liabilities related to acquisitions completed prior to the adoption date.

In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extends the period of time entities can utilize the reference rate reform relief guidance under ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting from December 31, 2022 to December 31, 2024. We expect to elect various optional expedients for contract modifications related to financial instruments affected by the reference rate reform through the effective date of December 31, 2024, as extended by ASU 2022-06. The application of this guidance did not have any impact on our consolidated financial statements.

In August 2022, the Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new book minimum tax of 15% on consolidated adjusted GAAP pre-tax earnings for corporations with average income in excess of $1 billion and is effective for us in tax years beginning after December 31, 2022. We do not expect to be subject to the corporate minimum tax. In addition, the IRA also introduced a nondeductible 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. During the three months ended April 30, 2023 the calculated excise tax was $0.4 million and was recognized as part of the cost basis of shares acquired in our consolidated statement of stockholders' equity. We do not expect taxes due on future repurchases of our shares to have a material effect on our business.

New Accounting Pronouncements Not Yet EffectiveThere are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on our condensed consolidated financial statements and related disclosures.

XML

REVENUE RECOGNITION

3 Months Ended

Apr. 30, 2023

Revenue from Contract with Customer [Abstract]

REVENUE RECOGNITION

REVENUE RECOGNITION

We derive our revenue primarily from providing customers the right to access our cloud-based solutions, the right to use our software for an indefinite or specified period of time, and related services and support based on when access or control of the software passes to our customers or the services are provided, in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. Revenue is reported net of applicable sales and use tax, value-added tax and other transaction taxes imposed on the related transactions, including mandatory government charges that are passed through to our customers.

We determine revenue recognition through the following five steps:

•Identification of the contract, or contracts, with a customer

•Identification of the performance obligations in the contract

•Determination of the transaction price

•Allocation of the transaction price to the performance obligations in the contract

•Recognition of revenue when, or as, performance obligations are satisfied.

We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.

Disaggregation of Revenue

The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions.

•Recurring revenue primarily consists of:

◦Cloud revenue, which consists primarily of software as a service (“SaaS”) revenue and optional managed services revenue.

▪SaaS revenue consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period).

▪Bundled SaaS revenue is recognized over time.

▪Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one- and three-year time frame. Unbundled SaaS can be deployed in the cloud, either by us or a cloud partner.

◦Support revenue, which consists of initial and renewal support.

•Nonrecurring revenue primarily consists of our perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties.

	Three Months Ended April 30,
(in thousands)	2023		2022
Recurring revenue:
Bundled SaaS revenue	$	59,453	$	49,285
Unbundled SaaS revenue	57,695		45,445
Optional managed services revenue	12,865		15,913
Total cloud revenue	130,013		110,643
Support revenue	36,426		48,724
Total recurring revenue	166,439		159,367
Nonrecurring revenue:
Perpetual revenue	24,334		33,258
Professional services revenue	25,793		25,281
Total nonrecurring revenue	50,127		58,539
Total revenue	$	216,566	$	217,906

Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:

(in thousands)	April 30, 2023		January 31, 2023
Accounts receivable, net	$	157,786	$	188,414
Contract assets, net	$	58,862	$	60,444
Long-term contract assets, net (included in other assets)	$	35,845	$	37,950
Contract liabilities	$	254,418	$	271,476
Long-term contract liabilities	$	15,914	$	18,047

We receive payments from customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to multi-year unbundled SaaS contracts and arrangements where our right to consideration is subject to the contractually agreed upon billing schedule. We expect billing and collection of a majority of our contract assets to occur within the next twelve months and asset impairment charges related to contract assets were immaterial in the three months ended April 30, 2023 and 2022. As of April 30, 2023, two partners, both authorized global resellers of our solutions, accounted for more than 10% of our aggregated accounts receivable and contract assets; Partner A was approximately 22% and Partner B was approximately 15%. As of January 31, 2023, Partner A and Partner B each accounted for approximately 15% of our aggregated accounts receivable and contract assets. Credit losses relating to these customers have historically been immaterial.

Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract. Revenue recognized during the three months ended April 30, 2023 and 2022 from amounts included in contract liabilities at the beginning of each period was $101.5 million and $96.9 million, respectively.

Remaining Performance Obligations

Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The majority of our arrangements are for periods of up to three years, with a significant portion being one year or less.

We elected to exclude amounts of variable consideration attributable to sales- or usage-based royalties in exchange for a license of our IP from the remaining performance obligations. The timing and amount of revenue recognition for our remaining performance obligations is influenced by several factors, including seasonality, the timing of renewals, the timing of delivery of software licenses, the average length of the contract terms, and foreign currency exchange rates.

The following table provides information about when we expect to recognize our remaining performance obligations:

(in thousands)	April 30, 2023		January 31, 2023
RPO:
Expected to be recognized within 1 year	$	435,708	$	464,346
Expected to be recognized in more than 1 year	256,195		262,695
Total RPO	$	691,903	$	727,041

XML

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.

3 Months Ended

Apr. 30, 2023

Earnings Per Share [Abstract]

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.

The following table summarizes the calculation of basic and diluted net loss per common share attributable to Verint Systems Inc. for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands, except per share amounts)	2023		2022
Net income	$	3,634	$	574
Net income attributable to noncontrolling interests	339		288
Net income attributable to Verint Systems Inc.	3,295		286
Dividends on preferred stock	(5,200)		(5,200)
Net loss attributable to Verint Systems Inc. for basic net loss per common share	(1,905)		(4,914)
Dilutive effect of dividends on preferred stock	—		—
Net loss attributable to Verint Systems Inc. for diluted net loss per common share	$	(1,905)	$	(4,914)
Weighted-average shares outstanding:
Basic	64,940		64,947
Dilutive effect of employee equity award plans	—		—
Dilutive effect of 2021 Notes	—		—
Dilutive effect of assumed conversion of preferred stock	—		—
Diluted	64,940		64,947
Net loss per common share attributable to Verint Systems Inc.:
Basic	$	(0.03)	$	(0.08)
Diluted	$	(0.03)	$	(0.08)

We excluded the following weighted-average potential common shares from the calculations of diluted net loss per common share during the applicable periods because their inclusion would have been anti-dilutive:

	Three Months Ended April 30,
(in thousands)	2023	2022
Common shares excluded from calculation:
Stock options and restricted stock-based awards	2,080	1,571
Series A Preferred Stock	5,498	5,498
Series B Preferred Stock	3,980	3,980

In periods for which we report a net loss attributable to Verint Systems Inc. common shares, basic net loss per common share and diluted net loss per common share are identical since the effect of all potential common shares is anti-dilutive and therefore excluded.

For the three months ended April 30, 2023, the average price of our common stock did not exceed the $62.08 per share conversion price of our 2021 Notes (as defined in Note 7, “Long-Term Debt”), and other requirements for the 2021 Notes to be

convertible were not met. The 2021 Notes will have a dilutive impact on net income per common share at any time when the average market price of our common stock for a quarterly reporting period exceeds the conversion price.

The Capped Calls (as defined in Note 7, “Long-Term Debt”) do not impact our diluted earnings per common share calculations as their effect would be anti-dilutive. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the $62.08 conversion price, with such reduction and/or offset subject to a cap of $100.00.

Further details regarding the 2021 Notes and Capped Calls appear in Note 7, “Long-Term Debt”.

The weighted-average common shares underlying the assumed conversion of the Preferred Stock, on an as-converted basis, were excluded from the calculations of diluted net loss per common share for the three months ended April 30, 2023 and 2022, as their effect would have been anti-dilutive. Further details regarding the Preferred Stock investment appear in Note 9, “Convertible Preferred Stock”.

XML

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

3 Months Ended

Apr. 30, 2023

Cash, Cash Equivalents, and Short-Term Investments [Abstract]

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

The following tables summarize our cash, cash equivalents, and short-term investments as of April 30, 2023 and January 31, 2023:

	April 30, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	148,871	$	—	$	—	$	148,871
Money market funds	80,624		—		—		80,624
Commercial paper	30,975		—		—		30,975
U.S. Treasury bills	249		—		—		249
Total cash and cash equivalents	$	260,719	$	—	$	—	$	260,719
Short-term investments:
Bank time deposits	$	3,646	$	—	$	—	$	3,646
Total short-term investments	$	3,646	$	—	$	—	$	3,646

	January 31, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	134,289	$	—	$	—	$	134,289
Money market funds	96,941		—		—		96,941
Commercial paper	50,869		—		—		50,869
Total cash and cash equivalents	$	282,099	$	—	$	—	$	282,099
Short-term investments:
Bank time deposits	$	697	$	—	$	—	$	697
Total short-term investments	$	697	$	—	$	—	$	697

Bank time deposits which are reported within short-term investments consist of deposits held outside of the United States with maturities of greater than 90 days, or without specified maturity dates which we intend to hold for periods in excess of 90 days. All other bank deposits are included within cash and cash equivalents.

During the three months ended April 30, 2023 and 2022, proceeds from maturities and sales of short-term investments were $0.2 million and $0.3 million, respectively.

XML

BUSINESS COMBINATIONS AND DIVESTITURES

3 Months Ended

Apr. 30, 2023

Business Combination and Asset Acquisition [Abstract]

BUSINESS COMBINATIONS AND DIVESTITURES

BUSINESS COMBINATIONS AND DIVESTITURES

Three Months Ended April 30, 2023

We did not complete any business combinations during the three months ended April 30, 2023.

Year Ended January 31, 2023

During the year ended January 31, 2023, we completed two business combinations:

•In August 2022, we completed the acquisition of a company with conversational AI technology including six employees.

•In January 2023, we completed the acquisition of a provider of appointment scheduling solutions including approximately 20 employees.

These business combinations were not material to our consolidated financial statements.

The combined consideration for these business combinations was approximately $38.4 million, including $26.1 million of combined cash paid at the closings, contingent consideration with an estimated fair value of $12.2 million, and purchase price adjustments of $0.1 million. The combined consideration was partially offset by $4.2 million of combined cash received in the acquisitions. The contingent consideration had a maximum payout amount of approximately $21.4 million as of the respective acquisition dates, and is contingent upon the achievement of certain performance targets over periods extending through January 2026. Cash paid for these business combinations was funded by cash on hand.

The combined purchase prices were allocated to intangible assets, including the recognition of $6.0 million of developed technology, $4.2 million of customer relationships, and $0.1 million of trade names. The acquisitions resulted in the recognition of $25.6 million of goodwill, of which $5.1 million is deductible for income tax purposes and $20.5 million is not deductible. Included among the factors contributing to the recognition of goodwill in these transactions were synergies in products and technologies, and the addition of skilled, assembled workforces. We incurred approximately $0.2 million of acquisition related costs, which were recorded as selling, general, and administrative expenses for the three months ended April 30, 2023.

Revenue and net income (loss) attributable to these acquisitions for the three months ended April 30, 2023 were not material.

Other Business Combination Information

For the three months ended April 30, 2023 and 2022, we recorded a charge of $0.2 million and benefit of $0.2 million, respectively, within selling, general and administrative expenses for changes in the fair values of contingent consideration obligations associated with business combinations, which was based on our historical business combinations achieving certain objectives and milestones. The aggregate fair values of the remaining contingent consideration obligations associated with business combinations was $12.9 million at April 30, 2023, of which $7.1 million was recorded within accrued expenses and other current liabilities, and $5.8 million was recorded within other liabilities.

Payments of contingent consideration earned under these agreements were $0.3 million and $2.7 million for the three months ended April 30, 2023 and 2022, respectively.

Divestiture

In March 2023, we completed the sale of an insignificant product line that we inherited as part of a legacy acquisition and did not fit with our current business priorities or strategic direction. The total consideration for the sale was $0.7 million, which is payable to us in three equal installments beginning July 2023, and through March 2025. The transaction reduced goodwill by $0.3 million and intangible assets by $0.2 million and resulted in a gain of approximately $0.2 million, which was recorded within other income, net in our condensed consolidated statement of operations.

XML

INTANGIBLE ASSETS AND GOODWILL

3 Months Ended

Apr. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL  

Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and removed from our condensed consolidated balance sheets, consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,478	$	(396,652)	$	61,826
Acquired technology	227,375		(211,851)		15,524
Trade names	4,487		(4,380)		107
Distribution network	2,440		(2,440)		—
Total intangible assets	$	692,780	$	(615,323)	$	77,457

 

	January 31, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,013	$	(390,113)	$	67,900
Acquired technology	229,317		(212,065)		17,252
Trade names	4,479		(4,359)		120
Distribution network	2,440		(2,440)		—
Total intangible assets	$	694,249	$	(608,977)	$	85,272

Total amortization expense recorded for acquisition-related intangible assets was $8.3 million and $10.5 million for the three months ended April 30, 2023 and 2022, respectively. The reported amount of net acquisition-related intangible assets can fluctuate from the impact of changes in foreign currency exchange rates on intangible assets not denominated in U.S. dollars.

Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows:

(in thousands)
Years Ending January 31,	Amount
2024 (remainder of year)	$	24,068
2025	16,730
2026	15,346
2027	11,572
2028	6,905
2029 and thereafter	2,836
Total	$	77,457

There were no impairments of acquired intangible assets during the three months ended April 30, 2023 and 2022.

Goodwill activity for the three months ended April 30, 2023 was as follows: 

(in thousands)	Amount
Three Months Ended April 30, 2023
Goodwill, gross, at January 31, 2023	$	1,403,256
Accumulated impairment losses through January 31, 2023	(56,043)
Goodwill, net, at January 31, 2023	1,347,213
Foreign currency translation and other	7,408
Business combinations, including adjustments to prior period acquisitions	140
Goodwill, net, at April 30, 2023	$	1,354,761
Balance at April 30, 2023
Goodwill, gross, at April 30, 2023	$	1,410,804
Accumulated impairment losses through April 30, 2023	(56,043)
Goodwill, net, at April 30, 2023	$	1,354,761

No events or circumstances indicating the potential for goodwill impairment were identified during the three months ended April 30, 2023.

XML

LONG-TERM DEBT

3 Months Ended

Apr. 30, 2023

Debt Disclosure [Abstract]

LONG-TERM DEBT

LONG-TERM DEBT

The following table summarizes our long-term debt at April 30, 2023 and January 31, 2023:

	April 30,		January 31,
(in thousands)	2023		2023
2021 Notes	$	315,000	$	315,000
Term Loan	—		100,000
Revolving Credit Facility	100,000		—
Less: unamortized debt discounts and issuance costs	(5,328)		(6,092)
Total debt	409,672		408,908
Less: current maturities	—		—
Long-term debt	$	409,672	$	408,908

2021 Notes

On April 9, 2021, we issued $315.0 million in aggregate principal amount of 0.25% convertible senior notes due April 15, 2026 (the “2021 Notes”), unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum.

We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the Capped Calls described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate an interest rate swap, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of April 30, 2023, the 2021 Notes were not convertible.

We incurred approximately $8.9 million of issuance costs in connection with the 2021 Notes, which were deferred and are presented as a reduction of long-term debt, and which are being amortized as interest expense over the term of the 2021 Notes.

Including the impact of the deferred debt issuance costs, the effective interest rate on the 2021 Notes was approximately 0.83% at April 30, 2023.

Based on the closing market price of our common stock on April 30, 2023, the if-converted value of the 2021 Notes was less than their aggregate principal amount.

Capped Calls

In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the “Capped Calls”) with certain counterparties. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap.

The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. Our exercise rights under the Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of April 30, 2023, no Capped Calls have been exercised.

Pursuant to their terms, the Capped Calls qualify for classification within stockholders’ equity, and their fair value is not remeasured and adjusted as long as they continue to qualify for stockholders’ equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital.

Credit Agreement

On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, 2021, and 2023, as further described below (as amended, the “Credit Agreement”).

The Credit Agreement provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan originally set to mature on June 29, 2024 (the “Term Loan”), and a $300.0 million revolving credit facility maturing on April 9, 2026 (the “Revolving Credit Facility”). The Revolving Credit Facility replaced our prior $300.0 million revolving credit facility (the “Prior Revolving Credit Facility”) and is subject to increase and reduction from time to time according to the terms of the Credit Agreement. The majority of the proceeds from the Term Loan were used to repay all outstanding term loans under our prior credit agreement.

Optional prepayments of loans under the Credit Agreement are generally permitted without premium or penalty. During the three months ended April 30, 2021, in addition to our regular quarterly $1.1 million principal payment, we repaid $309.0 million of our Term Loan, reducing the outstanding principal balance to $100.0 million. On April 27, 2023, we repaid the remaining $100.0 million outstanding principal balance on our Term Loan utilizing proceeds from borrowings under our Revolving Credit Facility, along with $0.5 million of accrued interest thereon. As a result, $0.2 million of combined deferred debt issuance costs and unamortized discount associated with the Term Loan were written off and are included within interest expense on our condensed consolidated statement of operations for the three months ended April 30, 2023.

Interest rates on loans under the Credit Agreement are periodically reset, at our option, originally at either a Eurodollar Rate (which was derived from LIBOR) or an ABR Rate (each as defined in the Credit Agreement), plus in each case a margin.

On May 10, 2023, we entered into an amendment to the Credit Agreement (the “Fourth Amendment”) related to the planned phase-out of LIBOR by the UK Financial Conduct Authority. Effective July 1, 2023, borrowings under the Credit Agreement will bear interest, at our option, at either: (i) the alternate base rate (as defined in the Credit Agreement), plus the applicable margin therefor (as defined in the Credit Agreement) or (ii) the adjusted Term Secured Overnight Financing Rate published by the CME Term SOFR Administrator (as more fully defined and set forth in the Credit Agreement, “Adjusted Term SOFR”), plus the applicable margin therefor. The applicable margin in each case is determined based on our Leverage Ratio (as defined below) and ranges from 0.25% to 1.25% for borrowings bearing interest at the alternate base rate and from 1.25% to 2.25% for borrowings bearing interest based on Adjusted Term SOFR.

Borrowings outstanding under the Revolving Credit Facility were $100.0 million at April 30, 2023, which is included in long-term debt on our condensed consolidated balance sheet. For borrowings under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement)

leverage ratio (the "Leverage Ratio"). As of April 30, 2023, the interest rate on our revolving credit facility borrowings was 6.52%. In addition, we are required to pay a commitment fee with respect to unused availability under the Revolving Credit Facility at rates per annum determined by reference to our Leverage Ratio. The proceeds of borrowings under the Revolving Credit Facility may be used for our working capital and general corporate purposes, including for permitted acquisitions and permitted stock repurchases, and the repayment of term loans, if any.

Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries, and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement.

The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders’ commitments to make loans under the Credit Agreement may be terminated.

Deferred debt issuance costs associated with the Term Loan were amortized using the effective interest rate method, and deferred debt issuance costs associated with the Revolving Credit Facility are being amortized on a straight-line basis.

Interest Expense

The following table presents the components of interest expense incurred on the 2021 Notes and on borrowings under our Credit Agreement, for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
2021 Notes:
Interest expense at 0.25% coupon rate	$	197	$	195
Amortization of deferred debt issuance costs	443		439
Total Interest Expense — 2021 Notes	$	640	$	634
Borrowings under Credit Agreement:
Interest expense at contractual rates	$	1,650	$	560
Amortization of debt discounts	5		5
Amortization of deferred debt issuance costs	204		211
Losses on early retirements of debt	237		—
Total Interest Expense — Borrowings under Credit Agreement	$	2,096	$	776

XML

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION

3 Months Ended

Apr. 30, 2023

Condensed Financial Information Disclosure [Abstract]

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION

Condensed Consolidated Balance Sheets

Inventories consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30,		January 31,
(in thousands)	2023		2023
Raw materials	$	3,505	$	3,325
Work-in-process	40		40
Finished goods	10,008		9,263
Total inventories	$	13,553	$	12,628

Condensed Consolidated Statements of Operations

Other income, net consisted of the following for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Foreign currency gains, net	$	237	$	1,713
Other, net	(213)		(39)
Total other income, net	$	24	$	1,674

Condensed Consolidated Statements of Cash Flows

The following table provides supplemental information regarding our condensed consolidated cash flows for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Cash paid for interest	$	2,513	$	930
Cash payments of income taxes, net	$	3,758	$	2,238
Cash payments for operating leases	$	1,640	$	12,195
Non-cash investing and financing transactions:
Finance leases of property and equipment	$	212	$	12
Accrued but unpaid purchases of property and equipment	$	360	$	988
Accrued but unpaid purchases of treasury stock	$	—	$	453
Excise tax on share repurchases	$	417	$	—

XML

CONVERTIBLE PREFERRED STOCK

3 Months Ended

Apr. 30, 2023

Equity [Abstract]

CONVERTIBLE PREFERRED STOCK

CONVERTIBLE PREFERRED STOCK

On December 4, 2019, we entered into the Investment Agreement with the Apax Investor whereby, subject to certain closing conditions, the Apax Investor agreed to make an investment in us in an amount up to $400.0 million as follows:

•On May 7, 2020, we issued a total of 200,000 shares of our Series A Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $2.7 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series A Preferred Stock.

•In connection with the completion of the Spin-Off, on April 6, 2021, we issued a total of 200,000 shares of our Series B Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $1.3 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series B Preferred Stock.

Each of the rights, preferences, and privileges of the Series A Preferred Stock and Series B Preferred Stock are set forth in separate certificates of designation filed with the Secretary of State of the State of Delaware on the applicable issuance date.

Voting Rights

Holders of the Preferred Stock have the right to vote on matters submitted to a vote of the holders of our common stock, on an as-converted basis; however, in no event will the holders of Preferred Stock have the right to vote shares of the Preferred Stock on an as-converted basis in excess of 19.9% of the voting power of the common stock outstanding immediately prior to December 4, 2019.

Dividends and Liquidation Rights

The Preferred Stock ranks senior to the shares of our common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of our affairs. Shares of Preferred

Stock have a liquidation preference of the greater of $1,000 per share or the amount that would be received if the shares are converted at the then applicable conversion price at the time of such liquidation.

Each series of Preferred Stock pays dividends at an annual rate of 5.2% until May 7, 2024, and thereafter at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends on the Preferred Stock are cumulative and payable semi-annually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. The dividend rate is subject to increase (i) to 6.0% per annum in the event the number of shares of common stock into which the Preferred Stock could be converted exceeds 19.9% of the voting power of outstanding common stock on December 4, 2019 (unless we obtain shareholder approval of the issuance of common stock upon conversion of the Preferred Stock) and (ii) by 1.0% each year, up to a maximum dividend rate of 10.0% per annum, in the event we fail to satisfy our obligations to redeem the Preferred Stock in specified circumstances.

For the three months ended April 30, 2023, we paid $10.4 million of preferred stock dividends, all of which was accrued as of January 31, 2023, and there were $6.9 million of cumulative undeclared and unpaid preferred stock dividends at April 30, 2023. There were no accrued dividends as of April 30, 2023. We reflected $5.2 million of preferred stock dividends in our condensed consolidated results of operations, for purposes of computing net loss attributable to Verint Systems Inc. common shares, for each of the three months ended April 30, 2023 and 2022.

Conversion

The Series A Preferred Stock was initially convertible into common stock at the election of the holder, subject to certain conditions, at an initial conversion price of $53.50 per share. The initial conversion price represented a conversion premium of 17.1% over the volume-weighted average price per share of our common stock over the 45 consecutive trading days immediately prior to December 4, 2019. In accordance with the Investment Agreement, the Series A Preferred Stock did not participate in the Spin-Off distribution of the Cognyte shares, which occurred on February 1, 2021, and the Series A Preferred Stock conversion price was instead adjusted to $36.38 per share based on the ratio of the relative trading prices of Verint and Cognyte following the Spin-Off. The Series B Preferred Stock is convertible at a conversion price of $50.25, based in part on our trading price over the 20 day trading period following the Spin-Off. As of April 30, 2023, the maximum number of shares of common stock that could be required to be issued upon conversion of the outstanding shares of Preferred Stock was approximately 9.6 million shares and Apax’s ownership in us on an as-converted basis was approximately 13.0%.

At any time after May 7, 2023, in the case of the Series A Preferred Stock, and April 6, 2024, in the case of the Series B Preferred Stock, we will have the option to require that all (but not less than all) of the then-outstanding shares of Preferred Stock of the series convert into common stock if the volume-weighted average price per share of the common stock for at least 30 trading days in any 45 consecutive trading day period exceeds 175% of the then-applicable conversion price of such series (a “Mandatory Conversion”).

We may redeem any or all of the Preferred Stock of a series for cash at any time after May 7, 2026, in the case of the Series A Preferred Stock, and April 6, 2027, in the case of the Series B Preferred Stock, at a redemption price equal to 100% of the liquidation preference of the shares of the Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date, plus a make-whole amount designed to allow the Apax Investor to earn a total 8.0% internal rate of return on such shares.

The Preferred Stock may not be sold or transferred without our prior written consent. The common stock issuable upon conversion of the Preferred Stock is not subject to this restriction. The restriction on the sale or transfer of the Preferred Stock does not apply to certain transfers to one or more permitted co-investors or transfers or pledges of the Preferred Stock pursuant to the terms of specified margin loans entered into by the Apax Investor as well as transfers effected pursuant to a merger, consolidation, or similar transaction consummated by us and transfers that are approved by our board of directors.

At any time after November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, or upon the occurrence of a change of control triggering event (as defined in the certificates of designation), the holders of the applicable series of Preferred Stock will have the right to cause us to redeem all of the outstanding shares of Preferred Stock for cash at a redemption price equal to 100% of the liquidation preference of the shares of such series, plus any accrued and unpaid dividends to, but excluding, the redemption date. Therefore, the Preferred Stock has been classified as temporary equity on our condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023, separate from permanent equity, as the potential required repurchase of the Preferred Stock, however remote in likelihood, is not solely under our control.

As of April 30, 2023, the Preferred Stock was not redeemable, and we have concluded that it is currently not probable of becoming redeemable, including from the occurrence of a change in control triggering event. The holders’ redemption rights which occur at November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, are not considered probable because there is a more than remote likelihood that the Mandatory Conversion may occur prior to such redemption rights. We therefore did not adjust the carrying amount of the Preferred Stock to its current redemption amount, which was its liquidation preference at April 30, 2023 plus accrued and unpaid dividends. As of April 30, 2023, the stated value of the liquidation preference for each series of Preferred Stock was $200.0 million and cumulative, unpaid dividends on each series of Preferred Stock was $3.5 million.

Future Tranche Right

We determined that our obligation to issue and the Apax Investor’s obligation to purchase 200,000 shares of the Series B Preferred Stock in connection with the completion of the Spin-Off and the satisfaction of other customary closing conditions (the “Future Tranche Right”) met the definition of a freestanding financial instrument as the Future Tranche Right is legally detachable and separately exercisable from the Series A Preferred Stock. At issuance, we allocated a portion of the proceeds from the issuance of the Series A Preferred Stock to the Future Tranche Right based upon its fair value at such time, with the remaining proceeds being allocated to the Series A Preferred Stock. The Future Tranche Right was remeasured at fair value each reporting period until the settlement of the right (at the time of the issuance of the Series B Preferred Stock), and changes in its fair value were recognized as a non-cash charge or benefit within other income (expense), net on the condensed consolidated statement of operations.

Upon issuance of the Series A Preferred Stock on May 7, 2020, the Future Tranche Right was recorded as an asset of $3.4 million, as the purchase price of the Series B Preferred Stock was greater than its estimated fair value at the expected settlement date. This resulted in a $203.4 million carrying value, before direct and incremental issuance costs, for the Series A Preferred Stock.

Immediately prior to the issuance of the Series B Preferred Stock, the Future Tranche Right was remeasured and upon the issuance of the Series B Preferred Stock in April 2021, the Future Tranche Right was settled, resulting in a reclassification of the $37.0 million fair value of the Future Tranche Right liability at that time to the carrying value of the Series B Preferred Stock. This resulted in a $237.0 million carrying value, before direct and incremental issuance costs, for the Series B Preferred Stock. As a result of the issuance of the Series B Preferred Stock, we no longer recognize changes in the fair value of the Future Tranche Right in our condensed consolidated statements of operations.

XML

STOCKHOLDERS' EQUITY

3 Months Ended

Apr. 30, 2023

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Common Stock Dividends

We did not declare or pay any cash dividends on our common stock during the three months ended April 30, 2023 and 2022. Under the terms of our Credit Agreement, we are subject to certain restrictions on declaring and paying cash dividends on our common stock.

In connection with the Spin-Off, each holder of Verint’s common stock received one ordinary share of Cognyte for every share of common stock of Verint held of record as of the close of business on January 25, 2021.

Treasury Stock

From time to time, our board of directors has approved limited programs to repurchase shares of our common stock from our directors or officers in connection with the vesting of restricted stock or restricted stock units to facilitate required income tax withholding by us or the payment of required income taxes by such holders. In addition, the terms of some of our equity award agreements with all grantees provide for automatic repurchases by us for the same purpose if a vesting-related or delivery-related tax event occurs at a time when the holder is not permitted to sell shares in the market. Our stock bonus program contains similar terms. Any such repurchases of common stock occur at prevailing market prices and are recorded as treasury stock.

We periodically purchase common stock from our directors, officers, and other employees to facilitate income tax withholding by us or the payment of required income taxes by such holders in connection with the vesting of equity awards occurring during a Company-imposed trading blackout or lockup period. When treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired.

No treasury stock remained outstanding at April 30, 2023 and January 31, 2023, respectively.

Stock Repurchase Programs

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million during the repurchase period.

During the year ended January 31, 2023, we repurchased approximately 649,000 shares of our common stock for a cost of $23.5 million under the current stock repurchase program. During the three months ended April 30, 2023, we repurchased approximately 1,593,000 shares of our common stock for a cost of $60.1 million, including excise tax of $0.4 million, under the current stock repurchase program. During the three months ended April 30, 2023, we retired all 1,593,000 shares, which was recorded as a reduction of common stock and additional paid-in capital. These shares were returned to the status of authorized and unissued shares. Our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the IRA. The excise tax of $0.4 million was recognized as part of the cost basis of shares acquired in the condensed consolidated statements of stockholders’ equity during the three months ended April 30, 2023. Subsequent to April 30, 2023 through June 1, 2023, we repurchased approximately 159,000 shares of our common stock for $5.5 million under this program.

During the three months ended April 30, 2022, we repurchased 2,000,000 shares of our common stock for a cost of $105.7 million under a prior stock repurchase program.

Issuance of Convertible Preferred Stock

On December 4, 2019, in conjunction with the planned Spin-Off, we announced that an affiliate of Apax Partners would invest up to $400.0 million in us, in the form of convertible preferred stock. Under the terms of the Investment Agreement, the Apax Investor purchased $200.0 million of our Series A Preferred Stock, which closed on May 7, 2020. In connection with the completion of the Spin-Off, the Apax Investor purchased $200.0 million of our Series B Preferred Stock, which closed on April 6, 2021. As of April 30, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 9, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss includes items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities and derivative financial instruments designated as hedges. Accumulated other comprehensive loss is presented as a separate line item in the stockholders’ equity section of our condensed consolidated balance sheets. Accumulated other comprehensive loss items have no impact on our net income as presented in our condensed consolidated statements of operations.

The following table summarizes changes in the components of our accumulated other comprehensive loss for the three months ended April 30, 2023:

(in thousands)	Unrealized Losses on Foreign Exchange Contracts Designated as Hedges		Foreign Currency Translation Adjustments		Total
Accumulated other comprehensive loss at January 31, 2023	$	(87)	$	(154,012)	$	(154,099)
Other comprehensive (loss) income before reclassifications	(290)		8,612		8,322
Amounts reclassified out of accumulated other comprehensive loss	(188)		—		(188)
Net other comprehensive (loss) income	(102)		8,612		8,510
Accumulated other comprehensive loss at April 30, 2023	$	(189)	$	(145,400)	$	(145,589)

All amounts presented in the table above are net of income taxes, if applicable. The accumulated net losses in foreign currency translation adjustments primarily reflect the strengthening of the U.S. dollar against the British pound sterling, which has resulted in lower U.S. dollar-translated balances of British pound sterling-denominated goodwill and intangible assets.

The amounts reclassified out of accumulated other comprehensive loss into the condensed consolidated statements of operations, with presentation location, for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022		Financial Statement Location
Unrealized losses on derivative financial instruments:
Foreign currency forward contracts	$	(2)	$	—	Cost of recurring revenue
	(20)		(9)		Cost of nonrecurring revenue
	(140)		(49)		Research and development, net
	(65)		(24)		Selling, general and administrative
	(227)		(82)		Total, before income taxes
	39		14		Benefit from income taxes
	$	(188)	$	(68)	Total, net of income taxes

XML

INCOME TAXES

3 Months Ended

Apr. 30, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

Our interim provision for income taxes is measured using an estimated annual effective income tax rate, adjusted for discrete items that occur within the periods presented.

For the three months ended April 30, 2023, we recorded an income tax provision of $4.4 million on pretax income of $8.0 million, which represented an effective income tax rate of 54.6%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions.

For the three months ended April 30, 2022, we recorded an income tax provision of $0.3 million on pretax income of $0.9 million, which represented an effective income tax rate of 34.0%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, partially offset by lower statutory rates in certain foreign jurisdictions.

As required by the authoritative guidance on accounting for income taxes, we evaluate the realizability of deferred income tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes guidance requires that a valuation allowance be established when it is more-likely-than-not that all or a portion of the deferred income tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred income tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We determined that there is sufficient negative evidence to maintain the valuation allowances against certain state and foreign deferred income tax assets as a result of historical losses in the most recent three-year period in certain state and foreign jurisdictions. We intend to maintain valuation allowances until sufficient positive evidence exists to support a reversal.

We had unrecognized income tax benefits of $87.7 million and $87.9 million (excluding interest and penalties) as of April 30, 2023 and January 31, 2023, respectively, that if recognized, would impact our effective income tax rate. The accrued liability for interest and penalties was $5.3 million and $5.2 million at April 30, 2023 and January 31, 2023, respectively. Interest and penalties are recorded as a component of the provision for income taxes in our condensed consolidated statements of operations. We regularly assess the adequacy of our provisions for income tax contingencies in accordance with the applicable authoritative guidance on accounting for income taxes. As a result, we may adjust the reserves for unrecognized income tax benefits for the impact of new facts and developments, such as changes to interpretations of relevant tax law, assessments from taxing authorities, settlements with taxing authorities, and lapses of statutes of limitation. Further, we believe that it is reasonably possible that the total amount of unrecognized income tax benefits at April 30, 2023 could decrease by approximately $7.0 million in the next twelve months as a result of settlement of certain tax audits or lapses of statutes of limitation. Such decreases may involve the payment of additional income taxes, the adjustment of deferred income taxes including the need for additional valuation allowances, and the recognition of income tax benefits. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. We also believe that it is reasonably possible that new issues may be raised by tax authorities or developments in tax audits may occur, which would require increases or decreases to the balance of reserves for unrecognized income tax benefits; however, an estimate of such changes cannot reasonably be made.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Apr. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of April 30, 2023 and January 31, 2023:

	April 30, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	80,624	$	—	$	—
U.S. Treasury bills, classified as cash and cash equivalents	249		—		—
Commercial paper, classified as cash and cash equivalents	—		30,975		—
Foreign currency forward contracts	—		5		—
Total assets	$	80,873	$	30,980	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	235	$	—
Contingent consideration — business combinations	—		—		12,884
Total liabilities	$	—	$	235	$	12,884

 

	January 31, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	96,941	$	—	$	—
Commercial paper, classified as cash and cash equivalents	—		50,869		—
Foreign currency forward contracts	—		19		—
Contingent consideration receivable	—		8		—
Total assets	$	96,941	$	50,896	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	124	$	—
Contingent consideration — business combinations	—		—		12,717
Total liabilities	$	—	$	124	$	12,717

The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2023:

	Three Months Ended April 30,
(in thousands)	2023
Fair value measurement at beginning of period	$	12,717
Contingent consideration liabilities recorded for business combinations	—
Changes in fair values, recorded in operating expenses	220
Payments of contingent consideration	(250)
Foreign currency translation and other	197
Fair value measurement at end of period	$	12,884

Our estimated liability for contingent consideration represents potential payments of additional consideration for business combinations, payable if certain defined performance goals are achieved. Changes in fair value of contingent consideration are recorded in the condensed consolidated statements of operations within selling, general and administrative expenses. There

were no liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2022.

There were no transfers between levels of the fair value measurement hierarchy during the three months ended April 30, 2023 and 2022.

Fair Value Measurements

Money Market Funds and U.S. Treasury Bills - We value our money market funds and U.S. treasury bills using quoted active market prices for such instruments.

Short-term Investments, Corporate Debt Securities, and Commercial Paper - The fair values of short-term investments, as well as corporate debt securities and commercial paper classified as cash equivalents, are estimated using observable market prices for identical securities that are traded in less-active markets, if available. When observable market prices for identical securities are not available, we value these short-term investments using non-binding market price quotes from brokers which we review for reasonableness using observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model.

Foreign Currency Forward Contracts - The estimated fair value of foreign currency forward contracts is based on quotes received from the counterparties thereto. These quotes are reviewed for reasonableness by discounting the future estimated cash flows under the contracts, considering the terms and maturities of the contracts and market foreign currency exchange rates using readily observable market prices for similar contracts.

Contingent Consideration Assets and Liabilities - Business Combinations and Divestitures - The fair value of the contingent consideration related to business combinations and divestitures is estimated using a probability-adjusted discounted cash flow model. These fair value measurements are based on significant inputs not observable in the market. The key internally developed assumptions used in these models are discount rates and the probabilities assigned to the milestones to be achieved. We remeasure the fair value of the contingent consideration at each reporting period, and any changes in fair value resulting from either the passage of time or events occurring after the acquisition date, such as changes in discount rates, or in the expectations of achieving the performance targets, are recorded within selling, general, and administrative expenses. Increases or decreases in discount rates would have inverse impacts on the related fair value measurements, while favorable or unfavorable changes in expectations of achieving performance targets would result in corresponding increases or decreases in the related fair value measurements. We utilized discount rates ranging from 6.6% to 7.7%, with a weighted average discount rate of 7.2% in our calculation of the estimated fair values of our contingent consideration liabilities as of April 30, 2023. We utilized discount rates ranging from 6.6% to 7.6%, with a weighted average discount rate of 6.9% in our calculations of the estimated fair values of our contingent consideration liabilities as of January 31, 2023. The contingent consideration receivable was fully paid as of April 30, 2023.

Other Financial Instruments

The carrying amounts of accounts receivable, contract assets, accounts payable, and accrued liabilities and other current liabilities approximate fair value due to their short maturities.

The estimated fair value of our Revolving Credit Facility borrowing was approximately $99.0 million at April 30, 2023. The estimated fair value of our Term Loan borrowing was approximately $100 million at January 31, 2023. On April 27, 2023, we repaid in full the remaining $100 million outstanding balance on our Term Loan utilizing proceeds from borrowings under our Revolving Credit Facility. We had no borrowings under our Revolving Credit Facility at January 31, 2023. The estimated fair values of the Term Loan borrowings were based upon indicative bid and ask prices as determined by the agent responsible for the syndication of our term loans. We considered these inputs to be within Level 3 of the fair value hierarchy because we cannot reasonably observe activity in the limited market in which participation in our Term Loan traded. The estimated fair value of borrowings under our Revolving Credit Facility is based upon indicative market values provided by one of our lenders. The indicative prices provided to us as at each of April 30, 2023 and January 31, 2023 did not significantly differ from par value.

The estimated fair values of our 2021 Notes were approximately $279.0 million and $282.0 million at April 30, 2023 and January 31, 2023, respectively. The estimated fair values of the 2021 Notes were determined based on quoted bid and ask prices in the over-the-counter market in which the 2021 Notes traded. We consider these inputs to be within Level 2 of the fair value hierarchy.

Assets and Liabilities Not Measured at Fair Value on a Recurring Basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets, operating lease right-of-use assets, and property, plant and equipment, are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.

Investments

During the three months ended April 30, 2023, we invested approximately $1.1 million in a privately-held company via a simple agreement for future equity (“SAFE”). The SAFE provides that, upon the completion by such company of a qualified equity financing, we will automatically receive the number of shares of capital stock of such company equal to the SAFE purchase amount divided by the Discount Price (as such term is defined in the SAFE). If there is a liquidity event affecting such company, such as a change in control or initial public offering, we will receive a cash payment equal to the greater of (a) the SAFE purchase amount or (b) the amount payable on the number of shares of common stock of such company equal to the SAFE purchase amount divided by the Liquidity Price (as such term is defined in the SAFE). Our investment is carried at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer and is included within other assets on the condensed consolidated balance sheets as of April 30, 2023.

The carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was $5.1 million as of April 30, 2023 and January 31, 2023. These investments were included within other assets on the condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023. There were no observable price changes in our investments in privately-held companies during the three months ended April 30, 2023 and 2022. We did not recognize any impairments during the three months ended April 30, 2023 and 2022.

XML

DERIVATIVE FINANCIAL INSTRUMENTS

3 Months Ended

Apr. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

Our primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk and interest rate risk, when deemed appropriate. We enter into these contracts in the normal course of business to mitigate risks and not for speculative purposes.

Foreign Currency Forward Contracts

Under our risk management strategy, we periodically use foreign currency forward contracts to manage our short-term exposures to fluctuations in operational cash flows resulting from changes in foreign currency exchange rates. These cash flow exposures result from portions of our forecasted operating expenses, primarily compensation and related expenses, which are transacted in currencies other than the U.S. dollar, most notably the Israeli shekel. We also periodically utilize foreign currency forward contracts to manage exposures resulting from forecasted customer collections to be remitted in currencies other than the applicable functional currency, and exposures from cash, cash equivalents and short-term investments denominated in currencies other than the applicable functional currency. These foreign currency forward contracts generally have maturities of no longer than twelve months, although occasionally we will execute a contract that extends beyond twelve months, depending upon the nature of the underlying risk.

We held outstanding foreign currency forward contracts with notional amounts of $6.6 million and $6.8 million as of April 30, 2023 and January 31, 2023, respectively.

Fair Values of Derivative Financial Instruments

The fair values of our derivative financial instruments and their classifications in our condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023 were as follows:

		Fair Value at
		April 30,		January 31,
(in thousands)	Balance Sheet Classification	2023		2023
Derivative assets:
Foreign currency forward contracts:
Designated as cash flow hedges	Prepaid expenses and other current assets	$	5	$	19
Total derivative assets		$	5	$	19
Derivative liabilities:
Foreign currency forward contracts:
Designated as cash flow hedges	Accrued expenses and other current liabilities	$	235	$	124
Total derivative liabilities		$	235	$	124

Derivative Financial Instruments in Cash Flow Hedging Relationships

The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the condensed consolidated statement of operations for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022
Net losses recognized in AOCL:
Foreign currency forward contracts	$	(350)	$	(270)
Net losses reclassified from AOCL to the condensed consolidated statements of operations:
Foreign currency forward contracts	$	(227)	$	(82)

For information regarding the line item locations of the net losses on derivative financial instruments reclassified out of AOCL into the condensed consolidated statements of operations, see Note 10, “Stockholders’ Equity”.

All of the foreign currency forward contracts underlying the net unrealized losses recorded in our accumulated other comprehensive loss at April 30, 2023 mature within twelve months, and therefore we expect all such losses to be reclassified into earnings within the next twelve months.

XML

STOCK-BASED COMPENSATION

3 Months Ended

Apr. 30, 2023

Share-Based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

Stock-Based Compensation Plan

On June 20, 2019, our stockholders approved the Verint Systems Inc. 2019 Long-Term Stock Incentive Plan (the “2019 Plan”). Upon approval of the 2019 Plan, new awards were no longer permitted under our prior stock-based compensation plan (the “2017 Amended Plan”). Awards outstanding at June 20, 2019 under the 2017 Amended Plan or other previous stock-based compensation plans were not impacted by the approval of the 2019 Plan. Collectively, our stock-based compensation plans are referred to herein as the “Plans”.

The 2019 Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance awards, other stock-based awards, and performance compensation awards. Subject to adjustment as provided in the 2019 Plan, up to an aggregate of (i) 9,475,000 shares of our common stock plus (ii) the number of shares of our common stock available for issuance under the 2017 Amended Plan as of June 20, 2019, plus (iii) the number of shares of our common stock that become available for issuance as a result of awards made under the 2017 Amended Plan or the 2019 Plan that are forfeited, cancelled, exchanged, or that terminate or expire, may be issued or transferred in connection with awards under the 2019 Plan. Each stock option or stock-settled stock appreciation right granted under the 2019 Plan will reduce the available plan capacity by one share and each other award denominated in shares that is granted under the 2019 Plan will reduce the available plan capacity by 2.38 shares.

In March 2021, our board of directors approved an adjustment of the available plan capacity to the 2019 Plan to 14,239,656 shares based on an adjustment ratio of approximately 1.45 as a result of the Spin-Off.

At our annual meeting of stockholders on June 22, 2023, our stockholders will be asked to consider a proposal to approve the Verint Systems Inc. 2023 Long-Term Stock Incentive Plan (the “2023 Plan”). If the 2023 Plan is approved, no further awards will be made under the 2019 Plan following the date of such approval.

Stock-Based Compensation Expense

We recognized stock-based compensation expense in the following line items on the condensed consolidated statements of operations for the three months ended April 30, 2023 and 2022: 

	Three Months Ended April 30,
(in thousands)	2023		2022
Cost of revenue — recurring	$	296	$	525
Cost of revenue — nonrecurring	140		640
Research and development, net	2,327		2,419
Selling, general and administrative	12,216		14,785
Total stock-based compensation expense	$	14,979	$	18,369

The following table summarizes stock-based compensation expense by type of award for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Restricted stock units and restricted stock awards	$	13,436	$	16,011
Stock bonus program and bonus share program	1,378		2,353
Total equity-settled awards	14,814		18,364
Phantom stock units (cash-settled awards)	165		5
Total stock-based compensation expense	$	14,979	$	18,369

Awards are generally subject to multi-year vesting periods. We recognize compensation expense for awards on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods, reduced by estimated forfeitures.

Awards under our stock bonus and bonus share programs are accounted for as liability-classified awards, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of our common stock, which for awards under our stock bonus program is determined using a discounted average price of our common stock.

Restricted Stock Units and Performance Stock Units

We periodically award RSUs to our directors, officers, and other employees. These awards contain various vesting conditions and are subject to certain restrictions and forfeiture provisions prior to vesting. Some of these awards to executive officers and certain employees vest upon the achievement of specified performance goals or market conditions (performance stock units or “PSUs”).

The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
	2023			2022
(in thousands, except per share data)	Shares or Units	Weighted-Average Grant Date Fair Value		Shares or Units	Weighted-Average Grant Date Fair Value
Beginning balance	2,230	$	52.42	2,454	$	42.99
Granted	1,665	$	37.36	1,557	$	56.42
Released	(475)	$	50.22	(465)	$	42.20
Forfeited	(32)	$	50.63	(47)	$	43.13
Ending balance	3,388	$	45.34	3,499	$	49.07

With respect to our stock bonus program, the activity presented in the table above only includes shares earned and released in consideration of the discount provided under that program. Consistent with the provisions of the Plans under which such shares are issued, other shares issued under the stock bonus program are not included in the table above because they do not reduce available plan capacity (since such shares are deemed to be purchased by the grantee at fair value in lieu of receiving an earned cash bonus). Activity presented in the table above includes all shares awarded and released under the bonus share program. Further details appear below under “Stock Bonus Program” and “Bonus Share Program”.

Our RSU and PSU awards may include a provision which allows the awards to be settled with cash payments upon vesting, rather than with delivery of common stock, at the discretion of our board of directors. As of April 30, 2023, for such awards that are outstanding, settlement with cash payments was not considered probable, and therefore these awards have been accounted for as equity-classified awards and are included in the table above.

In order to achieve an equitable modification of the existing awards following the Spin-Off, we converted unvested awards as of February 1, 2021 by a factor of approximately 1.45, resulting in additional awards being granted to remaining employees denominated solely in Verint common stock. As noted above, a corresponding adjustment was also made to the available capacity under the 2019 Plan.

The following table summarizes PSU activity in isolation under the Plans for the three months ended April 30, 2023 and 2022 (these amounts are also included in the Award Activity Table above for 2023 and 2022):

	Three Months Ended April 30,
(in thousands)	2023	2022
Beginning balance	532	547
Granted	277	278
Released	(230)	(89)
Forfeited	(10)	—
Ending balance	569	736

Excluding PSUs, we granted 1,388,000 RSUs during the three months ended April 30, 2023.

As of April 30, 2023, there was approximately $119.7 million of total unrecognized compensation expense, net of estimated forfeitures, related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 2.2 years.

Stock Bonus Program and Bonus Share Program

Our stock bonus program permits eligible employees to receive a portion of their earned bonuses, otherwise payable in cash, in the form of discounted shares of our common stock. Executive officers are eligible to participate in this program to the extent that capacity remains available under the program following the enrollment of all other participants. Shares awarded to executive officers with respect to the discount feature of the program are subject to a one-year vesting period. This program is subject to annual funding approval by our board of directors and an annual cap on the number of shares that can be issued. Subject to these limitations, the number of shares to be issued under the program for a given year is determined using a five-day trailing average price of our common stock when the awards are calculated, reduced by a discount determined by the board of directors each year (the “discount”). To the extent that this program is not funded in a given year or the number of

shares of common stock needed to fully satisfy employee enrollment exceeds the annual cap, the applicable portion of the employee bonuses will generally revert to being paid in cash.

Under our bonus share program, we may provide discretionary bonuses to employees or pay earned bonuses that are outside the stock bonus program in the form of shares of common stock. Unlike the stock bonus program, there is no enrollment for this program and no discount feature.

For bonuses in respect of the year ended January 31, 2023, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate for awards under these two programs, with up to 200,000 shares of common stock, and a discount of 15% approved for awards under our stock bonus program. We currently expect to issue approximately 27,000 shares under the stock bonus program and 178,000 shares under the bonus share program, in respect of the year ended January 31, 2023, which are expected to be issued during the first half of the year ending January 31, 2024.

In March 2023, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate under these two programs, with up to 200,000 shares of common stock, and a discount of 15%, for awards under our stock bonus program for the performance period ending January 31, 2024. Any shares earned under these programs will be issued during the year ended January 31, 2025.

The combined accrued liabilities for these two programs were $9.2 million and $7.9 million at April 30, 2023 and January 31, 2023, respectively.

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Apr. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Legal Proceedings

CTI Litigation

In March 2009, one of our former employees, Ms. Orit Deutsch, commenced legal actions in Israel against our former primary Israeli subsidiary, Cognyte Technologies Ltd. (formerly known as Verint Systems Limited or “VSL”) (Case Number 4186/09) and against our former affiliate CTI (Case Number 1335/09). Also, in March 2009, a former employee of Comverse Limited (CTI’s primary Israeli subsidiary at the time), Ms. Roni Katriel, commenced similar legal actions in Israel against Comverse Limited (Case Number 3444/09). In these actions, the plaintiffs generally sought to certify class action suits against the defendants on behalf of current and former employees of VSL and Comverse Limited who had been granted stock options in Verint and/or CTI and who were allegedly damaged as a result of a suspension on option exercises during an extended filing delay period that is discussed in our and CTI’s historical public filings. On June 7, 2012, the Tel Aviv District Court, where the cases had been filed or transferred, allowed the plaintiffs to consolidate and amend their complaints against the three defendants: VSL, CTI, and Comverse Limited.

On October 31, 2012, CTI distributed all of the outstanding shares of common stock of Comverse, Inc., its principal operating subsidiary and parent company of Comverse Limited, to CTI’s shareholders (the “Comverse Share Distribution”). In the period leading up to the Comverse Share Distribution, CTI either sold or transferred substantially all of its business operations and assets (other than its equity ownership interests in Verint and in its then-subsidiary, Comverse, Inc.) to Comverse, Inc. or to unaffiliated third parties. As the result of these transactions, Comverse, Inc. became an independent company and ceased to be affiliated with CTI, and CTI ceased to have any material assets other than its equity interests in Verint. Prior to the completion of the Comverse Share Distribution, the plaintiffs sought to compel CTI to set aside up to $150.0 million in assets to secure any future judgment, but the District Court did not rule on this motion. In February 2017, Mavenir Inc. became successor-in-interest to Comverse, Inc.

On February 4, 2013, Verint acquired the remaining CTI shell company in a merger transaction (the “CTI Merger”). As a result of the CTI Merger, Verint assumed certain rights and liabilities of CTI, including any liability of CTI arising out of the foregoing legal actions. However, under the terms of a Distribution Agreement entered into in connection with the Comverse Share Distribution, we, as successor to CTI, are entitled to indemnification from Comverse, Inc. (now Mavenir) for any losses we may suffer in our capacity as successor to CTI related to the foregoing legal actions.

Following an unsuccessful mediation process, on August 28, 2016, the District Court (i) denied the plaintiffs’ motion to certify the suit as a class action with respect to all claims relating to Verint stock options, (ii) dismissed the motion to certify the suit against VSL and Comverse Limited, and (iii) approved the plaintiffs’ motion to certify the suit as a class action against CTI

with respect to claims of current or former employees of Comverse Limited (now part of Mavenir) or of VSL who held unexercised CTI stock options at the time CTI suspended option exercises. The court also ruled that the merits of the case would be evaluated under New York law.

As a result of this ruling (which excluded claims related to Verint stock options from the case), one of the original plaintiffs in the case, Ms. Deutsch, was replaced by a new representative plaintiff, Mr. David Vaaknin. CTI appealed portions of the District Court’s ruling to the Israeli Supreme Court. On August 8, 2017, the Israeli Supreme Court partially allowed CTI’s appeal and ordered the case to be returned to the District Court to determine whether a cause of action exists under New York law based on the parties’ expert opinions.

Following two unsuccessful rounds of mediation in mid to late 2018 and in mid-2019, the proceedings resumed. On April 16, 2020, the District Court accepted the plaintiffs’ application to amend the motion to certify a class action and set deadlines for filing amended pleadings by the parties. CTI submitted a motion to appeal the District Court’s decision to the Israeli Supreme Court, as well as a motion to stay the proceedings in the District Court pending the resolution of the appeal. On July 6, 2020, the Israeli Supreme Court granted the motion for a stay. On July 27, 2020, the plaintiffs filed their response on the merits of the motion for leave to appeal. On December 15, 2021, the Israeli Supreme Court rejected CTI’s motion to appeal and the proceedings in the District Court resumed.

At the recommendation of the District Court, in June 2022, the parties conducted another round of mediation in New York. On July 10, 2022, the parties reached an agreement to settle the matter on terms set forth in a settlement agreement that was executed by all parties and submitted a motion for approval of the settlement agreement to the District Court. Under the terms of the settlement agreement, subject to full and final waiver, Mavenir Inc. and/or Comverse, Inc. and/or Mavenir Ltd. agreed to pay a total of $16.0 million (such amount to be paid in three phases as set forth in the settlement agreement) as compensation to the plaintiffs and members of the class. The compensation amount is comprehensive, final and absolute and includes within it all the amounts and expenses to be paid in connection with the settlement agreement. Under the terms of an associated guaranty agreement, Verint has guaranteed the payment of the compensation amount in the event it is not paid by the primary obligors. On February 7, 2023, the District Court approved the settlement without material changes. As of April 30, 2023, the first installment of the compensation amount had been paid by Mavenir, leaving two installments of approximately $4.7 million each to be paid between September 2023 and April 2024.

Under the terms of the Separation and Distribution Agreement entered into between Verint and Cognyte, Cognyte has agreed to indemnify Verint for Cognyte’s share of any losses that Verint may suffer related to the foregoing legal actions either in its capacity as successor to CTI, to the extent not indemnified by Mavenir, or due to its former ownership of Cognyte and VSL.

As of April 30, 2023, we had a remaining liability of $9.5 million, which is included within accrued expenses and other current liabilities, and an offsetting indemnification receivable of $9.5 million, which is included in prepaid expenses and other current assets. There was no impact to our condensed consolidated statement of operations.

Unfair Competition Litigation and Related Investigation

As previously disclosed, Verint Americas Inc., as successor to ForeSee Results, Inc. (“ForeSee”), was the defendant in two Eastern District of Michigan cases captioned ACSI LLC v. ForeSee Results, Inc., and CFI Group USA LLC v. Verint Americas Inc. The former case was filed on October 24, 2018 against ForeSee Results, Inc. by American Customer Satisfaction Index, LLC (“ACSI LLC”) (Case No. 2:18-cv-13319) and alleged infringement of two federally registered trademarks and common law unfair competition under federal and state law. The latter case was filed on September 5, 2019 against Verint Americas Inc. (as successor in interest to ForeSee) by CFI Group USA LLC (“CFI”) (Case No. 2:19-cv-12602) and alleged unfair competition and false advertising under federal and state law, as well as tortious interference with contract. We believe that the claims asserted by the plaintiffs in these matters were without merit. Following the filing of the Eastern District of Michigan litigation, ForeSee filed affirmative litigation in the U.S. District Court for the District of Delaware (Case No. 1:21-cv-00674, Complaint filed on May 7, 2021) against ACSI LLC, CFI, Claes Fornell, and CFI Software LLC (the “Fornell Group”) asserting fraud and other claims against ACSI LLC, CFI, Fornell, and CFI Software for, among other things, their breach of a “Joinder and Waiver Agreement” entered into in connection with the December 2013 sale of ForeSee to its previous owner and misrepresentations in the associated deal documents. Verint acquired ForeSee in December 2018.

In April 2023, the parties reached an agreement in principle to settle these actions, and on June 1, 2023, the parties signed a definitive settlement agreement. Under the terms of the settlement agreement, Verint will pay $9.0 million to the Fornell Group and the parties have agreed to certain restrictive covenants with respect to the future business activities of both ForeSee and the Fornell Group. The agreement provides that the settlement does not constitute a ruling on the merits, an admission as to any issue of fact or principle of law, or an admission of liability or wrongdoing by either ForeSee or Verint. Following the

execution of the settlement agreement, the two cases in Michigan against us, and the case in Delaware filed by us, have been [or are in the process of being] dismissed.

Verint was also informed that the U.S. Attorney’s Office for the Eastern District of Michigan’s Civil Division (“USAO”) is conducting a False Claims Act investigation concerning allegations ForeSee and/or Verint failed to provide the federal government the services described in certain government contracts related to ForeSee’s products inherited by Verint in the acquisition. Verint received a Civil Investigation Demand (“CID”) in connection with this investigation and provided responses. The False Claims Act contains provisions that allow for private persons (“relators”) to initiate actions by filing claims under seal. We believe that this investigation was initiated in coordination with the Eastern District of Michigan litigation discussed above. Verint continues to work cooperatively with the USAO in its review of this matter.

In March 2023, Verint and the Assistant U.S. Attorney overseeing the USAO investigation reached an agreement in principle to resolve the USAO matter. The proposed settlement, which would result in the payment by Verint of $7.0 million and would contain a statement of no admission to liability, is subject to definitive documentation as well as review and approval by the USAO, potential objection by any relators, and approval by a court if the investigation is in connection with a lawsuit initiated by a relator.

As of January 31, 2023, we recognized a $7.0 million legal settlement liability in respect of the USAO matter and a $3.5 million legal settlement liability in respect of the ACSI and CFI matters within accrued expenses and other current liabilities, and a corresponding insurance recovery receivable in prepaid expenses and other current assets on our consolidated balance sheets. These loss accruals and insurance recoveries were offset within selling, general and administrative expenses in our consolidated statements of operations for the year ended January 31, 2023, resulting in no impact on our consolidated statements of operations.

As of April 30, 2023, we have accrued a $7.0 million legal settlement liability in respect of the USAO matter and a $9.0 million legal settlement liability in respect of the ACSI and CFI matters within accrued expenses and other current liabilities. The incremental settlement costs of $5.5 million related to the ACSI and CFI matters as a result of the settlement described above, is included within selling, general and administrative expenses in our condensed consolidated statement of operations for the three months ended April 30, 2023. We reached a final settlement with one of our insurance carriers for a total cumulative insurance recovery of $14.5 million for the losses we incurred related to these actions, which offset settlement and legal expenses during the year ended January 31, 2023. We collected $2.0 million during the year ended January 31, 2023 and $12.5 million was collected in April 2023.

We are a party to various other litigation matters and claims that arise from time to time in the ordinary course of our business. While we believe that the ultimate outcome of any such current matters will not have a material adverse effect on us, their outcomes are not determinable and negative outcomes may adversely affect our financial position, liquidity, or results of operations.

XML

SUBSEQUENT EVENTS

3 Months Ended

Apr. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

Credit Agreement Amendment

On May 10, 2023, we entered into the Fourth Amendment (“Fourth Amendment”) to the Credit Agreement, with JPMorgan Chase Bank, N.A., as administrative agent, which amended the Credit Agreement to provide for the Eurodollar Rate thereunder, which was derived from LIBOR, together with all related LIBOR-based mechanics and provisions, to be replaced with Term SOFR (as defined in the Credit Agreement) and the administrative agent’s customary Term SOFR interest rate-based mechanics and related provisions. Please refer to Note 7, “Long-Term Debt” for a more detailed discussion of the Fourth Amendment and Credit Agreement.

Settlement of Litigation

On June 1, 2023, Verint and the Fornell Group signed a definitive settlement agreement to settle several litigation matters. Please refer to Note 15, “Commitments and Contingencies” for additional disclosure regarding the settlement.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Apr. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Preparation of Condensed Consolidated Financial Statements

Preparation of Condensed Consolidated Financial Statements

The condensed consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and on the same basis as the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the U.S. Securities and Exchange Commission (“SEC”), except for the recently adopted accounting pronouncements described below. The condensed consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the periods ended April 30, 2023 and 2022, and the condensed consolidated balance sheet as of April 30, 2023, are not audited but reflect all adjustments that, in the opinion of management, are of a normal recurring nature and that are considered necessary for a fair presentation of the results for the periods shown. The condensed consolidated balance sheet as of January 31, 2023 is derived from the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended January 31, 2023. Certain information and disclosures normally included in annual consolidated financial statements have been omitted

pursuant to the rules and regulations of the SEC. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the SEC. The results for interim periods are not necessarily indicative of a full year’s results.

Principles of Consolidation

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our condensed consolidated balance sheet, but separately from our stockholders’ equity.

Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment.

We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Effective

Recently Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which adds contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with revenue recognition guidance. We adopted this standard on a prospective basis for the annual and interim periods beginning February 1, 2023. The adoption of this standard did not have any impact on our condensed consolidated financial statements as the ultimate impact is dependent on the size and frequency of future acquisitions and does not affect contract assets or contract liabilities related to acquisitions completed prior to the adoption date.

In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extends the period of time entities can utilize the reference rate reform relief guidance under ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting from December 31, 2022 to December 31, 2024. We expect to elect various optional expedients for contract modifications related to financial instruments affected by the reference rate reform through the effective date of December 31, 2024, as extended by ASU 2022-06. The application of this guidance did not have any impact on our consolidated financial statements.

In August 2022, the Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new book minimum tax of 15% on consolidated adjusted GAAP pre-tax earnings for corporations with average income in excess of $1 billion and is effective for us in tax years beginning after December 31, 2022. We do not expect to be subject to the corporate minimum tax. In addition, the IRA also introduced a nondeductible 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. During the three months ended April 30, 2023 the calculated excise tax was $0.4 million and was recognized as part of the cost basis of shares acquired in our consolidated statement of stockholders' equity. We do not expect taxes due on future repurchases of our shares to have a material effect on our business.

New Accounting Pronouncements Not Yet EffectiveThere are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on our condensed consolidated financial statements and related disclosures.

Revenue Recognition

We derive our revenue primarily from providing customers the right to access our cloud-based solutions, the right to use our software for an indefinite or specified period of time, and related services and support based on when access or control of the software passes to our customers or the services are provided, in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. Revenue is reported net of applicable sales and use tax, value-added tax and other transaction taxes imposed on the related transactions, including mandatory government charges that are passed through to our customers.

We determine revenue recognition through the following five steps:

•Identification of the contract, or contracts, with a customer

•Identification of the performance obligations in the contract

•Determination of the transaction price

•Allocation of the transaction price to the performance obligations in the contract

•Recognition of revenue when, or as, performance obligations are satisfied.

We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.

XML

REVENUE RECOGNITION (Tables)

3 Months Ended

Apr. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions.

•Recurring revenue primarily consists of:

◦Cloud revenue, which consists primarily of software as a service (“SaaS”) revenue and optional managed services revenue.

▪SaaS revenue consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period).

▪Bundled SaaS revenue is recognized over time.

▪Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one- and three-year time frame. Unbundled SaaS can be deployed in the cloud, either by us or a cloud partner.

◦Support revenue, which consists of initial and renewal support.

•Nonrecurring revenue primarily consists of our perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties.

	Three Months Ended April 30,
(in thousands)	2023		2022
Recurring revenue:
Bundled SaaS revenue	$	59,453	$	49,285
Unbundled SaaS revenue	57,695		45,445
Optional managed services revenue	12,865		15,913
Total cloud revenue	130,013		110,643
Support revenue	36,426		48,724
Total recurring revenue	166,439		159,367
Nonrecurring revenue:
Perpetual revenue	24,334		33,258
Professional services revenue	25,793		25,281
Total nonrecurring revenue	50,127		58,539
Total revenue	$	216,566	$	217,906

Schedule of Contracts with Customers - Assets and Liabilities

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:

(in thousands)	April 30, 2023		January 31, 2023
Accounts receivable, net	$	157,786	$	188,414
Contract assets, net	$	58,862	$	60,444
Long-term contract assets, net (included in other assets)	$	35,845	$	37,950
Contract liabilities	$	254,418	$	271,476
Long-term contract liabilities	$	15,914	$	18,047

Schedule of Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction

The following table provides information about when we expect to recognize our remaining performance obligations:

(in thousands)	April 30, 2023		January 31, 2023
RPO:
Expected to be recognized within 1 year	$	435,708	$	464,346
Expected to be recognized in more than 1 year	256,195		262,695
Total RPO	$	691,903	$	727,041

XML

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. (Tables)

3 Months Ended

Apr. 30, 2023

Earnings Per Share [Abstract]

Schedule of Calculation of Basic and Diluted Net Loss Per Common Share Attributable To Verint Systems Inc.

The following table summarizes the calculation of basic and diluted net loss per common share attributable to Verint Systems Inc. for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands, except per share amounts)	2023		2022
Net income	$	3,634	$	574
Net income attributable to noncontrolling interests	339		288
Net income attributable to Verint Systems Inc.	3,295		286
Dividends on preferred stock	(5,200)		(5,200)
Net loss attributable to Verint Systems Inc. for basic net loss per common share	(1,905)		(4,914)
Dilutive effect of dividends on preferred stock	—		—
Net loss attributable to Verint Systems Inc. for diluted net loss per common share	$	(1,905)	$	(4,914)
Weighted-average shares outstanding:
Basic	64,940		64,947
Dilutive effect of employee equity award plans	—		—
Dilutive effect of 2021 Notes	—		—
Dilutive effect of assumed conversion of preferred stock	—		—
Diluted	64,940		64,947
Net loss per common share attributable to Verint Systems Inc.:
Basic	$	(0.03)	$	(0.08)
Diluted	$	(0.03)	$	(0.08)

Schedule of Anti-dilutive Securities

We excluded the following weighted-average potential common shares from the calculations of diluted net loss per common share during the applicable periods because their inclusion would have been anti-dilutive:

	Three Months Ended April 30,
(in thousands)	2023	2022
Common shares excluded from calculation:
Stock options and restricted stock-based awards	2,080	1,571
Series A Preferred Stock	5,498	5,498
Series B Preferred Stock	3,980	3,980

XML

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Tables)

3 Months Ended

Apr. 30, 2023

Cash, Cash Equivalents, and Short-Term Investments [Abstract]

Schedule of Cash, Cash Equivalents and Short-term Investments

The following tables summarize our cash, cash equivalents, and short-term investments as of April 30, 2023 and January 31, 2023:

	April 30, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	148,871	$	—	$	—	$	148,871
Money market funds	80,624		—		—		80,624
Commercial paper	30,975		—		—		30,975
U.S. Treasury bills	249		—		—		249
Total cash and cash equivalents	$	260,719	$	—	$	—	$	260,719
Short-term investments:
Bank time deposits	$	3,646	$	—	$	—	$	3,646
Total short-term investments	$	3,646	$	—	$	—	$	3,646

	January 31, 2023
(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:
Cash and bank time deposits	$	134,289	$	—	$	—	$	134,289
Money market funds	96,941		—		—		96,941
Commercial paper	50,869		—		—		50,869
Total cash and cash equivalents	$	282,099	$	—	$	—	$	282,099
Short-term investments:
Bank time deposits	$	697	$	—	$	—	$	697
Total short-term investments	$	697	$	—	$	—	$	697

XML

INTANGIBLE ASSETS AND GOODWILL (Tables)

3 Months Ended

Apr. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Acquisition-Related Intangible Assets

Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and removed from our condensed consolidated balance sheets, consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,478	$	(396,652)	$	61,826
Acquired technology	227,375		(211,851)		15,524
Trade names	4,487		(4,380)		107
Distribution network	2,440		(2,440)		—
Total intangible assets	$	692,780	$	(615,323)	$	77,457

 

	January 31, 2023
(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	458,013	$	(390,113)	$	67,900
Acquired technology	229,317		(212,065)		17,252
Trade names	4,479		(4,359)		120
Distribution network	2,440		(2,440)		—
Total intangible assets	$	694,249	$	(608,977)	$	85,272

Schedule of Estimated Future Amortization Expense on Finite-lived Acquisition-related Intangible Assets

Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows:

(in thousands)
Years Ending January 31,	Amount
2024 (remainder of year)	$	24,068
2025	16,730
2026	15,346
2027	11,572
2028	6,905
2029 and thereafter	2,836
Total	$	77,457

Schedule of Goodwill Activity

Goodwill activity for the three months ended April 30, 2023 was as follows: 

(in thousands)	Amount
Three Months Ended April 30, 2023
Goodwill, gross, at January 31, 2023	$	1,403,256
Accumulated impairment losses through January 31, 2023	(56,043)
Goodwill, net, at January 31, 2023	1,347,213
Foreign currency translation and other	7,408
Business combinations, including adjustments to prior period acquisitions	140
Goodwill, net, at April 30, 2023	$	1,354,761
Balance at April 30, 2023
Goodwill, gross, at April 30, 2023	$	1,410,804
Accumulated impairment losses through April 30, 2023	(56,043)
Goodwill, net, at April 30, 2023	$	1,354,761

XML

LONG-TERM DEBT (Tables)

3 Months Ended

Apr. 30, 2023

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

The following table summarizes our long-term debt at April 30, 2023 and January 31, 2023:

	April 30,		January 31,
(in thousands)	2023		2023
2021 Notes	$	315,000	$	315,000
Term Loan	—		100,000
Revolving Credit Facility	100,000		—
Less: unamortized debt discounts and issuance costs	(5,328)		(6,092)
Total debt	409,672		408,908
Less: current maturities	—		—
Long-term debt	$	409,672	$	408,908

Schedule of Components of Interest Expense

The following table presents the components of interest expense incurred on the 2021 Notes and on borrowings under our Credit Agreement, for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
2021 Notes:
Interest expense at 0.25% coupon rate	$	197	$	195
Amortization of deferred debt issuance costs	443		439
Total Interest Expense — 2021 Notes	$	640	$	634
Borrowings under Credit Agreement:
Interest expense at contractual rates	$	1,650	$	560
Amortization of debt discounts	5		5
Amortization of deferred debt issuance costs	204		211
Losses on early retirements of debt	237		—
Total Interest Expense — Borrowings under Credit Agreement	$	2,096	$	776

XML

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION (Tables)

3 Months Ended

Apr. 30, 2023

Condensed Financial Information Disclosure [Abstract]

Schedule of Inventories

Inventories consisted of the following as of April 30, 2023 and January 31, 2023:

 

	April 30,		January 31,
(in thousands)	2023		2023
Raw materials	$	3,505	$	3,325
Work-in-process	40		40
Finished goods	10,008		9,263
Total inventories	$	13,553	$	12,628

Schedule of Other (Expense) Income, Net

Other income, net consisted of the following for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Foreign currency gains, net	$	237	$	1,713
Other, net	(213)		(39)
Total other income, net	$	24	$	1,674

Schedule of Supplemental Information Regarding Condensed Consolidated Cash Flows

The following table provides supplemental information regarding our condensed consolidated cash flows for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Cash paid for interest	$	2,513	$	930
Cash payments of income taxes, net	$	3,758	$	2,238
Cash payments for operating leases	$	1,640	$	12,195
Non-cash investing and financing transactions:
Finance leases of property and equipment	$	212	$	12
Accrued but unpaid purchases of property and equipment	$	360	$	988
Accrued but unpaid purchases of treasury stock	$	—	$	453
Excise tax on share repurchases	$	417	$	—

XML

STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Apr. 30, 2023

Equity [Abstract]

Schedule of Components of Accumulated Other Comprehensive Loss

The following table summarizes changes in the components of our accumulated other comprehensive loss for the three months ended April 30, 2023:

(in thousands)	Unrealized Losses on Foreign Exchange Contracts Designated as Hedges		Foreign Currency Translation Adjustments		Total
Accumulated other comprehensive loss at January 31, 2023	$	(87)	$	(154,012)	$	(154,099)
Other comprehensive (loss) income before reclassifications	(290)		8,612		8,322
Amounts reclassified out of accumulated other comprehensive loss	(188)		—		(188)
Net other comprehensive (loss) income	(102)		8,612		8,510
Accumulated other comprehensive loss at April 30, 2023	$	(189)	$	(145,400)	$	(145,589)

Schedule of Amounts Reclassified Out of Accumulated Other Comprehensive Loss

The amounts reclassified out of accumulated other comprehensive loss into the condensed consolidated statements of operations, with presentation location, for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022		Financial Statement Location
Unrealized losses on derivative financial instruments:
Foreign currency forward contracts	$	(2)	$	—	Cost of recurring revenue
	(20)		(9)		Cost of nonrecurring revenue
	(140)		(49)		Research and development, net
	(65)		(24)		Selling, general and administrative
	(227)		(82)		Total, before income taxes
	39		14		Benefit from income taxes
	$	(188)	$	(68)	Total, net of income taxes

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Apr. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of April 30, 2023 and January 31, 2023:

	April 30, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	80,624	$	—	$	—
U.S. Treasury bills, classified as cash and cash equivalents	249		—		—
Commercial paper, classified as cash and cash equivalents	—		30,975		—
Foreign currency forward contracts	—		5		—
Total assets	$	80,873	$	30,980	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	235	$	—
Contingent consideration — business combinations	—		—		12,884
Total liabilities	$	—	$	235	$	12,884

 

	January 31, 2023
	Fair Value Hierarchy Category
(in thousands)	Level 1		Level 2		Level 3
Assets:
Money market funds	$	96,941	$	—	$	—
Commercial paper, classified as cash and cash equivalents	—		50,869		—
Foreign currency forward contracts	—		19		—
Contingent consideration receivable	—		8		—
Total assets	$	96,941	$	50,896	$	—
Liabilities:
Foreign currency forward contracts	$	—	$	124	$	—
Contingent consideration — business combinations	—		—		12,717
Total liabilities	$	—	$	124	$	12,717

Schedule of Changes in the Estimated Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2023:

	Three Months Ended April 30,
(in thousands)	2023
Fair value measurement at beginning of period	$	12,717
Contingent consideration liabilities recorded for business combinations	—
Changes in fair values, recorded in operating expenses	220
Payments of contingent consideration	(250)
Foreign currency translation and other	197
Fair value measurement at end of period	$	12,884

XML

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Apr. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of Derivative Financial Instruments

The fair values of our derivative financial instruments and their classifications in our condensed consolidated balance sheets as of April 30, 2023 and January 31, 2023 were as follows:

		Fair Value at
		April 30,		January 31,
(in thousands)	Balance Sheet Classification	2023		2023
Derivative assets:
Foreign currency forward contracts:
Designated as cash flow hedges	Prepaid expenses and other current assets	$	5	$	19
Total derivative assets		$	5	$	19
Derivative liabilities:
Foreign currency forward contracts:
Designated as cash flow hedges	Accrued expenses and other current liabilities	$	235	$	124
Total derivative liabilities		$	235	$	124

Schedule of the Effects of Derivative Financial Instruments Designated as Cash Flow Hedging Instruments

The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the condensed consolidated statement of operations for the three months ended April 30, 2023 and 2022 were as follows:

	Three Months Ended April 30,
(in thousands)	2023		2022
Net losses recognized in AOCL:
Foreign currency forward contracts	$	(350)	$	(270)
Net losses reclassified from AOCL to the condensed consolidated statements of operations:
Foreign currency forward contracts	$	(227)	$	(82)

XML

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Apr. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

We recognized stock-based compensation expense in the following line items on the condensed consolidated statements of operations for the three months ended April 30, 2023 and 2022: 

	Three Months Ended April 30,
(in thousands)	2023		2022
Cost of revenue — recurring	$	296	$	525
Cost of revenue — nonrecurring	140		640
Research and development, net	2,327		2,419
Selling, general and administrative	12,216		14,785
Total stock-based compensation expense	$	14,979	$	18,369

Schedule of Stock-Based Compensation Expense by Type of Award

The following table summarizes stock-based compensation expense by type of award for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
(in thousands)	2023		2022
Restricted stock units and restricted stock awards	$	13,436	$	16,011
Stock bonus program and bonus share program	1,378		2,353
Total equity-settled awards	14,814		18,364
Phantom stock units (cash-settled awards)	165		5
Total stock-based compensation expense	$	14,979	$	18,369

Schedule of RSU Activity

The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the three months ended April 30, 2023 and 2022:

	Three Months Ended April 30,
	2023			2022
(in thousands, except per share data)	Shares or Units	Weighted-Average Grant Date Fair Value		Shares or Units	Weighted-Average Grant Date Fair Value
Beginning balance	2,230	$	52.42	2,454	$	42.99
Granted	1,665	$	37.36	1,557	$	56.42
Released	(475)	$	50.22	(465)	$	42.20
Forfeited	(32)	$	50.63	(47)	$	43.13
Ending balance	3,388	$	45.34	3,499	$	49.07

Schedule of Performance Share Activity

The following table summarizes PSU activity in isolation under the Plans for the three months ended April 30, 2023 and 2022 (these amounts are also included in the Award Activity Table above for 2023 and 2022):

	Three Months Ended April 30,
(in thousands)	2023	2022
Beginning balance	532	547
Granted	277	278
Released	(230)	(89)
Forfeited	(10)	—
Ending balance	569	736

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) $ / shares in Units, organization in Thousands					3 Months Ended
	Apr. 06, 2021 USD ($)	Feb. 01, 2021 $ / shares shares	May 07, 2020 USD ($)	Dec. 04, 2019 USD ($)	Apr. 30, 2023 USD ($) professional organization office country $ / shares	Apr. 30, 2022 USD ($)	Jan. 31, 2023 $ / shares
Description of Business [Line Items]
Percentage of fortune 100 companies as customers					85.00%
Number of organizations as customer | organization					10
Number of countries customers located | country					175
Number of offices | office					30
Entity number of employees | professional					4,200
Common stock, par value (in dollars per share) | $ / shares		$ 0.001			$ 0.001		$ 0.001
Spin-off transaction, number of shares received (in shares) | shares		1
Excise tax on share repurchases					$ 417,000	$ 0
Apax
Description of Business [Line Items]
Percentage ownership of outstanding shares					13.00%
Convertible Preferred Stock
Description of Business [Line Items]
Sale of stock, consideration received on transaction				$ 400,000,000
Series A Preferred Stock | Series A Private Placement
Description of Business [Line Items]
Sale of stock, consideration received on transaction			$ 200,000,000
Series B Preferred Stock | Series B Private Placement
Description of Business [Line Items]
Sale of stock, consideration received on transaction	$ 200,000,000

XML

REVENUE RECOGNITION - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Current period revenue recognized from beginning balance of contract liabilities	$ 101.5	$ 96.9
Accounts Receivable | Customer Concentration Risk | Partner A
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	22.00%		15.00%
Accounts Receivable | Customer Concentration Risk | Partner B
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	15.00%		15.00%
Contract assets | Customer Concentration Risk | Partner A
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	22.00%		15.00%
Contract assets | Customer Concentration Risk | Partner B
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	15.00%		15.00%
Minimum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	1 year
Maximum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	3 years

XML

REVENUE RECOGNITION - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 216,566	$ 217,906
Bundled SaaS revenue
Disaggregation of Revenue [Line Items]
Revenue	59,453	49,285
Unbundled SaaS revenue
Disaggregation of Revenue [Line Items]
Revenue	57,695	45,445
Optional managed services revenue
Disaggregation of Revenue [Line Items]
Revenue	12,865	15,913
Total cloud revenue
Disaggregation of Revenue [Line Items]
Revenue	130,013	110,643
Support revenue
Disaggregation of Revenue [Line Items]
Revenue	36,426	48,724
Total recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	166,439	159,367
Perpetual revenue
Disaggregation of Revenue [Line Items]
Revenue	24,334	33,258
Professional services revenue
Disaggregation of Revenue [Line Items]
Revenue	25,793	25,281
Total nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	$ 50,127	$ 58,539

XML

REVENUE RECOGNITION - Contract Balances (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 157,786	$ 188,414
Contract assets, net	58,862	60,444
Long-term contract assets, net (included in other assets)	35,845	37,950
Contract liabilities	254,418	271,476
Long-term contract liabilities	$ 15,914	$ 18,047

XML

REVENUE RECOGNITION - Remaining Performance Obligations (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 691,903	$ 727,041
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period (up to)		1 year
Remaining performance obligations		$ 464,346
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period (up to)	1 year
Remaining performance obligations	$ 435,708
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period (up to)	3 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period (up to)
Remaining performance obligations		$ 262,695
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period (up to)
Remaining performance obligations	$ 256,195

XML

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Net Income Attributable to Verint Systems Inc. [Abstract]
Net income	$ 3,634	$ 574
Net income attributable to noncontrolling interests	339	288
Net income attributable to Verint Systems Inc.	3,295	286
Dividends on preferred stock	(5,200)	(5,200)
Net loss attributable to Verint Systems Inc. for basic net loss per common share	(1,905)	(4,914)
Dilutive effect of dividends on preferred stock	0	0
Net loss attributable to Verint Systems Inc. for diluted net loss per common share	$ (1,905)	$ (4,914)
Weighted-average shares outstanding:
Basic (in shares)	64,940	64,947
Dilutive effect of employee equity award plans (in shares)	0	0
Dilutive effect of assumed conversion of preferred stock (in shares)	0	0
Diluted (in shares)	64,940	64,947
Net loss per common share attributable to Verint Systems Inc.:
Basic (in dollars per share)	$ (0.03)	$ (0.08)
Diluted (in dollars per share)	$ (0.03)	$ (0.08)
2021 Notes
Weighted-average shares outstanding:
Dilutive effect of 2021 Notes (in shares)	0	0

XML

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Schedule of Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Stock options and restricted stock-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities excluded from calculations of diluted net loss per share (in shares)	2,080	1,571
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities excluded from calculations of diluted net loss per share (in shares)	5,498	5,498
Series B Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities excluded from calculations of diluted net loss per share (in shares)	3,980	3,980

XML

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Additional Information (Details) - 2021 Notes	Apr. 06, 2021 $ / shares
Class of Stock [Line Items]
Conversion price (in dollars per share)	$ 62.08
Capped calls, initial cap price (in dollars per share)	$ 100.00

XML

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Schedule of Available-for-sale Securities
Cash and cash equivalents, cost basis	$ 260,719	$ 285,046	$ 282,099
Cash and cash equivalents, fair value	260,719		282,099
Cost Basis	3,646		697
Gross Unrealized Gains	0		0
Gross Unrealized Losses	0		0
Estimated Fair Value	3,646		697
Proceeds from maturities and sales of short-term investments	200	$ 300
Bank time deposits
Schedule of Available-for-sale Securities
Cost Basis	3,646		697
Gross Unrealized Gains	0		0
Gross Unrealized Losses	0		0
Estimated Fair Value	3,646		697
Cash and bank time deposits
Schedule of Available-for-sale Securities
Cash and cash equivalents, cost basis	148,871		134,289
Cash and cash equivalents, fair value	148,871		134,289
Money market funds
Schedule of Available-for-sale Securities
Cash and cash equivalents, cost basis	80,624		96,941
Cash and cash equivalents, fair value	80,624		96,941
Commercial paper
Schedule of Available-for-sale Securities
Cash and cash equivalents, cost basis	30,975		50,869
Cash and cash equivalents, fair value	30,975		$ 50,869
U.S. Treasury bills
Schedule of Available-for-sale Securities
Cash and cash equivalents, cost basis	249
Cash and cash equivalents, fair value	$ 249

XML

BUSINESS COMBINATIONS AND DIVESTITURES - Business Combinations For Year Ended January 31, 2023 (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2023 USD ($) professional	Jan. 31, 2023 USD ($) employee business_combination	Aug. 31, 2022 employee
Business Acquisition [Line Items]
Number of businesses acquired | business_combination		2
Entity number of employees | professional	4,200
Goodwill	$ 1,354,761	$ 1,347,213
August 2022 Acquisition
Business Acquisition [Line Items]
Entity number of employees | employee			6
January 2023 Acquisition
Business Acquisition [Line Items]
Entity number of employees | employee		20
Business Combinations During Year Ended January 31, 2023
Business Acquisition [Line Items]
Total consideration for business combinations		$ 38,400
Cash paid at the closings of business combinations		26,100
Contingent consideration obligations, fair value		12,200
Purchase price adjustments of business combinations		100
Cash acquired from acquisition		4,200
Contingent consideration maximum payout amount		21,400
Goodwill		25,600
Business acquisition, goodwill deductible for income tax purposes		5,100
Business acquisition, goodwill not deductible for income tax purposes		20,500
Business acquisition related costs	$ 200
Business Combinations During Year Ended January 31, 2023 | Developed Technology
Business Acquisition [Line Items]
Identifiable intangible assets		6,000
Business Combinations During Year Ended January 31, 2023 | Customer relationships
Business Acquisition [Line Items]
Identifiable intangible assets		4,200
Business Combinations During Year Ended January 31, 2023 | Trade names
Business Acquisition [Line Items]
Identifiable intangible assets		$ 100

XML

BUSINESS COMBINATIONS AND DIVESTITURES - Other Business Combination Information (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Business Acquisition [Line Items]
Changes in fair values of contingent consideration obligations associated with business combinations	$ 200,000	$ (200,000)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling, general and administrative	Selling, general and administrative
Payments of contingent consideration earned	$ 300,000	$ 2,700,000
Level 3 | Recurring
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	12,884,000	$ 0	$ 12,717,000
Level 3 | Recurring | Accrued expenses and other current liabilities
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	7,100,000
Level 3 | Recurring | Other Noncurrent Liabilities
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	$ 5,800,000

XML

BUSINESS COMBINATIONS AND DIVESTITURES - Divestiture (Details) - Disposed of by Sale - Product Line Inherited As Part Of Legacy Acquisition $ in Millions	1 Months Ended
	Mar. 31, 2023 USD ($) installment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration from divestiture	$ 0.7
Consideration from divestiture, number of installments | installment	3
Goodwill disposed	$ 0.3
Intangible assets disposed	0.2
Gain on sale of transaction	$ 0.2

XML

INTANGIBLE ASSETS AND GOODWILL - Schedule of Acquisition-Related Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	$ 692,780	$ 694,249
Accumulated Amortization	(615,323)	(608,977)
Net	77,457	85,272
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	458,478	458,013
Accumulated Amortization	(396,652)	(390,113)
Net	61,826	67,900
Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	227,375	229,317
Accumulated Amortization	(211,851)	(212,065)
Net	15,524	17,252
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	4,487	4,479
Accumulated Amortization	(4,380)	(4,359)
Net	107	120
Distribution network
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	2,440	2,440
Accumulated Amortization	(2,440)	(2,440)
Net	$ 0	$ 0

XML

INTANGIBLE ASSETS AND GOODWILL - Additional Information (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 8,300,000	$ 10,500,000
Impairment of intangible assets, finite-lived	$ 0	$ 0

XML

INTANGIBLE ASSETS AND GOODWILL - Schedule of Estimated Future Amortization Expense on Finite-lived Acquisition-related Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remainder of year)	$ 24,068
2025	16,730
2026	15,346
2027	11,572
2028	6,905
2029 and thereafter	2,836
Net	$ 77,457	$ 85,272

XML

INTANGIBLE ASSETS AND GOODWILL - Goodwill Activity (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Goodwill [Roll Forward]
Goodwill, gross at the beginning of the period	$ 1,410,804	$ 1,403,256
Accumulated impairment losses	(56,043)	$ (56,043)
Goodwill, net at the beginning of the period	1,347,213
Foreign currency translation and other	7,408
Business combinations, including adjustments to prior period acquisitions	140
Goodwill, net, at the end of the period	$ 1,354,761

XML

LONG-TERM DEBT - Schedule of Long-Term Debt (Details) - USD ($)	Apr. 30, 2023	Jan. 31, 2023	Apr. 30, 2021
Debt Instrument [Line Items]
Less: unamortized debt discounts and issuance costs	$ (5,328,000)	$ (6,092,000)
Total debt	409,672,000	408,908,000
Less: current maturities	0	0
Long-term debt	409,672,000	408,908,000
2021 Notes
Debt Instrument [Line Items]
Long-term debt outstanding	315,000,000	315,000,000
Term Loan
Debt Instrument [Line Items]
Long-term debt outstanding	0	100,000,000	$ 100,000,000
Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt outstanding	$ 100,000,000	$ 0

XML

LONG-TERM DEBT - 2021 Notes (Details)			3 Months Ended
	Apr. 09, 2021 USD ($)	Apr. 06, 2021 USD ($) $ / shares	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)
Debt Instrument [Line Items]
Payments of debt-related costs			$ 9,000	$ 93,000
Series B Preferred Stock | Series B Private Placement
Debt Instrument [Line Items]
Sale of stock, consideration received on transaction		$ 200,000,000
2021 Notes
Debt Instrument [Line Items]
Debt principal amount	$ 315,000,000
Coupon interest rate	0.25%
Convertible debt, conversion ratio	0.0161092
Convertible debt, conversion price (in dollars per share) | $ / shares		$ 62.08
Payments of debt-related costs	$ 8,900,000
Effective interest rate (as a percent)			0.83%

XML

LONG-TERM DEBT - Capped Calls (Details) $ / shares in Units, $ in Millions	Apr. 06, 2021 USD ($) $ / shares
Debt Instrument [Line Items]
Purchases of capped calls, net of taxes | $	$ 41.1
2021 Notes
Debt Instrument [Line Items]
Capped calls, initial conversion price (in dollars per share)	$ 62.08
Capped calls, initial cap price (in dollars per share)	$ 100.00

XML

LONG-TERM DEBT - Credit Agreement (Details)			3 Months Ended
	May 10, 2023	Apr. 27, 2023 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)	Apr. 30, 2021 USD ($)	Jan. 31, 2023 USD ($)	Jun. 29, 2017 USD ($)
Debt Instrument [Line Items]
Accrued interest paid			$ 2,513,000	$ 930,000
Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity							$ 725,000,000
Term Loan
Debt Instrument [Line Items]
Debt face amount							425,000,000
Required quarterly principal payment					$ 1,100,000
Repayments of debt		$ 100,000,000			309,000,000
Long-term debt outstanding			0		$ 100,000,000	$ 100,000,000
Deferred debt issuance costs			200,000
Unamortized debt discount			200,000
Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity							$ 300,000,000
Long-term debt outstanding			$ 100,000,000			$ 0
Accrued interest paid		$ 500,000
Interest rate at end of period (as a percent)			6.52%
Consolidated total debt to consolidated EBITDA ratio			4.50
Fourth Amendment To Credit Agreement | Base Rate | Minimum | Subsequent Event
Debt Instrument [Line Items]
Interest rate margin (as a percent)	0.25%
Fourth Amendment To Credit Agreement | Base Rate | Maximum | Subsequent Event
Debt Instrument [Line Items]
Interest rate margin (as a percent)	1.25%
Fourth Amendment To Credit Agreement | Adjusted Term SOFR | Minimum | Subsequent Event
Debt Instrument [Line Items]
Interest rate margin (as a percent)	1.25%
Fourth Amendment To Credit Agreement | Adjusted Term SOFR | Maximum | Subsequent Event
Debt Instrument [Line Items]
Interest rate margin (as a percent)	2.25%

XML

LONG-TERM DEBT - Components of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 09, 2021
Debt Instrument [Line Items]
Losses on early retirements of debt	$ 237	$ 0
2021 Notes
Debt Instrument [Line Items]
Interest expense at coupon or contractual rate	197	195
Amortization of deferred debt issuance costs	443	439
Total interest expense	640	634
Coupon interest rate			0.25%
Credit Agreement
Debt Instrument [Line Items]
Interest expense at coupon or contractual rate	1,650	560
Amortization of debt discounts	5	5
Amortization of deferred debt issuance costs	204	211
Losses on early retirements of debt	237	0
Total interest expense	$ 2,096	$ 776

XML

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Inventories (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Condensed Financial Information Disclosure [Abstract]
Raw materials	$ 3,505	$ 3,325
Work-in-process	40	40
Finished goods	10,008	9,263
Total inventories	$ 13,553	$ 12,628

XML

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Other Income, net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Condensed Financial Information Disclosure [Abstract]
Foreign currency gains, net	$ 237	$ 1,713
Other, net	(213)	(39)
Total other income, net	$ 24	$ 1,674

XML

SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Supplemental Information Regarding Condensed Consolidated Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Condensed Financial Information Disclosure [Abstract]
Cash paid for interest	$ 2,513	$ 930
Cash payments of income taxes, net	3,758	2,238
Cash payments for operating leases	1,640	12,195
Non-cash investing and financing transactions:
Finance leases of property and equipment	212	12
Accrued but unpaid purchases of property and equipment	360	988
Accrued but unpaid purchases of treasury stock	0	453
Excise tax on share repurchases	$ 417	$ 0

XML

CONVERTIBLE PREFERRED STOCK - Additional Information (Details) - USD ($)	Apr. 06, 2021	May 07, 2020	Dec. 04, 2019	Apr. 30, 2023	Jan. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Accrued dividends on preferred stock				$ 0	$ 10,400,000
Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction			$ 400,000,000
Series A Preferred Stock | Series A Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200,000,000
Sale of stock, number of shares issued (in shares)		200,000
Sale of stock, price per share (in dollars per share)		$ 1,000
Sale of stock, direct and indirect costs		$ 2,700,000
Series B Preferred Stock | Series B Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200,000,000
Sale of stock, number of shares issued (in shares)	200,000
Sale of stock, price per share (in dollars per share)	$ 1,000
Sale of stock, direct and indirect costs	$ 1,300,000

XML

CONVERTIBLE PREFERRED STOCK - Voting Rights (Details)	Dec. 04, 2019
Equity [Abstract]
Holders of preferred stock voting rights, as percentage of voting power of common stock outstanding	19.90%

XML

CONVERTIBLE PREFERRED STOCK - Dividends and Liquidation Rights (Details) - USD ($)		3 Months Ended
	May 07, 2020	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023	Dec. 04, 2019
Subsidiary, Sale of Stock [Line Items]
Holders of preferred stock voting rights, as percentage of voting power of common stock outstanding					19.90%
Preferred stock dividend payments		$ 10,400,000	$ 10,400,000
Preferred stock dividends, unpaid and undeclared		6,900,000
Accrued dividends on preferred stock		0		$ 10,400,000
Dividends on preferred stock		$ 5,200,000	$ 5,200,000
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, liquidation preference (in dollars per share)	$ 1,000
Preferred Stock | Minimum
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate, increase percentage each year	1.00%
Preferred Stock | Maximum
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate, increase percentage each year	10.00%
Preferred Stock | Dividend for the first 48-month anniversary of closing date
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	5.20%
Preferred Stock | Dividend after the first 48-month anniversary of closing date
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	4.00%
Preferred Stock | Dividend increase term in the event
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	6.00%

XML

CONVERTIBLE PREFERRED STOCK - Conversion (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	Apr. 06, 2021	May 07, 2020	Apr. 30, 2023	Feb. 01, 2021
Subsidiary, Sale of Stock [Line Items]
Shares issuable upon conversion (in shares)			9.6
Common stock, trading days		30 days
Convertible preferred stock, threshold percentage of conversion trigger		175.00%
Preferred stock, redemption price in percentage		100.00%
Internal rate of return		8.00%
Preferred stock dividends, unpaid and undeclared			$ 6.9
Apax
Subsidiary, Sale of Stock [Line Items]
Percentage ownership of outstanding shares			13.00%
Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Conversion price (in dollars per share)		$ 53.50		$ 36.38
Conversion premium		17.10%
Common stock, consecutive trading days		45 days
Preferred stock, liquidation preference			$ 200.0
Preferred stock dividends, unpaid and undeclared			3.5
Series B Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Conversion price (in dollars per share)	$ 50.25
Conversion price, trading days	20 days
Preferred stock, liquidation preference			200.0
Preferred stock dividends, unpaid and undeclared			$ 3.5
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, redemption price in percentage		100.00%

XML

CONVERTIBLE PREFERRED STOCK - Future Tranche Right (Details) - USD ($) $ in Thousands	Apr. 06, 2021	Apr. 30, 2023	Jan. 31, 2023	May 07, 2020
Subsidiary, Sale of Stock [Line Items]
Future tranche right, fair value				$ 3,400
Temporary equity		$ 436,321	$ 436,321
Series B Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Temporary equity	$ 237,000	235,693	235,693
Future tranche right	$ 37,000
Series B Preferred Stock | Series B Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	200,000
Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Temporary equity		$ 200,628	$ 200,628	$ 203,400

XML

STOCKHOLDERS' EQUITY - Common Stock Dividends (Details) - USD ($)		3 Months Ended
	Feb. 01, 2021	Apr. 30, 2023	Apr. 30, 2022
Equity [Abstract]
Dividends on common stock		$ 0	$ 0
Spin-off transaction, number of shares received (in shares)	1

XML

STOCKHOLDERS' EQUITY - Treasury Stock (Details) - shares	Apr. 30, 2023	Jan. 31, 2023
Stockholders' Equity Note [Abstract]
Treasury stock outstanding (in shares)	0	0

XML

STOCKHOLDERS' EQUITY - Stock Repurchase Programs (Details) - USD ($) shares in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Jun. 01, 2023	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023	Dec. 07, 2022
Class of Stock [Line Items]
Excise tax on share repurchases		$ 417,000	$ 0
December 2022 Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount					$ 200,000,000
Stock repurchased during period (in shares)		1,593		649
Stock repurchased during period, value		$ 60,100,000		$ 23,500,000
Shares retired (in shares)		1,593
Excise tax on share repurchases		$ 400,000
December 2022 Repurchase Program | Subsequent Event
Class of Stock [Line Items]
Stock repurchased during period (in shares)	159
Stock repurchased during period, value	$ 5,500,000
Prior Stock Repurchase Program
Class of Stock [Line Items]
Stock repurchased during period (in shares)			2,000
Stock repurchased during period, value			$ 105,700,000

XML

STOCKHOLDERS' EQUITY - Issuance of Convertible Preferred Stock (Details) - USD ($)	Apr. 06, 2021	May 07, 2020	Dec. 04, 2019	Apr. 30, 2023
Apax
Class of Stock [Line Items]
Percentage ownership of outstanding shares				13.00%
Convertible Preferred Stock
Class of Stock [Line Items]
Sale of stock, consideration received on transaction			$ 400,000,000
Series A Preferred Stock | Series A Private Placement
Class of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200,000,000
Series B Preferred Stock | Series B Private Placement
Class of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200,000,000

XML

STOCKHOLDERS' EQUITY - Summary of Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Activity in Accumulated Other Comprehensive Loss
Beginning balances	$ 858,149	$ 954,579
Other comprehensive (loss) income before reclassifications	8,322
Amounts reclassified out of accumulated other comprehensive loss	(188)
Other comprehensive income (loss)	8,510	(30,045)
Ending balances	823,388	835,453
Unrealized Losses on Foreign Exchange Contracts Designated as Hedges
Activity in Accumulated Other Comprehensive Loss
Beginning balances	(87)
Other comprehensive (loss) income before reclassifications	(290)
Amounts reclassified out of accumulated other comprehensive loss	(188)
Other comprehensive income (loss)	(102)
Ending balances	(189)
Foreign Currency Translation Adjustments
Activity in Accumulated Other Comprehensive Loss
Beginning balances	(154,012)
Other comprehensive (loss) income before reclassifications	8,612
Amounts reclassified out of accumulated other comprehensive loss	0
Other comprehensive income (loss)	8,612
Ending balances	(145,400)
AOCI Attributable to Parent
Activity in Accumulated Other Comprehensive Loss
Beginning balances	(154,099)	(118,515)
Other comprehensive income (loss)	8,510	(30,045)
Ending balances	$ (145,589)	$ (148,560)

XML

STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Research and development, net	$ (31,782)	$ (30,947)
Selling, general and administrative	(101,279)	(102,882)
Total, before income taxes	7,997	870
Benefit from income taxes	(4,363)	(296)
Net income	3,634	574
Recurring
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Cost of revenue	(39,643)	(41,028)
Nonrecurring
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Cost of revenue	(26,795)	(32,068)
Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Research and development, net	(140)	(49)
Selling, general and administrative	(65)	(24)
Total, before income taxes	(227)	(82)
Benefit from income taxes	39	14
Net income	(188)	(68)
Foreign currency forward contracts | Recurring | Reclassification out of Accumulated Other Comprehensive Income
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Cost of revenue	(2)	0
Foreign currency forward contracts | Nonrecurring | Reclassification out of Accumulated Other Comprehensive Income
Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Cost of revenue	$ (20)	$ (9)

XML

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Income Tax Disclosure [Abstract]
(Benefit from) provision for income taxes	$ 4,363	$ 296
Income (loss) before provision of income taxes	$ 7,997	$ 870
Effective income tax rate (as a percent)	54.60%	34.00%
Unrecognized tax benefits (excluding interest and penalties)	$ 87,700		$ 87,900
Unrecognized tax benefits, income tax penalties and interest accrued	5,300		$ 5,200
Decrease in unrecognized tax benefits is reasonably possible	$ 7,000

XML

FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Recurring - USD ($)	Apr. 30, 2023	Jan. 31, 2023	Apr. 30, 2022
Level 1
Assets:
Money market funds	$ 80,624,000	$ 96,941,000
U.S. Treasury bills, classified as cash and cash equivalents	249,000
Commercial paper, classified as cash and cash equivalents	0	0
Foreign currency forward contracts	0	0
Contingent consideration receivable		0
Total assets	80,873,000	96,941,000
Liabilities:
Foreign currency forward contracts	0	0
Contingent consideration — business combinations	0	0
Total liabilities	0	0
Level 2
Assets:
Money market funds	0	0
U.S. Treasury bills, classified as cash and cash equivalents	0
Commercial paper, classified as cash and cash equivalents	30,975,000	50,869,000
Foreign currency forward contracts	5,000	19,000
Contingent consideration receivable		8,000
Total assets	30,980,000	50,896,000
Liabilities:
Foreign currency forward contracts	235,000	124,000
Contingent consideration — business combinations	0	0
Total liabilities	235,000	124,000
Level 3
Assets:
Money market funds	0	0
U.S. Treasury bills, classified as cash and cash equivalents	0
Commercial paper, classified as cash and cash equivalents	0	0
Foreign currency forward contracts	0	0
Contingent consideration receivable		0
Total assets	0	0
Liabilities:
Foreign currency forward contracts	0	0
Contingent consideration — business combinations	12,884,000	12,717,000	$ 0
Total liabilities	$ 12,884,000	$ 12,717,000

XML

FAIR VALUE MEASUREMENTS - Additional Information (Details)		3 Months Ended
	Apr. 27, 2023 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)	Apr. 30, 2021 USD ($)	Jan. 31, 2023 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions
SAFE, investment during period		$ 1,100,000
Noncontrollling equity investment in privately-held companies without readily determinable fair values		5,100,000			$ 5,100,000
Noncontrollling equity investment in privately-held companies, impairments		$ 0	$ 0
Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Repayments of debt	$ 100,000,000			$ 309,000,000
Discount Rate | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Contingent consideration, liability, measurement input		0.066			0.066
Discount Rate | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Contingent consideration, liability, measurement input		0.077			0.076
Discount Rate | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Contingent consideration, liability, measurement input		0.072			0.069
Level 3 | Revolving Credit Facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Fair value of debt		$ 99,000,000			$ 0
Level 3 | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Fair value of debt					100,000,000
Level 3 | Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Contingent consideration — business combinations		12,884,000	$ 0		12,717,000
Level 2 | 2021 Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Fair value of debt		279,000,000			282,000,000
Level 2 | Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Contingent consideration — business combinations		$ 0			$ 0

XML

FAIR VALUE MEASUREMENTS - Schedule of Changes in the Estimated Fair Value of Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in fair values, recorded in operating expenses	$ 200	$ (200)
Contingent consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value measurement at beginning of period	12,717
Contingent consideration liabilities recorded for business combinations	0
Changes in fair values, recorded in operating expenses	220
Payments of contingent consideration	(250)
Foreign currency translation and other	197
Fair value measurement at end of period	$ 12,884

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Details) - Unrealized Losses on Foreign Exchange Contracts Designated as Hedges - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
DERIVATIVE FINANCIAL INSTRUMENTS
Derivative, term (no longer than)	12 months
Notional amounts of derivative financial instruments	$ 6.6	$ 6.8
Maximum maturity of foreign currency derivatives	12 months

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Fair Values of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Fair Values of Derivative Financial Instruments
Assets, fair value	$ 5	$ 19
Liabilities, fair value	235	124
Prepaid expenses and other current assets | Foreign currency forward contracts | Designated as cash flow hedges
Fair Values of Derivative Financial Instruments
Assets, fair value	5	19
Accrued expenses and other current liabilities | Foreign currency forward contracts | Designated as cash flow hedges
Fair Values of Derivative Financial Instruments
Liabilities, fair value	$ 235	$ 124

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of the Effects of Derivative Financial Instruments Designated as Cash Flow Hedging Instruments (Details) - Foreign currency forward contracts - Cash flow hedging - Designated as cash flow hedges - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
DERIVATIVE FINANCIAL INSTRUMENTS
Net (losses) recognized in accumulated other comprehensive (loss) income	$ (350)	$ (270)
Net (losses) reclassified from accumulated other comprehensive (loss) income to the consolidated statements of operations	$ (227)	$ (82)

XML

STOCK-BASED COMPENSATION - Stock-Based Compensation Plan (Details) - 2019 Long-Term Stock Incentive Plan	Apr. 30, 2023 shares	Mar. 31, 2021 shares	Feb. 01, 2021
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	9,475,000	14,239,656
Reduction of available plan capacity for each stock option or stock-settled stock appreciation right (in shares)	1
Reduction of available plan capacity for each other award (in shares)	2.38
Unvested awards conversion factor			1.45

XML

STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Stock-Based Compensation Plans
Stock-based compensation	$ 14,979	$ 18,369
Cost of revenue — recurring
Stock-Based Compensation Plans
Stock-based compensation	296	525
Cost of revenue — nonrecurring
Stock-Based Compensation Plans
Stock-based compensation	140	640
Research and development, net
Stock-Based Compensation Plans
Stock-based compensation	2,327	2,419
Selling, general and administrative
Stock-Based Compensation Plans
Stock-based compensation	$ 12,216	$ 14,785

XML

STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense by Type of Award (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Stock-Based Compensation Plans
Stock-based compensation	$ 14,979	$ 18,369
Equity Settled Awards
Stock-Based Compensation Plans
Stock-based compensation	14,814	18,364
Equity Settled Awards | Restricted stock units and restricted stock awards
Stock-Based Compensation Plans
Stock-based compensation	13,436	16,011
Equity Settled Awards | Stock bonus program and bonus share program
Stock-Based Compensation Plans
Stock-based compensation	1,378	2,353
Cash Settled Awards | Phantom stock units (cash-settled awards)
Stock-Based Compensation Plans
Stock-based compensation	$ 165	$ 5

XML

STOCK-BASED COMPENSATION - Restricted Stock Units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Summary of award activity
Beginning balance (in shares)	2,230	2,454
Granted (in shares)	1,665	1,557
Released (in shares)	(475)	(465)
Forfeited (in shares)	(32)	(47)
Ending balance (in shares)	3,388	3,499
Weighted-Average Grant-Date Fair Value
Beginning balance (in dollars per share)	$ 52.42	$ 42.99
Granted (in dollars per share)	37.36	56.42
Released (in dollars per share)	50.22	42.20
Forfeited (in dollars per share)	50.63	43.13
Ending balance (in dollars per share)	$ 45.34	$ 49.07
Restricted Stock Units (RSUs)
Summary of award activity
Granted (in shares)	1,388
Additional disclosures
Unrecognized compensation expense	$ 119.7
Remaining weighted-average vesting period over which expense is expected to be recognized (in years)	2 years 2 months 12 days

XML

STOCK-BASED COMPENSATION - Schedule of PSU Activity (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Summary of award activity
Beginning balance (in shares)	2,230	2,454
Granted (in shares)	1,665	1,557
Released (in shares)	(475)	(465)
Forfeited (in shares)	(32)	(47)
Ending balance (in shares)	3,388	3,499
Performance- based RSUs
Summary of award activity
Beginning balance (in shares)	532	547
Granted (in shares)	277	278
Released (in shares)	(230)	(89)
Forfeited (in shares)	(10)	0
Ending balance (in shares)	569	736

XML

STOCK-BASED COMPENSATION - Stock Bonus Program and Bonus Share Program (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Stock-Based Compensation Plans
Shares issued (in shares)		1,665,000	1,557,000
Stock Bonus Program
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, award vesting period		1 year
Share-based compensation arrangement by share-based payment award, determination of shares issuable trailing period of average price of common stock		5 days
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	200,000			200,000
Discount from market price (as a percent)	15.00%			15.00%
Shares expected to issue (in shares)		27,000
Combined Stock Bonus Program and Bonus Share Program
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	300,000			300,000
Accrued bonuses		$ 9.2		$ 7.9
Bonus Share Program
Stock-Based Compensation Plans
Shares expected to issue (in shares)		178,000

XML

COMMITMENTS AND CONTINGENCIES (Details)				1 Months Ended		3 Months Ended	12 Months Ended
	Jul. 10, 2022 USD ($) phase	Oct. 31, 2012 USD ($)	Jun. 07, 2012 defendant	Apr. 30, 2023 USD ($) installment	Mar. 31, 2023 USD ($)	Apr. 30, 2023 USD ($) installment Claim	Jan. 31, 2023 USD ($)	Jun. 30, 2019 round	Feb. 14, 2022 Claim
Loss Contingencies [Line Items]
Loss contingency, claims settled and dismissed | Claim						2
Estimated insurance recoveries							$ 14,500,000
Insurance recoveries collected				$ 12,500,000			2,000,000
CTI Litigation
Loss Contingencies [Line Items]
Litigation settlement, rounds of mediation, number | round								2
CTI Litigation | Settled Litigation
Loss Contingencies [Line Items]
Number of defendants | defendant			3
Loss contingency, damages sought, value		$ 150,000,000
Litigation settlement, amount agreed to pay	$ 16,000,000
Litigation settlement, number of payment phases | phase	3
Litigation settlement, number of payment installments remaining | installment				2		2
Litigation liability				$ 9,500,000		$ 9,500,000
Litigation settlement indemnification receivable				9,500,000		9,500,000
Litigation settlement, income statement impact						0
CTI Litigation | Settled Litigation | Accrued expenses and other current liabilities
Loss Contingencies [Line Items]
Litigation liability				4,700,000		4,700,000
CTI Litigation | Settled Litigation | Other Liabilities
Loss Contingencies [Line Items]
Litigation liability				4,700,000		4,700,000
DOJ False Claims Act Litigation | Settled Litigation
Loss Contingencies [Line Items]
Estimated litigation liability, current				7,000,000		7,000,000
DOJ False Claims Act Litigation | Pending Litigation
Loss Contingencies [Line Items]
Litigation settlement, income statement impact							0
Litigation settlement, proposed amount					$ 7,000,000
Estimated litigation liability, current							7,000,000
ACSI And CFI Complaints | Settled Litigation
Loss Contingencies [Line Items]
Litigation settlement, amount agreed to pay				9,000,000
Estimated litigation liability, incremental settlement costs				$ 5,500,000		$ 5,500,000
ACSI And CFI Complaints | Pending Litigation
Loss Contingencies [Line Items]
Litigation settlement, income statement impact							0
Loss contingency, pending claims, number | Claim									2
Estimated litigation liability, current							$ 3,500,000